Pharmaceutical composition for treating cancer comprising microrna as active ingredient

ABSTRACT

The present invention relates to a pharmaceutical composition for treatment of cancer, which comprises, as an active ingredient, one or more miRNAs selected from the group consisting of miR-3670, miR-8078, and miR-4477a. The pharmaceutical composition for treatment of cancer according to the present invention exhibits excellent effects of inhibiting cancer cell proliferation and inducing cancer cell apoptosis. Thus, the pharmaceutical composition of the present invention can be effectively used as an anticancer therapeutic agent.

TECHNICAL FIELD

The present invention relates to an anticancer pharmaceutical composition comprising double-stranded miRNA as an active ingredient. More specifically, the present invention relates to an anticancer pharmaceutical composition comprising, as pharmaceutically active ingredient, miR-3670, miR-8078, or miR-4477a which is capable of effectively inhibiting cancer cell proliferation or inducing cancer cell apoptosis, together with a pharmaceutically acceptable carrier.

BACKGROUND ART

As effective and traditional methods for treating diseases caused by uncontrolled gene control, particularly diseases referred to as cancers, methods of removing tumors by surgical excision have been used. However, where primary cancer is metastasized to other organs, surgical excision is impossible and anticancer chemotherapies have been used. As anticancer agents for chemotherapy, monomolecular compounds synthesized by organic or inorganic methods have been mainly used. Such anticancer drugs have been developed and used against cancer diseases in order mainly to effectively target proteins that disturb signaling pathways by overexpression of phosphorylation proteins included in signaling pathways, thereby inhibiting the activity of the proteins. Such traditional chemotherapies may cause many side effects, because anticancer drugs used are artificially synthesized foreign substances and target already overexpressed proteins.

The development of therapeutic drugs to replace the traditional chemotherapies has been attempted in various ways. One of such attempts is the use of small interfering RNA (hereinafter referred to as siRNA) (Iorns, E., Lord, C. J., Turner, N. & Ashworth, A. Utilizing RNA interference to enhance cancer drug discovery. Nat Rev Drug Discov 6, 556-68. 2007). siRNA is a single-stranded RNA consisting of 16 to 27 nucleotides and serves as one component of a ribonucleoprotein complex known as an RNA Induced Silencing Complex (RISC) in cells (Tomari, Y. & Zamore, P. D. Perspective: machines for RNAi. Genes Dev 19, 517-29, 2005, Chu, C. Y. & Rana, T. M. Potent RNAi by short RNA triggers. Rna 14, 1714-9, 2008, Mittal, V. Improving the efficiency of RNA interference in mammals. Nat Rev Genet 5, 355-65, 2004, Reynolds, A. et al. Rational siRNA design for RNA interference. Nat Biotechnol 22, 326-30. 2004). The RISC functions as RNA scissors to cleave messenger RNA (hereinafter referred to as mRNA) to thereby inhibit the production of protein from mRNA. siRNA contained in the RISC may bind to mRNA having a sequence complementary to the siRNA sequence to form double-stranded RNA, and the RISC may act as RNA scissors to cleave target mRNA so that the mRNA can no longer function as a template that repeatedly produces protein.

The siRNA-based anticancer drugs as described above are considered advanced over the monomolecular anticancer drugs in that they cleave mRNA before protein production and use RNA and the intracellular RISC pathway. However, there is a side effect that cannot be solved even by the siRNA-based technology (Jackson, A. L. et al. Widespread siRNA “off-target” transcript silencing mediated by seed region sequence complementarity. Rna 12, 1179-87, 2006, Jackson, A. L. et al. Position-specific chemical modification of siRNAs reduces “off-target” transcript silencing. Rna 12, 1197-205, 2006, Jackson, A. L. et al. Expression profiling reveals off-target gene regulation by RNAi. Nat Biotechnol 21, 635-7, 2003, Nielsen, C. B. et al. Determinants of targeting by endogenous and exogenous microRNAs and siRNAs. Rna 13, 1894-910, 2007, Peek, A. S. & Behlke, M. A. Design of active small interfering RNAs. Curr Opin Mol Ther 9, 110-8, 2007.). This side effect is a phenomenon known as the off-target effect. As described above, siRNA acts to cleave mRNA having a sequence complementary to the siRNA sequence. However, siRNA may also bind to and cleave a non-target mRNA which is not complementary to the entire sequence of the siRNA, but is complementary to only a portion of the siRNA sequence. This phenomenon is known as the off-target effect.

To overcome the above-described technical disadvantage of siRNA-based anticancer agents, studies on the use of microRNA (hereinafter referred to as “miRNA”) as therapeutic agents are in progress (Agostini, M. & Knight, R. A. miR-34: from bench to bedside. Oncotarget 5, 872-81, 2014, van Rooij, E., Purcell, A. L. & Levin, A. A. Developing MicroRNA Therapeutics. Circulation Research 110, 496-507, 2012, Burnett, J. C. & Rossi, J. J. RNA-based therapeutics: current progress and future prospects. Chem Biol 19, 60-71, 2012, Dangwal, S. & Thum, T. microRNA therapeutics in cardiovascular disease models. Annu Rev Pharmacol Toxicol 54, 185-203, 2014.). miRNA is an RNA consisting of 16 to 27 nucleotides and is classified as protein non-coding RNA against a messenger RNA (mRNA) that is translated into protein (Carthew, R. W. & Sontheimer, E. J. Origins and Mechanisms of miRNAs and siRNAs. Cell 136, 642-55, 2009, MacFarlane, L.-A. & Murphy, P. R. MicroRNA: Biogenesis, Function and Role in Cancer. Current Genomics 11, 537-561, 2010, Bartel, D. P. MicroRNAs: target recognition and regulatory functions. Cell 136, 215-33, 2009.). miRNA is found in the genome of higher animal and plant cells, and is known to play a key role in regulating cell metabolisms and functions, including cell production, growth, differentiation and death. Until now, about 2000 kinds of miRNAs have been found in the human genome, and the functions of a considerable amount of the miRNAs are not yet known.

miRNA is transcribed from the genome into RNA by RNA polymerase known as Pol II, and the initial length of the miRNA is various without being specified (Carthew, R. W. & Sontheimer, E. J. Origins and Mechanisms of miRNAs and siRNAs. Cell 136, 642-55, 2009, Brodersen, P. & Voinnet, O. Revisiting the principles of microRNA target recognition and mode of action. Nat Rev Mol Cell Biol 10, 141-148, 2009). This is attributable to the positional variety of miRNA in the genome. This is because miRNA is produced in various ways, including the case in which miRNA located in an intron (mRNA non-coding region) is transcribed at the same time point as mRNA production and in the case in which miRNA located in the intergenic region of the genome is transcribed individually (Malone, C. D. & Hannon, G. J. Small RNAs as guardians of the genome. Cell 136, 656-68, 2009.). miRNA produced in the initial stage as described above is known as primary microRNA (miR). Primary miR is processed into precursor miR (precursor miRNA, or pre-miR) by, for example, RNase known as intranuclear Drosha (Bartel, D. P. MicroRNAs: target recognition and regulatory functions. Cell 136, 215-33, 2009). Pre-miR has an RNA hairpin structure and consists of about 70-80 nucleotides. Pre-miR in the cellular nucleus is transported from the nucleus to the cytosol by exportin protein or the like, and is further processed in the cytosol by another RNase known as Dicer to thereby produce double-stranded mature microRNA (hereinafter, miR described without a qualifier means mature miR) consisting of 16-27 nucleotides. One RNA strand of double-stranded miR is selected, activated by binding to the ribonucleoprotein complex RISC, and binds to target mRNA based on the sequence of miR.

Generally, mRNA can be largely divided into three regions based on whether or not these regions are involved in protein coding: a coding region containing protein coding translation information, and 5′-UTR (Un-Translated Region) and 3′-UTR which have no protein coding information. While siRNA that induces cleavage of target mRNA having a sequence complementary thereto acts regardless of the 5′-UTR, 3′-UTR and coding region of mRNA, miR binds mainly to the 3′-UTR (Carthew, R. W. & Sontheimer, E. J. Origins and Mechanisms of miRNAs and siRNAs. Cell 136, 642-55, 2009, Bartel, D. P. MicroRNAs: target recognition and regulatory functions. Cell 136, 215-33, 2009.).

In addition to the difference in the position of binding to mRNA, the characteristic difference between siRNA and miRNA is that siRNA binds mainly to mRNA having a sequence complementary to the entire sequence of siRNA, whereas miRNA recognizes target mRNA, mainly through a seed region sequence located 2-8 nucleotides from the 5′ end of the miRNA and having a limited length. Thus, even when the entire sequence of miRNA is not completely complementary to the sequence of a target sequence and contains a non-complementary sequence portion, the activity of the miRNA is not affected by the non-complementary sequence portion (Bartel, D. P. MicroRNAs: target recognition and regulatory functions. Cell 136, 215-33, 2009). Since the seed region is 6-8 nucleotides in length, there are various kinds of mRNAs whose 3′ UTR has a sequence complementary to the seed region, and for this region, several kinds of mRNAs can be simultaneously controlled using one kind of miRNA. This nature of miRNA enables the miRNA to function as an efficient regulator in the control of many cellular physiological aspects, including cell division, growth, differentiation and death. Furthermore, the function of miRNA as a regulator provides an advantage in achieving effective anticancer effects. This is because miRNA can inhibit expression of a number of oncogenes at the same time, whereas siRNA aims to inhibit expression of a single gene.

The 3′ UTR of many mRNAs contains a portion to which one or more miRNAs can bind. According to bioinformatics calculation, it is known that about 30% of all mRNAs is regulated by miRNA.

The fact that miRNA acts as a major regulator in signaling pathways can be seen from the fact that miRNA plays an important role in major diseases, including cancer (MacFarlane, L.-A. & Murphy, P. R. MicroRNA: Biogenesis, Function and Role in Cancer. Current Genomics 11, 537-561. 2010, Malone, C. D. & Hannon, G. J. Small RNAs as guardians of the genome. Cell 136, 656-68. 2009, Nicoloso, M. S., Spizzo, R., Shimizu, M., Rossi, S. & Calin, G. A. MicroRNAs—the micro steering wheel of tumour metastases. Nat Rev Cancer 9, 293-302. 2009, Landi, D., Gemignani, F. & Landi, S. Role of variations within microRNA-binding sites in cancer. Mutagenesis 27, 205-10. 2012.). In fact, several studies revealed that expression patterns of miRNAs in cancer cells greatly differ from expression patterns of miRNAs in normal cells. In addition, it is known that expression patterns of miRNAs greatly differ depending on primary organs in which cancer occurred. Specifically, various cancers, including lung cancer, liver cancer, skin cancer and blood cancer, show characteristic miRNA expression patterns according to the primary organs, indicating that miRNA plays an important role in cancer biology. In particular, it is known that the expression levels of miRNAs in cancer cells are generally lower than their expression levels in normal cells.

Based on the deep connection of miRNA in cancer, it has recently been attempted to use miRNAs as anticancer therapeutic agents. For example, miRNA, named “miR-34a”, is under clinical trials to verify its abilities to inhibit cancer cell proliferation and induce cancer cell apoptosis (Wiggins, J. F. et al. Development of a lung cancer therapeutic based on the tumor suppressor microRNA-34. Cancer Res 70, 5923-30. 2010, Bader, A. G. et al. miR-34 Regulated Genes and Pathways as Targets for Therapeutic Intervention. Google Patents, 2009, Hermeking, H. The miR-34 family in cancer and apoptosis. Cell Death Differ 17, 193-9. 2010, Chang, T. C. et al. Transactivation of miR-34a by p53 broadly influences gene expression and promotes apoptosis. Mol Cell 26, 745-52. 2007.).

Accordingly, the present inventors have made extensive efforts to identify miRNA having better abilities to inhibit cancer cell proliferation and induce cancer cell apoptosis than miR-34a which is under clinical trials. As a result, the present inventors have identified miR-3670, miR-8078 and miR-4477a, which have excellent anticancer efficacy, and have found that these miRNAs exhibit anticancer effects by effectively inhibiting expressions of a number of genes known as oncogenes, thereby competing the present invention.

DISCLOSURE OF INVENTION Technical Problem

It is an object of the present invention to identify miRNA having excellent abilities to inhibit cancer cell proliferation and induce cancer cell apoptosis, and to provide a pharmaceutical composition for the treatment of cancer, which comprises the miRNA as an active ingredient.

Technical Solution

To achieve the above object, the present invention provides a pharmaceutical composition for treating cancer, which comprises, as an active ingredient, one or more miRNAs selected from the group consisting of miR-3670, miR-8078 and miR-4477a.

BRIEF DESCRIPTION OF THE DRAWINGS

FIG. 1 shows the results of measuring the protein expression inhibitory abilities of miR-34a, miR-100 and miR-125b. In order to measure whether or not the miRNA used in construction of the screening library would have activity, miR-34a, miR-100 and miR-125b were typically selected from an entire screening library, and each of mRNA 3′UTRs known to be silenced by these miRNAs was inserted into the 3′UTR of luciferase expression vectors and the protein expression inhibitory abilities were measured.

FIG. 2 shows the results obtained by treating lung cancer NCI-H460 cells with a screening library consisting of about 1700 kinds of miRNAs, quantifying the growth of the cells using Resazurin reagent, and expressing the quantification results as relative growth values.

FIG. 3 shows the results obtained by selecting about 50 kinds of miRNAs showing excellent efficacy in the NCI-H460 cell line, and measuring the relative cancer cell growth inhibitory abilities of the selected miRNAs using WST-1 reagent.

FIG. 4 shows the results obtained by transfecting each of miR-34a, miR-3670, miR-8078 and miR-4477a into a lung cancer cell line, staining the cells with FITC-labeled Annexin V, and analyzing the stained cells by flow cytometery to determine the apoptotic effect of the miRNAs on the lung cancer cell line.

FIG. 5 shows the results obtained by transfecting each miRNA into a lung cancer cell line, culturing the cells on soft agar for 2 weeks, and measuring the effects of the miRNAs against the colony-forming ability of the lung cancer cell line.

FIG. 6 shows the results obtained by selecting target candidates using the miRNA target prediction software, and expressing the apoptotic abilities of siRNAs, which target the selected candidates, as Z-score.

FIG. 7 shows the results of qPCR performed to analyze the extent to which the expression of the genes shown in FIG. 6 would be inhibited by miRNA.

FIG. 8 shows the results obtained by cloning the 3′ UTR of the genes, shown in FIG. 6, into the 3′ UTR of luciferase, and measuring the extent to which the expression of the luciferase protein would be inhibited by miRNA.

BEST MODE FOR CARRYING OUT THE INVENTION

Unless defined otherwise, all technical and scientific terms used herein have the same meaning as commonly understood by one of ordinary skill in the art to which the invention pertains. Generally, the nomenclature used herein is those well known and commonly employed in the art.

In the present invention, it has been attempted to identify miRNA having better efficacy than miR-34a known to have anticancer effects and to evaluate the anticancer effects of the identified miRNA.

In the present invention, a screening library consisting of about 1700 miRNAs was synthesized (Table 1). NCI-H460 (lung cancer cell line) was treated with the screening library, and the abilities of the miRNAs to inhibit the growth of the cancer cells were measured. As a result, miR-3670, miR-8078 and miR-4477a, which exhibited better efficacy than miR-34a and have the following nucleotide sequences, were identified (Table 3). It was found that the identified miRNAs have excellent anticancer effects (FIGS. 4 to 8).

Therefore, the present invention is directed to a pharmaceutical composition for treating cancer, which comprises as an active ingredient, one or more miRNAs selected from the group consisting of miR-3670, miR-8078 and miR-4477a.

In the present invention, the miR-3670 may comprise, as an active ingredient, a double-stranded RNA having the nucleotide sequences of SEQ ID NO: 35 and SEQ ID NO: 36 or SEQ ID NO: 35 and SEQ ID NO: 67.

In the present invention, the miR-4477a may comprise, as an active ingredient, a double-stranded RNA having the nucleotide sequences of SEQ ID NO: 43 and SEQ ID NO: 44 or SEQ ID NO: 43 and SEQ ID NO: 68.

In the present invention, the miR-8078 may comprise, as an active ingredient, a double-stranded RNA having the nucleotide sequences of SEQ ID NO: 65 and SEQ ID NO: 66 or SEQ ID NO: 65 and SEQ ID NO: 69.

In other words, an miR-3670 template strand of the present invention may be represented by SEQ ID NO: 35.

(MIMAT0018093. SEQ ID NO: 35) 5′-AGAGCUCACAGCUGUCCUUCUCUA-3′

Although miRNA which is active in vivo is single-stranded, it should be delivered into cells, in a double-stranded form together with a nucleotide sequence having a length similar thereto, so that it will bind to the RISC. Herein, the antisense sequence binding to the sequence is complementary to the active sequence. The complementary sequence may be a perfect complementary sequence or an endogenous sequence. Nucleotides located either at the 3′ end of each double-stranded sequence or at the 3′ end of one strand may not bind with nucleotides of the antisense sequence, and such nucleotides are known as the 3′-overhang. The double-stranded sequence may comprise the 3′-overhang.

In other words, the perfect complementary sequence of the miR-3670 may be represented by SEQ ID NO: 36.

(SEQ ID NO: 36) 5′-GAGAAGGACAGCUGUGAGCUCUUU-3′

In addition, the endogenous complementary sequence of the miR-3670 may be represented by SEQ ID NO: 67.

(SEQ ID NO: 67) 5′-GACUGGUAUAGCUGCUUUUGGAGCCUCA-3′

As described in the Background Art section above, the seed sequence corresponding to 8-9^(th) nucleotides counting from the second nucleotide of the active sequence of miRNA is the major factor of activity. A long double-stranded sequence comprising the seed region may be used in preparation of double-stranded RNA.

Similarly to miR-3670, active sequences of miR-4477a and miR-8078 and complementary sequences for forming double-stranded sequences therewith may be represented by the following sequences. These double-stranded sequences may comprise the 3′-overhang as described above to form long double-stranded sequences, and may also comprise the seed region to form long double-stranded sequences.

miR-4477a

(MIMAT0019004 SEQ ID NO: 43) 5′-CUAUUAAGGACAUUUGUGAUUC-3′

The perfect complementary sequence of the miR-4477a:

(SEQ ID NO: 44) 5′-AUCACAAAUGUCCUUAAUAGUU-3′

The endogenous complementary sequence of the miR-4477a:

(SEQ ID NO: 68) 5′-AUCACAAAUGUCCUUAAUGGCA-3′

miR-8078

(MIMAT0031005, SEQ ID NO: 65) 5′-GGUCUAGGCCCGGUGAGAGACUC

The perfect complementary sequence of the miR-8078:

(SEQ ID NO: 66) 5′-GUCUCUCACCGGGCCUAGACCUU

The endogenous complementary sequence of the miR-8078:

(SEQ ID NO: 69) 5′-CUCCACCGGGCUGACCGGCCUG-3′

In the present invention, it was found that the miRNAs identified through library screening exhibit anticancer effects by controlling genes generally known to play a major role in the induction, production and growth of cancer cells. miRNAs characterized in that one kind of miRNA can simultaneously control expressions of a number of mRNA at the same time. This nature was also found in the present invention, and is useful for the development of new oligo-based anticancer drugs.

It was found that the miR-3670 of the present invention inhibits the expressions of the CBX4, NRAS, CASR, TXLNA, SNIP1, HNF1A, FZD4, TRIB1, ADMA19, and CKAP5 at the same time, the miR-8078 inhibits the expressions of GREB1, HECTD3, and RIPK4, and the miR-4477a inhibits the expressions of STIL, KIF11, AKAP11, and FAM120A at the same time (FIG. 6).

Target genes to be inhibited by the miRNA of the present invention are known to have the following functions.

It is known that CBX4 (polycomb chromobox 4) is involved in tumor angiogenesis and stimulation of tumor metastasis, and NRAS plays a major role in tumor growth and cell division (Orouji, E. et al. MAP Kinase pathway gene copy alterations in NRAS/BRAF wild-type advanced melanoma. Int J Cancer (2015); Zheng, C. et al. MicroRNA-195 functions as a tumor suppressor by inhibiting CBX4 in hepatocellular carcinoma. Oncol Rep 33, 1115-22 (2015); Jiao, H. K. et al. Prognostic significance of Cbx4 expression and its beneficial effect for transarterial chemoembolization in hepatocellular carcinoma. Cell Death Dis 6, e1689 (2015); Ohashi, K. et al. Characteristics of lung cancers harboring NRAS mutations. Clin Cancer Res 19, 2584-91 (2013)).

CASR is found to be overexpressed in tumors and is required for tumor metastasis, and TXLNA is known to be related to tumor growth and metastasis. Reported clinical results indicated that a patient group showing high expression levels of TXLNA has low survival rate (Mashidori, T., Shirataki, H., Kamai, T., Nakamura, F. & Yoshida, K. Increased alpha-taxilin protein expression is associated with the metastatic and invasive potential of renal cell cancer. Biomed Res 32, 103-10 (2011); Tennakoon, S., Aggarwal, A. & Kallay, E. The calcium-sensing receptor and the hallmarks of cancer. Biochim Biophys Acta (2015); Ohtomo, N. et al. Expression of alpha-taxilin in hepatocellular carcinoma correlates with growth activity and malignant potential of the tumor. Int J Oncol 37, 1417-23 (2010)).

SNIP1 known as a transcriptional coactivator stimulates expression of cyclin D1 which is essential for cell growth and division. It is known that a patient group showing high expression levels of SNIP1 has poor prognosis. Furthermore, it is known that SNIP1 binds to c-Myc functioning as a major regulator of cell proliferation to thereby stimulate tumor growth (Li, Q. et al. SNIP1: a new activator of HSE signaling pathway. Mol Cell Biochem 362, 1-6 (2012); Fujii, M. et al. SNIP1 is a candidate modifier of the transcriptional activity of c-Myc on E box-dependent target genes. Mol Cell 24, 771-83 (2006); Roche, K. C., Rocha, S., Bracken, C. P. & Perkins, N. D. Regulation of ATR-dependent pathways by the FHA domain containing protein SNIP1. Oncogene 26, 4523-30 (2007); Jeon, H. S. et al. High expression of SNIP1 correlates with poor prognosis in non-small cell lung cancer and SNIP1 interferes with the recruitment of HDAC1 to RB in vitro. Lung Cancer 82, 24-30 (2013); Liang, X. et al. Hypoxia-inducible factor-1 alpha, in association with TWIST2 and SNIP1, is a critical prognostic factor in patients with tongue squamous cell carcinoma. Oral Oncol 47, 92-7 (2011)).

HNF1A and FZD4 are components in the Wnt signaling pathway, which are deeply involved in tumor growth and survival. The Wnt signaling pathways have been intensively studied in tumor biology, and the importance thereof is widely known. TRIB1 is known to play a role to inhibit growth, metastasis and apoptosis of tumor cell and to regulate the MAPK signaling pathway which is a major signaling pathway of tumor growth (Pecina-Slaus, N. et al. Wnt signaling transcription factors TCF-1 and LEF-1 are upregulated in malignant astrocytic brain tumors. Histol Histopathol 29, 1557-64 (2014); Ueno, K. et al. Tumor suppressor microRNA-493 decreases cell motility and migration ability in human bladder cancer cells by downregulating RhoC and FZD4. Mol Cancer Ther 11, 244-53 (2012); Lin, Z. Y. et al. MicroRNA-224 inhibits progression of human prostate cancer by downregulating TRIB1. Int J Cancer 135, 541-50 (2014); Soubeyrand, S., Naing, T., Martinuk, A. & McPherson, R. ERK1/2 regulates hepatocyte Tribl in response to mitochondrial dysfunction. Biochim Biophys Acta 1833, 3405-14 (2013)).

ADAM19 is a protein distributed in the cell membrane, and is known to perform a variety of biological functions, including cell-cell interactions and cell-extracellular matrix interactions. As known in tumor biology, ADAM19 is deeply associated with tumor growth and metastasis. CKAP5 gene found to play an important role in tumor survival through gene functional screening was found to be controlled by the miRNA in the present invention. GREB1 is associated with the signaling pathways of tissues or tumors that respond to hormones, and is known to be overexpressed in various kinds of tumor cells to stimulate the growth of the cells (Zhang, Q. et al. Role of microRNA-30c targeting ADAM19 in colorectal cancer. PLoS One 10, e0120698 (2015); Shan, N., Shen, L., Wang, J., He, D. & Duan, C. MiR-153 inhibits migration and invasion of human non-small-cell lung cancer by targeting ADAM19. Biochem Biophys Res Commun 456, 385-91 (2015); Martens-de Kemp, S. R. et al. Functional genetic screens identify genes essential for tumor cell survival in head and neck and lung cancer. Clin Cancer Res 19, 1994-2003 (2013); Rae, J. M. et al. GREB1 is a novel androgen-regulated gene required for prostate cancer growth. Prostate 66, 886-94 (2006); Zhang, L. et al. Development of transcriptomic biomarker signature in human saliva to detect lung cancer. Cell Mol Life Sci 69, 3341-50 (2012); Laviolette, L. A., Hodgkinson, K. M., Minhas, N., Perez-Iratxeta, C. & Vanderhyden, B. C. 17beta-estradiol upregulates GREB1 and accelerates ovarian tumor progression in vivo. Int J Cancer 135, 1072-84 (2014)).

HECTD3 is E3 ubiquitin ligase and is known to attach polyubiquitin to caspase-8, which triggers apoptosis, to induce degradation of caspase-8, thereby inhibiting tumor cell apoptosis. Also, HECTD3 is known to stabilize MALT1 protein to thereby increase resistance to cisplatin anticancer drugs. RIPK4 is receptor-interacting protein kinase 4, and is known to induce accumulation of the cell growth signaling factor β-catennin and activate the Wnt signaling pathway. It is known that artificial removal of RIPK4 can inhibit tumor growth in tumor animal models (Li, Y. et al. The HECTD3 E3 ubiquitin ligase facilitates cancer cell survival by promoting K63-linked polyubiquitination of caspase-8. Cell Death Dis 4, e935 (2013); Li, Y. et al. The HECTD3 E3 ubiquitin ligase suppresses cisplatin-induced apoptosis via stabilizing MALT1. Neoplasia 15, 39-48 (2013); Huang, X. et al. Phosphorylation of Dishevelled by protein kinase RIPK4 regulates Wnt signaling. Science 339, 1441-5 (2013)).

The STIL gene, which is an essential factor in G2 phase-to-M phase transition in the cell cycle is known to be highly expressed in various kinds of cells and to be necessary for tumor growth and survival. It is known that KIF11 is also necessary for tumor cell growth and metastasis and that inhibition of the activity of KIF11 can inhibit tumor growth (Erez, A. et al. Sil overexpression in lung cancer characterizes tumors with increased mitotic activity. Oncogene 23, 5371-7 (2004); Erez, A. et al. The SIL gene is essential for mitotic entry and survival of cancer cells. Cancer Res 67, 4022-7 (2007); Tang, Y., Orth, J. D., Xie, T. & Mitchison, T. J. Rapid induction of apoptosis during Kinesin-5 inhibitor-induced mitotic arrest in HL60 cells. Cancer Lett 310, 15-24 (2011); Venere, M. et al. The mitotic kinesin KIF11 is a driver of invasion, proliferation, and self-renewal in glioblastoma. Sci Transl Med 7, 304ra143 (2015)).

AKAP11 that binds protein kinase A (PKA) to increase the PKA activity also binds to GSK-3 beta to promote PKA-mediated phosphorylation of GSK-3. Phosphorylated GSK-3 beta loses its activity, which is a major mechanism that is recognized as a growth stimulating signal in cells to induce tumor growth. Tumor cells are exposed to various stress conditions, such as acidic conditions, oxygen deficient conditions, etc., and maintain a mechanism by which death of tumor cells is inhibited even under such severe conditions. For example, it is known that FAM120A that is an RNA-binding protein activates kinases such as Src to inhibit cell apoptosis and increase drug resistance (Logue, J. S. et al. AKAP220 protein organizes signaling elements that impact cell migration. J Biol Chem 286, 39269-81 (2011); Whiting, J. L. et al. Protein Kinase A Opposes the Phosphorylation-dependent Recruitment of Glycogen Synthase Kinase 3beta to A-kinase Anchoring Protein 220. J Biol Chem 290, 19445-57 (2015); Tanji, C. et al. A-kinase anchoring protein AKAP220 binds to glycogen synthase kinase-3beta (GSK-3beta) and mediates protein kinase A-dependent inhibition of GSK-3beta. J Biol Chem 277, 36955-61 (2002); Tanaka, M. et al. A novel RNA-binding protein, Ossa/C9orf10, regulates activity of Src kinases to protect cells from oxidative stress-induced apoptosis. Mol Cell Biol 29, 402-13 (2009); Bartolome, R. A. et al. IL13 Receptor alpha2 Signaling Requires a Scaffold Protein, FAM120A, to Activate the FAK and PI3K Pathways in Colon Cancer Metastasis. Cancer Res 75, 2434-44 (2015)).

In the present invention, it was shown that, when the intracellular contents of the above-described genes were reduced using siRNA, cell growth was inhibited, like when miR-3670, miR4477a or miR-8078 was used (FIG. 6). In addition, the results of qPCR indicated that when miR-3670, miR-4477a or miR-8078 was delivered into lung cancer cells, the mRNA expression levels of the genes were reduced (FIG. 7). Furthermore, the luciferase assay results indicated that the above-described genes are genes that are targeted directly by miR-3670, miR-4477a or miR-8078 (FIG. 8). This suggests that miR-3670, miR-4477a or miR-8078 directly and simultaneously inhibits expressions of various genes important in tumor cell growth and survival to thereby induce tumor cell apoptosis.

In the present invention, the cancer may be one or more cancers selected from the group consisting of: a primary cancer such as lung cancer, liver cancer, stomach cancer, colorectal cancer, pancreatic cancer, gallbladder and bile duct cancer, breast cancer, leukemia, esophageal cancer, non-Hodgkin lymphoma, thyroid cancer, cervical cancer, or skin cancer; a metastatic carcinoma arising from metastasis to other organs from the primary cancer site of origin; and a neoplastic cell disease caused by the promotion of abnormally excessive cell division, but is not limited thereto.

The sequence of miRNA that can be used as an active ingredient of a pharmaceutical composition for treating cancer according to the present invention is a sequence derived from the human genome, but may be an miRNA sequence obtained from other animal genomes without limiting the miRNA-derived genome to the human genome.

In the present invention, miRNA may be used as various miRNA mimics, which generates biologically equivalent effect. For example, modified miRNA comprising an miRNA sequence containing the same seed region may be used. Herein, the length of SEQ ID NO: 1 or SEQ ID NO: 2 may be reduced, and a short-length miRNA mimic consisting of 15 nucleotides may also be used.

In the present invention, miRNA mimics for the miRNA may partially comprise a phosphorothioate structure in which a RNA phosphate backbone structure is substituted with another element such as sulfur. Moreover, those obtained by wholly or partially substituting RNA with DNA, PNA (peptide nucleic acid) or LNA (locked nucleic acid) molecule may also be used. In addition, those obtained by substituting the 2′ hydroxyl group of RNA sugar with various functional structures may also be used. Such modification includes, but not limited to, methylation, methoxylation, fluorination or the like.

In the present invention, miRNA is not limited to the mature miRNA and the double-stranded RNA of the miRNA mimic derived therefrom, but can be used in the form of an miRNA precursor. The miRNA precursor can also be obtained by substitution of the above-described RNA phosphate backbone structure, whole or partial substitution of RNA nucleic acid with a DNA, PNA or LNA molecule, or modification of the 2′ hydroxyl group of RNA sugar.

In the present invention, miRNA can be used in the form of an miRNA precursor or a primary miRNA (pri-miRNA), and it can be synthesized by a chemical method or delivered to cells in the form of a plasmid so as to be expressed.

Examples of a method of delivering miRNA to cells cultured in a culture dish, which can be used in the present invention, include a method of using a mixture of miRNA and cationic lipid, a method of delivering miRNA to cells by electrical stimulus, and a method of using virus, but are not limited thereto.

A pharmaceutical composition for treating cancer comprising the miRNA of the present invention as an active ingredient may further comprise a pharmaceutically acceptable carrier, and may be formulated together with the carrier.

As used herein, the term “pharmaceutically acceptable carrier” refers to a carrier or diluent that does not impair the biological activity and characteristics of an administered compound without irritating an organism. As a pharmaceutically acceptable carrier in a composition that is formulated as a liquid solution, a sterile and biocompatible carrier is used. The pharmaceutically acceptable carrier may be physiological saline, sterile water, Ringer's solution, buffered saline, albumin injection solution, dextrose solution, maltodextrin solution, glycerol, ethanol, or a mixture of two or more thereof. In addition, the composition of the present invention may, if necessary, comprise other conventional additives, including antioxidants, buffers, and bacteriostatic agents. Further, the composition of the present invention may be formulated as injectable forms such as aqueous solutions, suspensions or emulsions with the aid of diluents, dispersants, surfactants, binders and lubricants. In addition, the composition according to the present invention may be formulated in the form of pills, capsules, granules, or tablets.

A composition for preventing or treating cancer, which comprises the miRNA of the present invention and a pharmaceutically acceptable carrier, can be applied as any formulation comprising it as an active ingredient and may be prepared as an oral or parenteral formulation. Pharmaceutical formulations of the present invention include those suitable for oral, rectal, nasal, topical (including buccal and sublingual), subcutaneous, vaginal or parenteral (including intramuscular, subcutaneous and intravenous) administration or a form suitable for administration by inhalation or insufflation.

Examples of oral formulations comprising the composition of the present invention as an active ingredient include tablets, troches, lozenges, aqueous or emulsified suspensions, powders, granules, emulsions, hard or soft capsules, syrups, or elixirs. Formulations such as tablets or capsules may include a binder such as lactose, saccharose, sorbitol, mannitol, starch, amylopectin, cellulose or gelatin, an expedient such as dicalcium phosphate, a disintegrant such as corn starch or sweet potato starch, and a lubricant such as magnesium stearate, calcium stearate, sodium stearyl fumarate or polyethylene glycol wax. Capsule formulations may comprise, in addition to the above-mentioned substances, a liquid carrier such as fatty oil.

Parenteral formulations comprising the composition of the present invention as an active ingredient include injectable forms for subcutaneous, intravenous or intramuscular injection, suppositories, or sprays inhalable via the respiratory organ, such as aerosols. Injectable formulations may be prepared by mixing the composition of the present invention with a stabilizer or a buffer in water to prepare a solution or a suspension, and loading the solution or suspension into ampules or vials to prepare unit dosage forms. Suppository formulations include suppositories or retention enemas, e.g. containing conventional suppository bases such as cocoa buffer or other glycerides. For spray formulations, such as aerosols, a propellant for spraying a water-dispersed concentrate or wet powder may be used in combination with an additive.

EXAMPLES

Hereinafter, the present invention will be described in further detail with reference to examples. It will be obvious to a person having ordinary skill in the art that these examples are for illustrative purposes only and are not to be construed to limit the scope of the present invention.

Example 1: Construction of miRNA Screening Library

Based on stem-loop structure the 21 version human miRNA sequence provided from the miRNA database miRBase (www mirbase.org), a screening library consisting of about 1700 kinds of miRNAs was synthesized as double-stranded miRNA sequences by a solid synthesis method that is used in conventional oligo synthesis. Each strand of the synthesized miRNAs was purified by reverse phase separation using C18 resin. All the synthesized miRNA strands were analyzed by MALDI-TOF MS spectrometry to determine whether or not the desired sequences were synthesized. For synthesis of double-stranded miRNAs, complementary strands were heated in the presence of salt at 95° C. for 2 minutes, and then cooled slowly for preparation of double strands.

TABLE 1 miRNA Sequences miRNA Sequence 1 Sequence 2 hsa-let-7a-1 UGAGGUAGUAGGUUGUAUAGUU CUAUACAAUCUACUGUCUUUC hsa-let-7a-2 UGAGGUAGUAGGUUGUAUAGUU CUGUACAGCCUCCUAGCUUUCC hsa-let-7b CUAUACAACCUACUGCCUUCCC UGAGGUAGUAGGUUGUGUGGUU hsa-let-7c UGAGGUAGUAGGUUGUAUGGUU CUGUACAACCUUCUAGCUUUCC hsa-let-7d CUAUACGACCUGCUGCCUUUCU AGAGGUAGUAGGUUGCAUAGUU hsa-let-7e CUAUACGGCCUCCUAGCUUUCC UGAGGUAGGAGGUUGUAUAGUU hsa-let-7f-1 UGAGGUAGUAGAUUGUAUAGUU CUAUACAAUCUAUUGCCUUCCC hsa-let-7f-2 UGAGGUAGUAGAUUGUAUAGUU CUAUACAGUCUACUGUCUUUCC hsa-let-7g CUGUACAGGCCACUGCCUUGC UGAGGUAGUAGUUUGUACAGUU hsa-let-7i UGAGGUAGUAGUUUGUGCUGUU CUGCGCAAGCUACUGCCUUGCU hsa-miR-1 UGGAAUGUAAAGAAGUAUGUAU ACAUACUUCUUUAUAUGCCCAU hsa-miR-100 CAAGCUUGUAUCUAUAGGUAUG AACCCGUAGAUCCGAACUUGUG hsa-miR-101 UACAGUACUGUGAUAACUGAA CAGUUAUCACAGUGCUGAUGCU hsa-miR-103a AGCAGCAUUGUACAGGGCUAUGA AGCUUCUUUACAGUGCUGCCUUG hsa-miR-103b UCAUAGCCCUGUACAAUGCUGCU CAGCAUUGUACAGGGCUAUGAUU hsa-miR-105 UCAAAUGCUCAGACUCCUGUGGU ACGGAUGUUUGAGCAUGUGCUA hsa-miR-106a CUGCAAUGUAAGCACUUCUUAC AAAAGUGCUUACAGUGCAGGUAG hsa-miR-106b UAAAGUGCUGACAGUGCAGAU CCGCACUGUGGGUACUUGCUGC hsa-miR-107 AGCAGCAUUGUACAGGGCUAUCA AUAGCCCUGUACAAUGCUGCUUU hsa-miR-10a CAAAUUCGUAUCUAGGGGAAUA UACCCUGUAGAUCCGAAUUUGUG hsa-miR-10b ACAGAUUCGAUUCUAGGGGAAU UACCCUGUAGAACCGAAUUUGUG hsa-miR-1178 UUGCUCACUGUUCUUCCCUAG CAGGGUCAGCUGAGCAUG hsa-miR-1179 AAGCAUUCUUUCAUUGGUUGG AACCAAUGAAAGAAUGCUUUU hsa-miR-1180 UUUCCGGCUCGCGUGGGUGUGU GGACCCACCCGGCCGGGAAUA hsa-miR-1181 CCGUCGCCGCCACCCGAGCCG GCUCGGGUGGCGGCGACGGUU hsa-miR-1182 GAGGGUCUUGGGAGGGAUGUGAC CACAUCCCUCCCAAGACCCUCUU hsa-miR-1183 CACUGUAGGUGAUGGUGAGAGUGGGCA CCCACUCUCACCAUCACCUACAGUGUU hsa-miR-1184 CCUGCAGCGACUUGAUGGCUUCC AAGCCAUCAAGUCGCUGCAGGUU hsa-miR-1185-1 AGAGGAUACCCUUUGUAUGUU AUAUACAGGGGGAGACUCUUAU hsa-miR-1185-2 AGAGGAUACCCUUUGUAUGUU AUAUACAGGGGGAGACUCUCAU hsa-miR-1193 GGGAUGGUAGACCGGUGACGUGC ACGUCACCGGUCUACCAUCCCUU hsa-miR-1197 UAGGACACAUGGUCUACUUCU AAGUAGACCAUGUGUCCUAUU hsa-miR-1199 CCUGAGCCCGGGCCGCGCAG UGCGGCCGGUGCUCAACCUGC hsa-miR-1200 CUCCUGAGCCAUUCUGAGCCUC GGCUCAGAAUGGCUCAGGAGUU hsa-miR-1202 GUGCCAGCUGCAGUGGGGGAG CCCCCACUGCAGCUGGCACUU hsa-miR-1203 CCCGGAGCCAGGAUGCAGCUC GCUGCAUCCUGGCUCCGGGUU hsa-miR-1204 UCGUGGCCUGGUCUCCAUUAU AAUGGAGACCAGGCCACGAUU hsa-miR-1205 UCUGCAGGGUUUGCUUUGAG CAAAGCAAACCCUGCAGAUU hsa-miR-1206 UGUUCAUGUAGAUGUUUAAGC UUAAACAUCUACAUGAACAUU hsa-miR-1207 UGGCAGGGAGGCUGGGAGGGG UCAGCUGGCCCUCAUUUC hsa-miR-1208 UCACUGUUCAGACAGGCGGA CGCCUGUCUGAACAGUGAUU hsa-miR-122 UGGAGUGUGACAAUGGUGUUUG AACGCCAUUAUCACACUAAAUA hsa-miR-1224 CCCCACCUCCUCUCUCCUCAG GUGAGGACUCGGGAGGUGG hsa-miR-1225 GUGGGUACGGCCCAGUGGGGGG UGAGCCCCUGUGCCGCCCCCAG hsa-miR-1226 GUGAGGGCAUGCAGGCCUGGAUGGGG UCACCAGCCCUGUGUUCCCUAG hsa-miR-1227 GUGGGGCCAGGCGGUGG CGUGCCACCCUUUUCCCCAG hsa-miR-1228 GUGGGCGGGGGCAGGUGUGUG UCACACCUGCCUCGCCCCCC hsa-miR-1229 GUGGGUAGGGUUUGGGGGAGAGCG CUCUCACCACUGCCCUCCCACAG hsa-miR-1231 GUGUCUGGGCGGACAGCUGC AGCUGUCCGCCCAGACACUU hsa-miR-1233 AGUGGGAGGCCAGGGCACGGCA UGAGCCCUGUCCUCCCGCAG hsa-miR-1234 UCGGCCUGACCACCCACCCCAC GGGGUGGGUGGUCAGGCCGAUU hsa-miR-1236 UGAGUGACAGGGGAAAUGGGGA CCUCUUCCCCUUGUCUCUCCAG hsa-miR-1237 CGGGGGCGGGGCCGAAGCGCG UCCUUCUGCUCCGUCCCCCAG hsa-miR-1238 CUUCCUCGUCUGUCUGCCCC GUGAGUGGGAGCCCCAGUGUGUG hsa-miR-124 UAAGGCACGCGGUGAAUGCC CGUGUUCACAGCGGACCUUGAU hsa-miR-1243 AACUGGAUCAAUUAUAGGAGUG CUCCUAUAAUUGAUCCAGUUUU hsa-miR-1244 AAGUAGUUGGUUUGUAUGAGAUGGUU CCAUCUCAUACAAACCAACUACUUUU hsa-miR-1245a AAGUGAUCUAAAGGCCUACAU GUAGGCCUUUAGAUCACUUUU hsa-miR-1245b UCAGAUGAUCUAAAGGCCUAUA UAGGCCUUUAGAUCACUUAAA hsa-miR-1246 AAUGGAUUUUUGGAGCAGG UGCUCCAAAAAUCCAUUUU hsa-miR-1247 CCCCGGGAACGUCGAGACUGGAGC ACCCGUCCCGUUCGUCCCCGGA hsa-miR-1248 ACCUUCUUGUAUAAGCACUGUGCUAAA UAGCACAGUGCUUAUACAAGAAGGUUU hsa-miR-1249 ACGCCCUUCCCCCCCUUCUUCA AGGAGGGAGGAGAUGGGCCAAGUU hsa-miR-1250 ACAUUUUCCAGCCCAUUCA ACGGUGCUGGAUGUGGCCUUU hsa-miR-1251 CGCUUUGCUCAGCCAGUGUAG ACUCUAGCUGCCAAAGGCGCU hsa-miR-1252 AGAAGGAAAUUGAAUUCAUUUA CAAAUGAGCUUAAUUUCCUUUU hsa-miR-1253 AGAGAAGAAGAUCAGCCUGCA CAGGCUGAUCUUCUUCUCUUU hsa-miR-1254 AGCCUGGAAGCUGGAGCCUGCAGU UGCAGGCUCCAGCUUCCAGGCUUU hsa-miR-1255a AGGAUGAGCAAAGAAAGUAGAUU UCUACUUUCUUUGCUCAUCCUUU hsa-miR-1255b AACCACUUUCUUUGCUCAUCCA CGGAUGAGCAAAGAAAGUGGUU hsa-miR-1256 AGGCAUUGACUUCUCACUAGCU CUAGUGAGAAGUCAAUGCCUUU hsa-miR-1257 AGUGAAUGAUGGGUUCUGACC UCAGAACCCAUCAUUCACUUU hsa-miR-1258 AGUUAGGAUUAGGUCGUGGAA CCACGACCUAAUCCUAACUUU hsa-miR-125a ACAGGUGAGGUUCUUGGGAGCC UCCCUGAGACCCUUUAACCUGUGA hsa-miR-125b-1 UCCCUGAGACCCUAACUUGUGA ACGGGUUAGGCUCUUGGGAGCU hsa-miR-125b-2 UCCCUGAGACCCUAACUUGUGA UCACAAGUCAGGCUCUUGGGAC hsa-miR-126 UCGUACCGUGAGUAAUAAUGCG CAUUAUUACUUUUGGUACGCG hsa-miR-1260a AUCCCACCUCUGCCACCA GUGGCAGAGGUGGGAUUU hsa-miR-1260b AUCCCACCACUGCCACCAU GGUGGCAGUGGUGGGAUUU hsa-miR-1261 AUGGAUAAGGCUUUGGCUU GCCAAAGCCUUAUCCAUUU hsa-miR-1262 AUGGGUGAAUUUGUAGAAGGAU CCUUCUACAAAUUCACCCAUUU hsa-miR-1263 AUGGUACCCUGGCAUACUGAGU UCAGUAUGCCAGGGUACCAUUU hsa-miR-1264 CAAGUCUUAUUUGAGCACCUGUU CAGGUGCUCAAAUAAGACUUGUU hsa-miR-1265 CAGGAUGUGGUCAAGUGUUGUU CAACACUUGACCACAUCCUGUU hsa-miR-1266 CCUCAGGGCUGUAGAACAGGGCU CCCUGUUCUAUGCCCUGAGGGA hsa-miR-1267 CCUGUUGAAGUGUAAUCCCCA GGGAUUACACUUCAACAGGUU hsa-miR-1268a CGGGCGUGGUGGUGGGGG CCCACCACCACGCCCGUU hsa-miR-1268b CGGGCGUGGUGGUGGGGGUG CCCCCACCACCACGCCCGUU hsa-miR-1269a CUGGACUGAGCCGUGCUACUGG AGUAGCACGGCUCAGUCCAGUU hsa-miR-1269b CUGGACUGAGCCAUGCUACUGG AGUAGCAUGGCUCAGUCCAGUU hsa-miR-127 UCGGAUCCGUCUGAGCUUGGCU CUGAAGCUCAGAGGGCUCUGAU hsa-miR-1270 CUGGAGAUAUGGAAGAGCUGUGU ACAGCUCUUCCAUAUCUCCAGUU hsa-miR-1271 AGUGCCUGCUAUGUGCCAGGCA CUUGGCACCUAGCAAGCACUCA hsa-miR-1272 GAUGAUGAUGGCAGCAAAUUCUGAAA UCAGAAUUUGCUGCCAUCAUCAUCUU hsa-miR-1273a GGGCGACAAAGCAAGACUCUUUCUU GAAAGAGUCUUGCUUUGUCGCCCUU hsa-miR-1273c GGCGACAAAACGAGACCCUGUC CAGGGUCUCGUUUUGUCGCCUU hsa-miR-1273d GAACCCAUGAGGUUGAGGCUGCAGU UGCAGCCUCAACCUCAUGGGUUCUU hsa-miR-1273e UUGCUUGAACCCAGGAAGUGGA CACUUCCUGGGUUCAAGCAAUU hsa-miR-1273f GGAGAUGGAGGUUGCAGUG CUGCAACCUCCAUCUCCUU hsa-miR-1273g GGUGGUUGAGGCUGCAGUAAGU ACCACUGCACUCCAGCCUGAG hsa-miR-1273h CUGGGAGGUCAAGGCUGCAGU CUGCAGACUCGACCUCCCAGGC hsa-miR-1275 GUGGGGGAGAGGCUGUC CAGCCUCUCCCCCACUU hsa-miR-1276 UAAAGAGCCCUGUGGAGACA UCUCCACAGGGCUCUUUAUU hsa-miR-1277 UACGUAGAUAUAUAUGUAUUUU AAAUAUAUAUAUAUAUGUACGUAU hsa-miR-1278 UAGUACUGUGCAUAUCAUCUAU AGAUGAUAUGCACAGUACUAUU hsa-miR-1279 UCAUAUUGCUUCUUUCU AAAGAAGCAAUAUGAUU hsa-miR-128-1 UCACAGUGAACCGGUCUCUUU CGGGGCCGUAGCACUGUCUGAGA hsa-miR-128-2 UCACAGUGAACCGGUCUCUUU GGGGGCCGAUACACUGUACGAGA hsa-miR-1281 UCGCCUCCUCCUCUCCC GAGAGGAGGAGGCGAUU hsa-miR-1282 UCGUUUGCCUUUUUCUGCUU GCAGAAAAAGGCAAACGAUU hsa-miR-1283 UCUACAAAGGAAAGCGCUUUCU AAAGCGCUUUCCUUUGUAGAUU hsa-miR-1284 UCUAUACAGACCCUGGCUUUUC AAAGCCAGGGUCUGUAUAGAUU hsa-miR-1285 UCUGGGCAACAAAGUGAGACCU GAUCUCACUUUGUUGCCCAGG hsa-miR-1286 UGCAGGACCAAGAUGAGCCCU GGCUCAUCUUGGUCCUGCAUU hsa-miR-1287 CUCUAGCCACAGAUGCAGUGAU UGCUGGAUCAGUGGUUCGAGUC hsa-miR-1288 UGGACUGCCCUGAUCUGGAGA GCAGAUCAGGACUGUAACUCACC hsa-miR-1289 UGGAGUCCAGGAAUCUGCAUUUU AAUGCAGAUUCCUGGACUCCAUU hsa-miR-129-1 CUUUUUGCGGUCUGGGCUUGC AAGCCCUUACCCCAAAAAGUAU hsa-miR-129-2 CUUUUUGCGGUCUGGGCUUGC AAGCCCUUACCCCAAAAAGCAU hsa-miR-1290 UGGAUUUUUGGAUCAGGGA CCUGAUCCAAAAAUCCAUU hsa-miR-1291 UGGCCCUGACUGAAGACCAGCAGU UGCUGGUCUUCAGUCAGGGCCAUU hsa-miR-1292 UGGGAACGGGUUCCGGCAGACGCUG UCGCGCCCCGGCUCCCGUUC hsa-miR-1293 UGGGUGGUCUGGAGAUUUGUGC ACAAAUCUCCAGACCACCCAUU hsa-miR-1294 UGUGAGGUUGGCAUUGUUGUCU ACAACAAUGCCAACCUCACAUU hsa-miR-1295a UUAGGCCGCAGAUCUGGGUGA ACCCAGAUCUGCGGCCUAAUU hsa-miR-1295b AAUAGGCCACGGAUCUGGGCAA CACCCAGAUCUGCGGCCUAAU hsa-miR-1296 UUAGGGCCCUGGCUCCAUCUCC GAGUGGGGCUUCGACCCUAACC hsa-miR-1297 UUCAAGUAAUUCAGGUG CCUGAAUUACUUGAAUU hsa-miR-1298 CAUCUGGGCAACUGACUGAAC UUCAUUCGGCUGUCCAGAUGUA hsa-miR-1299 UUCUGGAAUUCUGUGUGAGGGA CCUCACACAGAAUUCCAGAAUU hsa-miR-1301 CGCUCUAGGCACCGCAGCA UUGCAGCUGCCUGGGAGUGACUUC hsa-miR-1302 UUGGGACAUACUUAUGCUAAA UAGCAUAAGUAUGUCCCAAUU hsa-miR-1303 UUUAGAGACGGGGUCUUGCUCU AGCAAGACCCCGUCUCUAAAUU hsa-miR-1304 UUUGAGGCUACAGUGAGAUGUG UCUCACUGUAGCCUCGAACCCC hsa-miR-1305 UUUUCAACUCUAAUGGGAGAGA UCUCCCAUUAGAGUUGAAAAUU hsa-miR-1306 CCACCUCCCCUGCAAACGUCCA ACGUUGGCUCUGGUGGUG hsa-miR-1307 ACUCGGCGUGGCGUCGGUCGUG UCGACCGGACCUCGACCGGCU hsa-miR-130a UUCACAUUGUGCUACUGUCUGC CAGUGCAAUGUUAAAAGGGCAU hsa-miR-130b CAGUGCAAUGAUGAAAGGGCAU ACUCUUUCCCUGUUGCACUAC hsa-miR-132 UAACAGUCUACAGCCAUGGUCG ACCGUGGCUUUCGAUUGUUACU hsa-miR-1321 CAGGGAGGUGAAUGUGAU CACAUUCACCUCCCUGUU hsa-miR-1322 GAUGAUGCUGCUGAUGCUG GCAUCAGCAGCAUCAUCUU hsa-miR-1323 UCAAAACUGAGGGGCAUUUUCU AAAAUGCCCCUCAGUUUUGAUU hsa-miR-1324 CCAGACAGAAUUCUAUGCACUUUC AAGUGCAUAGAAUUCUGUCUGGUU hsa-miR-133a AGCUGGUAAAAUGGAACCAAAU UUUGGUCCCCUUCAACCAGCUG hsa-miR-133b UUUGGUCCCCUUCAACCAGCUA GCUGGUUGAAGGGGACCAAAUU hsa-miR-134 UGUGACUGGUUGACCAGAGGGG CCUGUGGGCCACCUAGUCACCAA hsa-miR-1343 CUCCUGGGGCCCGCACUCUCGC UGGGGAGCGGCCCCCGGGUGGG hsa-miR-135a UAUAGGGAUUGGAGCCGUGGCG UAUGGCUUUUUAUUCCUAUGUGA hsa-miR-135b AUGUAGGGCUAAAAGCCAUGGG UAUGGCUUUUCAUUCCUAUGUGA hsa-miR-136 CAUCAUCGUCUCAAAUGAGUCU ACUCCAUUUGUUUUGAUGAUGGA hsa-miR-137 UUAUUGCUUAAGAAUACGCGUAG ACGCGUAUUCUUAAGCAAUAAUU hsa-miR-138-1 AGCUGGUGUUGUGAAUCAGGCCG GCUACUUCACAACACCAGGGCC hsa-miR-138-2 AGCUGGUGUUGUGAAUCAGGCCG GCUAUUUCACGACACCAGGGUU hsa-miR-139 UCUACAGUGCACGUGUCUCCAGU UGGAGACGCGGCCCUGUUGGAGU hsa-miR-140 CAGUGGUUUUACCCUAUGGUAG UACCACAGGGUAGAACCACGG hsa-miR-141 UAACACUGUCUGGUAAAGAUGG CAUCUUCCAGUACAGUGUUGGA hsa-miR-142 CAUAAAGUAGAAAGCACUACU UGUAGUGUUUCCUACUUUAUGGA hsa-miR-143 GGUGCAGUGCUGCAUCUCUGGU UGAGAUGAAGCACUGUAGCUC hsa-miR-144 UACAGUAUAGAUGAUGUACU GGAUAUCAUCAUAUACUGUAAG hsa-miR-145 GUCCAGUUUUCCCAGGAAUCCCU GGAUUCCUGGAAAUACUGUUCU hsa-miR-1468 CUCCGUUUGCCUGUUUCGCUG AGCAAAAUAAGCAAAUGGAAAA hsa-miR-1469 CUCGGCGCGGGGCGCGGGCUCC AGCCCGCGCCCCGCGCCGAGUU hsa-miR-146a UGAGAACUGAAUUCCAUGGGUU CCUCUGAAAUUCAGUUCUUCAG hsa-miR-146b UGCCCUGUGGACUCAGUUCUGG UGAGAACUGAAUUCCAUAGGCU hsa-miR-1470 GCCCUCCGCCCGUGCACCCCG GGGUGCACGGGCGGAGGGCUU hsa-miR-1471 GCCCGCGUGUGGAGCCAGGUGU ACCUGGCUCCACACGCGGGCUU hsa-miR-147a GUGUGUGGAAAUGCUUCUGC AGAAGCAUUUCCACACACUU hsa-miR-147b GUGUGCGGAAAUGCUUCUGCUA GCAGAAGCAUUUCCGCACACUU hsa-miR-148a AAAGUUCUGAGACACUCCGACU UCAGUGCACUACAGAACUUUGU hsa-miR-148b AAGUUCUGUUAUACACUCAGGC UCAGUGCAUCACAGAACUUUGU hsa-miR-149 AGGGAGGGACGGGGGCUGUGC UCUGGCUCCGUGUCUUCACUCCC hsa-miR-150 CUGGUACAGGCCUGGGGGACAG UCUCCCAACCCUUGUACCAGUG hsa-miR-151a UCGAGGAGCUCACAGUCUAGU CUAGACUGAAGCUCCUUGAGG hsa-miR-151b UCGAGGAGCUCACAGUCU ACUGUGAGCUCCUCGAUU hsa-miR-152 AGGUUCUGUGAUACACUCCGACU UCAGUGCAUGACAGAACUUGG hsa-miR-153 UCAUUUUUGUGAUGUUGCAGCU UUGCAUAGUCACAAAAGUGAUC hsa-miR-1537 AGCUGUAAUUAGUCAGUUUUCU AAAACCGUCUAGUUACAGUUGU hsa-miR-1538 CGGCCCGGGCUGCUGCUGUUCCU GAACAGCAGCAGCCCGGGCCGUU hsa-miR-1539 UCCUGCGCGUCCCAGAUGCCC GCAUCUGGGACGCGCAGGAUU hsa-miR-154 AAUCAUACACGGUUGACCUAUU UAGGUUAUCCGUGUUGCCUUCG hsa-miR-155 CUCCUACAUAUUAGCAUUAACA UUAAUGCUAAUCGUGAUAGGGGU hsa-miR-1587 UUGGGCUGGGCUGGGUUGGG CAACCCAGCCCAGCCCAAUU hsa-miR-15a CAGGCCAUAUUGUGCUGCCUCA UAGCAGCACAUAAUGGUUUGUG hsa-miR-15b CGAAUCAUUAUUUGCUGCUCUA UAGCAGCACAUCAUGGUUUACA hsa-miR-16-1 UAGCAGCACGUAAAUAUUGGCG CCAGUAUUAACUGUGCUGCUGA hsa-miR-16-2 UAGCAGCACGUAAAUAUUGGCG CCAAUAUUACUGUGCUGCUUUA hsa-miR-17 ACUGCAGUGAAGGCACUUGUAG CAAAGUGCUUACAGUGCAGGUAG hsa-miR-181a-1 AACAUUCAACGCUGUCGGUGAGU ACCAUCGACCGUUGAUUGUACC hsa-miR-181a-2 AACAUUCAACGCUGUCGGUGAGU ACCACUGACCGUUGACUGUACC hsa-miR-181b-1 AACAUUCAUUGCUGUCGGUGGGU CUCACUGAACAAUGAAUGCAA hsa-miR-181b-2 AACAUUCAUUGCUGUCGGUGGGU CUCACUGAUCAAUGAAUGCA hsa-miR-181c AACCAUCGACCGUUGAGUGGAC AACAUUCAACCUGUCGGUGAGU hsa-miR-181d CCACCGGGGGAUGAAUGUCAC AACAUUCAUUGUUGUCGGUGGGU hsa-miR-182 UUUGGCAAUGGUAGAACUCACACU UGGUUCUAGACUUGCCAACUA hsa-miR-1825 UCCAGUGCCCUCCUCUCC AGAGGAGGGCACUGGAUU hsa-miR-1827 UGAGGCAGUAGAUUGAAU UCAAUCUACUGCCUCAUU hsa-miR-183 UAUGGCACUGGUAGAAUUCACU GUGAAUUACCGAAGGGCCAUAA hsa-miR-184 UGGACGGAGAACUGAUAAGGGU CCUUAUCAGUUCUCCGUCCAUU hsa-miR-185 AGGGGCUGGCUUUCCUCUGGUC UGGAGAGAAAGGCAGUUCCUGA hsa-miR-186 CAAAGAAUUCUCCUUUUGGGCU GCCCAAAGGUGAAUUUUUUGGG hsa-miR-187 UCGUGUCUUGUGUUGCAGCCGG GGCUACAACACAGGACCCGGGC hsa-miR-188 CAUCCCUUGCAUGGUGGAGGG CUCCCACAUGCAGGGUUUGCA hsa-miR-18a UAAGGUGCAUCUAGUGCAGAUAG ACUGCCCUAAGUGCUCCUUCUGG hsa-miR-18b UAAGGUGCAUCUAGUGCAGUUAG UGCCCUAAAUGCCCCUUCUGGC hsa-miR-1908 CGGCGGGGACGGCGAUUGGUC CCGGCCGCCGGCUCCGCCCCG hsa-miR-1909 CGCAGGGGCCGGGUGCUCACCG UGAGUGCCGGUGCCUGCCCUG hsa-miR-190a UGAUAUGUUUGAUAUAUUAGGU CUAUAUAUCAAACAUAUUCCU hsa-miR-190b UGAUAUGUUUGAUAUUGGGUU CCCAAUAUCAAACAUAUCAUU hsa-miR-191 GCUGCGCUUGGAUUUCGUCCCC CAACGGAAUCCCAAAAGCAGCUG hsa-miR-1910 CCAGUCCUGUGCCUGCCGCCU GAGGCAGAAGCAGGAUGACA hsa-miR-1911 CACCAGGCAUUGUGGUCUCC UGAGUACCGCCAUGUCUGUUGGG hsa-miR-1912 UACCCAGAGCAUGCAGUGUGAA CACACUGCAUGCUCUGGGUAUU hsa-miR-1913 UCUGCCCCCUCCGCUGCUGCCA GCAGCAGCGGAGGGGGCAGAUU hsa-miR-1914 CCCUGUGCCCGGCCCACUUCUG GGAGGGGUCCCGCACUGGGAGG hsa-miR-1915 ACCUUGCCUUGCUGCCCGGGCC CCCCAGGGCGACGCGGCGGG hsa-miR-192 CUGCCAAUUCCAUAGGUCACAG CUGACCUAUGAAUUGACAGCC hsa-miR-193a UGGGUCUUUGCGGGCGAGAUGA AACUGGCCUACAAAGUCCCAGU hsa-miR-193b CGGGGUUUUGAGGGCGAGAUGA AACUGGCCCUCAAAGUCCCGCU hsa-miR-194 UGUAACAGCAACUCCAUGUGGA CCAGUGGGGCUGCUGUUAUCUG hsa-miR-195 UAGCAGCACAGAAAUAUUGGC CCAAUAUUGGCUGUGCUGCUCC hsa-miR-196a UAGGUAGUUUCAUGUUGUUGGG CGGCAACAAGAAACUGCCUGAG hsa-miR-196b UCGACAGCACGACACUGCCUUC UAGGUAGUUUCCUGUUGUUGGG hsa-miR-197 CGGGUAGAGAGGGCAGUGGGAGG UUCACCACCUUCUCCACCCAGC hsa-miR-1972 UCAGGCCAGGCACAGUGGCUCA AGCCACUGUGCCUGGCCUGAUU hsa-miR-1973 ACCGUGCAAAGGUAGCAUA UGCUACCUUUGCACGGUUU hsa-miR-1976 CCUCCUGCCCUCCUUGCUGU AGCAAGGAGGGCAGGAGGUU hsa-miR-198 GGUCCAGAGGGGAGAUAGGUUC ACCUAUCUCCCCUCUGGACCUU hsa-miR-199a ACAGUAGUCUGCACAUUGGUUA CCCAGUGUUCAGACUACCUGUUC hsa-miR-199b CCCAGUGUUUAGACUAUCUGUUC ACAGUAGUCUGCACAUUGGUUA hsa-miR-19a UGUGCAAAUCUAUGCAAAACUGA AGUUUUGCAUAGUUGCACUACA hsa-miR-19b-1 UGUGCAAAUCCAUGCAAAACUGA AGUUUUGCAGGUUUGCAUCCAGC hsa-miR-19b-2 UGUGCAAAUCCAUGCAAAACUGA AGUUUUGCAGGUUUGCAUUUCA hsa-miR-200a UAACACUGUCUGGUAACGAUGU CAUCUUACCGGACAGUGCUGGA hsa-miR-200b CAUCUUACUGGGCAGCAUUGGA UAAUACUGCCUGGUAAUGAUGA hsa-miR-200c UAAUACUGCCGGGUAAUGAUGGA CGUCUUACCCAGCAGUGUUUGG hsa-miR-202 UUCCUAUGCAUAUACUUCUUUG AGAGGUAUAGGGCAUGGGAA hsa-miR-203a AGUGGUUCUUAACAGUUCAACAGUU GUGAAAUGUUUAGGACCACUAG hsa-miR-203b UAGUGGUCCUAAACAUUUCACA UUGAACUGUUAAGAACCACUGGA hsa-miR-204 GCUGGGAAGGCAAAGGGACGU UUCCCUUUGUCAUCCUAUGCCU hsa-miR-205 UCCUUCAUUCCACCGGAGUCUG GAUUUCAGUGGAGUGAAGUUC hsa-miR-2052 UGUUUUGAUAACAGUAAUGU AUUACUGUUAUCAAAACAUU hsa-miR-2053 GUGUUAAUUAAACCUCUAUUUAC AAAUAGAGGUUUAAUUAACACUU hsa-miR-2054 CUGUAAUAUAAAUUUAAUUUAUU UAAAUUAAAUUUAUAUUACAGUU hsa-miR-206 UGGAAUGUAAGGAAGUGUGUGG ACACACUUCCUUACAUUCCAUU hsa-miR-208a AUAAGACGAGCAAAAAGCUUGU GAGCUUUUGGCCCGGGUUAUAC hsa-miR-208b AAGCUUUUUGCUCGAAUUAUGU AUAAGACGAACAAAAGGUUUGU hsa-miR-20a UAAAGUGCUUAUAGUGCAGGUAG ACUGCAUUAUGAGCACUUAAAG hsa-miR-20b CAAAGUGCUCAUAGUGCAGGUAG ACUGUAGUAUGGGCACUUCCAG hsa-miR-21 UAGCUUAUCAGACUGAUGUUGA CAACACCAGUCGAUGGGCUGU hsa-miR-210 AGCCCCUGCCCACCGCACACUG CUGUGCGUGUGACAGCGGCUGA hsa-miR-211 GCAGGGACAGCAAAGGGGUGC UUCCCUUUGUCAUCCUUCGCCU hsa-miR-2110 UUGGGGAAACGGCCGCUGAGUG CUCAGCGGCCGUUUCCCCAAUU hsa-miR-2113 AUUUGUGCUUGGCUCUGUCAC GACAGAGCCAAGCACAAAUUU hsa-miR-2114 UAGUCCCUUCCUUGAAGCGGUC CGAGCCUCAAGCAAGGGACUU hsa-miR-2115 CAUCAGAAUUCAUGGAGGCUAG AGCUUCCAUGACUCCUGAUGGA hsa-miR-2116 GGUUCUUAGCAUAGGAGGUCU CCUCCCAUGCCAAGAACUCCC hsa-miR-2117 UGUUCUCUUUGCCAAGGACAG GUCCUUGGCAAAGAGAACAUU hsa-miR-212 UAACAGUCUCCAGUCACGGCC ACCUUGGCUCUAGACUGCUUACU hsa-miR-214 UGCCUGUCUACACUUGCUGUGC ACAGCAGGCACAGACAGGCAGU hsa-miR-215 UCUGUCAUUUCUUUAGGCCAAUA AUGACCUAUGAAUUGACAGAC hsa-miR-216a UAAUCUCAGCUGGCAACUGUGA UCACAGUGGUCUCUGGGAUUAU hsa-miR-216b AAAUCUCUGCAGGCAAAUGUGA ACACACUUACCCGUAGAGAUUCUA hsa-miR-217 UACUGCAUCAGGAACUGAUUGGA CAAUCAGUUCCUGAUGCAGUAUU hsa-miR-218-1 UUGUGCUUGAUCUAACCAUGU AUGGUUCCGUCAAGCACCAUGG hsa-miR-218-2 UUGUGCUUGAUCUAACCAUGU CAUGGUUCUGUCAAGCACCGCG hsa-miR-219a-1 UGAUUGUCCAAACGCAAUUCU AGAGUUGAGUCUGGACGUCCCG hsa-miR-219a-2 UGAUUGUCCAAACGCAAUUCU AGAAUUGUGGCUGGACAUCUGU hsa-miR-219b AGAUGUCCAGCCACAAUUCUCG AGAAUUGCGUUUGGACAAUCAGU hsa-miR-22 AGUUCUUCAGUGGCAAGCUUUA AAGCUGCCAGUUGAAGAACUGU hsa-miR-221 AGCUACAUUGUCUGCUGGGUUUC ACCUGGCAUACAAUGUAGAUUU hsa-miR-222 AGCUACAUCUGGCUACUGGGU CUCAGUAGCCAGUGUAGAUCCU hsa-miR-223 CGUGUAUUUGACAAGCUGAGUU UGUCAGUUUGUCAAAUACCCCA hsa-miR-224 AAAAUGGUGCCCUAGUGACUACA CAAGUCACUAGUGGUUCCGUU hsa-miR-2276 GCCCUCUGUCACCUUGCAGACG UCUGCAAGUGUCAGAGGCGAGG hsa-miR-2277 AGCGCGGGCUGAGCGCUGCCAGUC UGACAGCGCCCUGCCUGGCUC hsa-miR-2278 GAGAGCAGUGUGUGUUGCCUGG AGGCAACACACACUGCUCUCUU hsa-miR-2355 AUCCCCAGAUACAAUGGACAA AUUGUCCUUGCUGUUUGGAGAU hsa-miR-2392 UAGGAUGGGGGUGAGAGGUG CCUCUCACCCCCAUCCUAUU hsa-miR-23a AUCACAUUGCCAGGGAUUUCC GGGGUUCCUGGGGAUGGGAUUU hsa-miR-23b AUCACAUUGCCAGGGAUUACC UGGGUUCCUGGCAUGCUGAUUU hsa-miR-23c AUCACAUUGCCAGUGAUUACCC GUAAUCACUGGCAAUGUGAUUU hsa-miR-24-1 UGGCUCAGUUCAGCAGGAACAG UGCCUACUGAGCUGAUAUCAGU hsa-miR-24-2 UGGCUCAGUUCAGCAGGAACAG UGCCUACUGAGCUGAAACACAG hsa-miR-2467 AGCAGAGGCAGAGAGGCUCAGG UGAGGCUCUGUUAGCCUUGGCUC hsa-miR-25 AGGCGGAGACUUGGGCAAUUG CAUUGCACUUGUCUCGGUCUGA hsa-miR-2681 GUUUUACCACCUCCAGGAGACU UAUCAUGGAGUUGGUAAAGCAC hsa-miR-2682 CGCCUCUUCAGCGCUGUCUUCC CAGGCAGUGACUGUUCAGACGUC hsa-miR-26a-1 UUCAAGUAAUCCAGGAUAGGCU CCUAUUCUUGGUUACUUGCACG hsa-miR-26a-2 UUCAAGUAAUCCAGGAUAGGCU CCUAUUCUUGAUUACUUGUUUC hsa-miR-26b UUCAAGUAAUUCAGGAUAGGU CCUGUUCUCCAUUACUUGGCUC hsa-miR-27a UUCACAGUGGCUAAGUUCCGC AGGGCUUAGCUGCUUGUGAGCA hsa-miR-27b UUCACAGUGGCUAAGUUCUGC AGAGCUUAGCUGAUUGGUGAAC hsa-mmiRR-28 CACUAGAUUGUGAGCUCCUGGA AAGGAGCUCACAGUCUAUUGAG hsa-miR-2861 GGGGCCUGGCGGUGGGCGG GCCCACCGCCAGGCCCCUU hsa-miR-2909 GUUAGGGCCAACAUCUCUUGG AAGAGAUGUUGGCCCUAACUU hsa-miR-296 GAGGGUUGGGUGGAGGCUCUCC AGGGCCCCCCCUCAAUCCUGU hsa-miR-297 AUGUAUGUGUGCAUGUGCAUG UGCACAUGCACACAUACAUUU hsa-miR-298 AGCAGAAGCAGGGAGGUUCUCCCA GGAGAACCUCCCUGCUUCUGCUUU hsa-miR-299 UGGUUUACCGUCCCACAUACAU UAUGUGGGAUGGUAAACCGCUU hsa-miR-29a ACUGAUUUCUUUUGGUGUUCAG UAGCACCAUCUGAAAUCGGUUA hsa-miR-29b-1 UAGCACCAUUUGAAAUCAGUGUU GCUGGUUUCAUAUGGUGGUUUAGA hsa-miR-29b-2 UAGCACCAUUUGAAAUCAGUGUU CUGGUUUCACAUGGUGGCUUAG hsa-miR-29c UGACCGAUUUCUCCUGGUGUUC UAGCACCAUUUGAAAUCGGUUA hsa-miR-300 UAUACAAGGGCAGACUCUCUCU AGAGAGUCUGCCCUUGUAUAUU hsa-miR-301a GCUCUGACUUUAUUGCACUACU CAGUGCAAUAGUAUUGUCAAAGC hsa-miR-301b CAGUGCAAUGAUAUUGUCAAAGC GCUCUGACGAGGUUGCACUACU hsa-miR-302a UAAGUGCUUCCAUGUUUUGGUGA ACUUAAACGUGGAUGUACUUGCU hsa-miR-302b UAAGUGCUUCCAUGUUUUAGUAG ACUUUAACAUGGAAGUGCUUUC hsa-miR-302c UUUAACAUGGGGGUACCUGCUG UAAGUGCUUCCAUGUUUCAGUGG hsa-miR-302d ACUUUAACAUGGAGGCACUUGC UAAGUGCUUCCAUGUUUGAGUGU hsa-miR-302e UAAGUGCUUCCAUGCUU GCAUGGAAGCACUUAUU hsa-miR-302f UAAUUGCUUCCAUGUUU ACAUGGAAGCAAUUAUU hsa-miR-3064 UUGCCACACUGCAACACCUUACA UCUGGCUGUUGUGGUGUGCAA hsa-miR-3065 UCAGCACCAGGAUAUUGUUGGAG UCAACAAAAUCACUGAUGCUGGA hsa-miR-3074 GAUAUCAGCUCAGUAGGCACCG GUUCCUGCUGAACUGAGCCAG hsa-miR-30a CUUUCAGUCGGAUGUUUGCAGC UGUAAACAUCCUCGACUGGAAG hsa-miR-30b UGUAAACAUCCUACACUCAGCU CUGGGAGGUGGAUGUUUACUUC hsa-miR-30c-1 UGUAAACAUCCUACACUCUCAGC CUGGGAGAGGGUUGUUUACUCC hsa-miR-30c-2 UGUAAACAUCCUACACUCUCAGC CUGGGAGAAGGCUGUUUACUCU hsa-miR-30d UGUAAACAUCCCCGACUGGAAG CUUUCAGUCAGAUGUUUGCUGC hsa-miR-30e UGUAAACAUCCUUGACUGGAAG CUUUCAGUCGGAUGUUUACAGC hsa-miR-31 UGCUAUGCCAACAUAUUGCCAU AGGCAAGAUGCUGGCAUAGCU hsa-miR-3115 AUAUGGGUUUACUAGUUGGU CAACUAGUAAACCCAUAUUU hsa-miR-3116 UGCCUGGAACAUAGUAGGGACU UCCCUACUAUGUUCCAGGCAUU hsa-miR-3117 AUAGGACUCAUAUAGUGCCAG AGACACUAUACGAGUCAUAU hsa-miR-3118 UGUGACUGCAUUAUGAAAAUUCU AAUUUUCAUAAUGCAGUCACAUU hsa-miR-3119 UGGCUUUUAACUUUGAUGGC CAUCAAAGUUAAAAGCCAUU hsa-miR-3120 CCUGUCUGUGCCUGCUGUACA CACAGCAAGUGUAGACAGGCA hsa-miR-3121 UCCUUUGCCUAUUCUAUUUAAG UAAAUAGAGUAGGCAAAGGACA hsa-miR-3122 GUUGGGACAAGAGGACGGUCUU GACCGUCCUCUUGUCCCAACUU hsa-miR-3123 CAGAGAAUUGUUUAAUC UUAAACAAUUCUCUGUU hsa-miR-3124 UUCGCGGGCGAAGGCAAAGUC ACUUUCCUCACUCCCGUGAAGU hsa-miR-3125 UAGAGGAAGCUGUGGAGAGA UCUCCACAGCUUCCUCUAUU hsa-miR-3126 CAUCUGGCAUCCGUCACACAGA UGAGGGACAGAUGCCAGAAGCA hsa-miR-3127 UCCCCUUCUGCAGGCCUGCUGG AUCAGGGCUUGUGGAAUGGGAAG hsa-miR-3128 UCUGGCAAGUAAAAAACUCUCAU GAGAGUUUUUUACUUGCCAGAUU hsa-miR-3129 GCAGUAGUGUAGAGAUUGGUUU AAACUAAUCUCUACACUGCUGC hsa-miR-3130 GCUGCACCGGAGACUGGGUAA UACCCAGUCUCCGGUGCAGCC hsa-miR-3131 UCGAGGACUGGUGGAAGGGCCUU GGCCCUUCCACCAGUCCUCGAUU hsa-miR-3132 UGGGUAGAGAAGGAGCUCAGAGGA CUCUGAGCUCCUUCUCUACCCAUU hsa-miR-3133 UAAAGAACUCUUAAAACCCAAU UGGGUUUUAAGAGUUCUUUAUU hsa-miR-3134 UGAUGGAUAAAAGACUACAUAUU UAUGUAGUCUUUUAUCCAUCAUU hsa-miR-3135a UGCCUAGGCUGAGACUGCAGUG CUGCAGUCUCAGCCUAGGCAUU hsa-miR-3135b GGCUGGAGCGAGUGCAGUGGUG CCACUGCACUCGCUCCAGCCUU hsa-miR-3136 CUGACUGAAUAGGUAGGGUCAUU UGGCCCAACCUAUUCAGUUAGU hsa-miR-3137 UCUGUAGCCUGGGAGCAAUGGGGU CCCAUUGCUCCCAGGCUACAGAUU hsa-miR-3138 UGUGGACAGUGAGGUAGAGGGAGU UCCCUCUACCUCACUGUCCACAUU hsa-miR-3139 UAGGAGCUCAACAGAUGCCUGUU CAGGCAUCUGUUGAGCUCCUAUU hsa-miR-3140 ACCUGAAUUACCAAAAGCUUU AGCUUUUGGGAAUUCAGGUAGU hsa-miR-3141 GAGGGCGGGUGGAGGAGGA CUCCUCCACCCGCCCUCUU hsa-miR-3142 AAGGCCUUUCUGAACCUUCAGA UGAAGGUUCAGAAAGGCCUUUU hsa-miR-3143 AUAACAUUGUAAAGCGCUUCUUUCG AAAGAAGCGCUUUACAAUGUUAUUU hsa-miR-3144 AUAUACCUGUUCGGUCUCUUUA AGGGGACCAAAGAGAUAUAUAG hsa-miR-3145 AGAUAUUUUGAGUGUUUGGAAUUG AACUCCAAACACUCAAAACUCA hsa-miR-3146 CAUGCUAGGAUAGAAAGAAUGG AUUCUUUCUAUCCUAGCAUGUU hsa-miR-3147 GGUUGGGCAGUGAGGAGGGUGUGA ACACCCUCCUCACUGCCCAACCUU hsa-miR-3148 UGGAAAAAACUGGUGUGUGCUU GCACACACCAGUUUUUUCCAUU hsa-miR-3149 UUUGUAUGGAUAUGUGUGUGUAU ACACACACAUAUCCAUACAAAUU hsa-miR-3150a CAACCUCGACGAUCUCCUCAGC CUGGGGAGAUCCUCGAGGUUGG hsa-miR-3150b CAACCUCGAGGAUCUCCCCAGC UGAGGAGAUCGUCGAGGUUGG hsa-miR-3151 GGUGGGGCAAUGGGAUCAGGU CCUGAUCCCACAGCCCACCU hsa-miR-3152 AUUGCCUCUGUUCUAACACAAG UGUGUUAGAAUAGGGGCAAUAA hsa-miR-3153 GGGGAAAGCGAGUAGGGACAUUU AUGUCCCUACUCGCUUUCCCCUU hsa-miR-3154 CAGAAGGGGAGUUGGGAGCAGA UGCUCCCAACUCCCCUUCUGUU hsa-miR-3155a CCAGGCUCUGCAGUGGGAACU UUCCCACUGCAGAGCCUGGUU hsa-miR-3155b CCAGGCUCUGCAGUGGGA CCACUGCAGAGCCUGGUU hsa-miR-3156 CUCCCACUUCCAGAUCUUUCU AAAGAUCUGGAAGUGGGAGACA hsa-miR-3157 CUGCCCUAGUCUAGCUGAAGCU UUCAGCCAGGCUAGUGCAGUCU hsa-miR-3158 AAGGGCUUCCUCUCUGCAGGAC CCUGCAGAGAGGAAGCCCUUC hsa-miR-3159 UAGGAUUACAAGUGUCGGCCAC GGCCGACACUUGUAAUCCUAUU hsa-miR-3160 AGAGCUGAGACUAGAAAGCCCA GGCUUUCUAGUCUCAGCUCUCC hsa-miR-3161 CUGAUAAGAACAGAGGCCCAGAU CUGGGCCUCUGUUCUUAUCAGUU hsa-miR-3162 UUAGGGAGUAGAAGGGUGGGGAG UCCCUACCCCUCCACUCCCCA hsa-miR-3163 UAUAAAAUGAGGGCAGUAAGAC CUUACUGCCCUCAUUUUAUAUU hsa-miR-3164 UGUGACUUUAAGGGAAAUGGCG CCAUUUCCCUUAAAGUCACAUU hsa-miR-3165 AGGUGGAUGCAAUGUGACCUCA AGGUCACAUUGCAUCCACCUUU hsa-miR-3166 CGCAGACAAUGCCUACUGGCCUA GGCCAGUAGGCAUUGUCUGCGUU hsa-miR-3167 AGGAUUUCAGAAAUACUGGUGU ACCAGUAUUUCUGAAAUCCUUU hsa-miR-3168 GAGUUCUACAGUCAGAC CUGACUGUAGAACUCUU hsa-miR-3169 UAGGACUGUGCUUGGCACAUAG AUGUGCCAAGCACAGUCCUAUU hsa-miR-3170 CUGGGGUUCUGAGACAGACAGU UGUCUGUCUCAGAACCCCAGUU hsa-miR-3171 AGAUGUAUGGAAUCUGUAUAUAUC UAUAUACAGAUUCCAUACAUCUUU hsa-miR-3173 AAAGGAGGAAAUAGGCAGGCCA UGCCCUGCCUGUUUUCUCCUUU hsa-miR-3174 UAGUGAGUUAGAGAUGCAGAGCC CUCUGCAUCUCUAACUCACUAUU hsa-miR-3175 CGGGGAGAGAACGCAGUGACGU GUCACUGCGUUCUCUCCCCGUU hsa-miR-3176 ACUGGCCUGGGACUACCGG GGUAGUCCCAGGCCAGUUU hsa-miR-3177 UGUGUACACACGUGCCAGGCGCU UGCACGGCACUGGGGACACGU hsa-miR-3178 GGGGCGCGGCCGGAUCG AUCCGGCCGCGCCCCUU hsa-miR-3179 AGAAGGGGUGAAAUUUAAACGU GUUUAAAUUUCACCCCUUCUUU hsa-miR-3180 CUUCCAGACGCUCCGCCCCACGUCG UGGGGCGGAGCUUCCGGAGGCC hsa-miR-3181 AUCGGGCCCUCGGCGCCGG GGCGCCGAGGGCCCGAUUU hsa-miR-3182 GCUUCUGUAGUGUAGUC CUACACUACAGAAGCUU hsa-miR-3183 GCCUCUCUCGGAGUCGCUCGGA CGAGCGACUCCGAGAGAGGCUU hsa-miR-3184 AAAGUCUCGCUCUCUGCCCCUCA UGAGGGGCCUCAGACCGAGCUUUU hsa-miR-3185 AGAAGAAGGCGGUCGGUCUGCGG GCAGACCGACCGCCUUCUUCUUU hsa-miR-3186 CAGGCGUCUGUCUACGUGGCUU UCACGCGGAGAGAUGGCUUUG hsa-miR-3187 UUGGCCAUGGGGCUGCGCGG CCUGGGCAGCGUGUGGCUGAAGG hsa-miR-3188 AGAGGCUUUGUGCGGAUACGGGG CCGUAUCCGCACAAAGCCUCUUU hsa-miR-3189 CCCUUGGGUCUGAUGGGGUAG UGCCCCAUCUGUGCCCUGGGUAGGA hsa-miR-3190 UGUGGAAGGUAGACGGCCAGAGA UCUGGCCAGCUACGUCCCCA hsa-miR-3191 CUCUCUGGCCGUCUACCUUCCA UGGGGACGUAGCUGGCCAGACAG hsa-miR-3192 UCUGGGAGGUUGUAGCAGUGGAA CUCUGAUCGCCCUCUCAGCUC hsa-miR-3193 UCCUGCGUAGGAUCUGAGGAGU UCCUCAGAUCCUACGCAGGAUU hsa-miR-3194 AGCUCUGCUGCUCACUGGCAGU GGCCAGCCACCAGGAGGGCUG hsa-miR-3195 CGCGCCGGGCCCGGGUU CCCGGGCCCGGCGCGUU hsa-miR-3196 CGGGGCGGCAGGGGCCUC GGCCCCUGCCGCCCCGUU hsa-miR-3197 GGAGGCGCAGGCUCGGAAAGGCG CCUUUCCGAGCCUGCGCCUCCUU hsa-miR-3198 GUGGAGUCCUGGGGAAUGGAGA UCCAUUCCCCAGGACUCCACUU hsa-miR-3199 AGGGACUGCCUUAGGAGAAAGUU CUUUCUCCUAAGGCAGUCCCUUU hsa-miR-32 CAAUUUAGUGUGUGUGAUAUUU UAUUGCACAUUACUAAGUUGCA hsa-miR-3200 CACCUUGCGCUACUCAGGUCUG AAUCUGAGAAGGCGCACAAGGU hsa-miR-3201 GGGAUAUGAAGAAAAAU UUUUCUUCAUAUCCCUU hsa-miR-3202 UGGAAGGGAGAAGAGCUUUAAU UAAAGCUCUUCUCCCUUCCAUU hsa-miR-320a AAAAGCUGGGUUGAGAGGGCGA GCCCUCUCAACCCAGCUUUUUU hsa-miR-320b AAAAGCUGGGUUGAGAGGGCAA GCCCUCUCAACCCAGCUUUUUU hsa-miR-320c AAAAGCUGGGUUGAGAGGGU CCUCUCAACCCAGCUUUUUU hsa-miR-320d AAAAGCUGGGUUGAGAGGA CUCUCAACCCAGCUUUUUU hsa-miR-320e AAAGCUGGGUUGAGAAGG UUCUCAACCCAGCUUUUU hsa-miR-323a AGGUGGUCCGUGGCGCGUUCGC CACAUUACACGGUCGACCUCU hsa-miR-323b AGGUUGUCCGUGGUGAGUUCGCA CCCAAUACACGGUCGACCUCUU hsa-miR-324 CGCAUCCCCUAGGGCAUUGGUGU ACUGCCCCAGGUGCUGCUGG hsa-miR-325 CCUAGUAGGUGUCCAGUAAGUGU ACUUACUGGACACCUACUAGGUU hsa-miR-326 CCUCUGGGCCCUUCCUCCAG GGAGGAAGGGCCCAGAGGUU hsa-miR-328 CUGGCCCUCUCUGCCCUUCCGU GGGGGGGCAGGAGGGGCUCAGGG hsa-miR-329 AACACACCUGGUUAACCUCUUU GAGGUUUUCUGGGUUUCUGUUUC hsa-miR-330 GCAAAGCACACGGCCUGCAGAGA UCUCUGGGCCUGUGUCUUAGGC hsa-miR-331 CUAGGUAUGGUCCCAGGGAUCC GCCCCUGGGCCUAUCCUAGAA hsa-miR-335 UCAAGAGCAAUAACGAAAAAUGU UUUUUCAUUAUUGCUCCUGACC hsa-miR-337 GAACGGCUUCAUACAGGAGUU CUCCUAUAUGAUGCCUUUCUUC hsa-miR-338 UCCAGCAUCAGUGAUUUUGUUG AACAAUAUCCUGGUGCUGAGUG hsa-miR-339 UGAGCGCCUCGACGACAGAGCCG UCCCUGUCCUCCAGGAGCUCACG hsa-miR-33a GUGCAUUGUAGUUGCAUUGCA CAAUGUUUCCACAGUGCAUCAC hsa-miR-33b GUGCAUUGCUGUUGCAUUGC CAGUGCCUCGGCAGUGCAGCCC hsa-miR-340 UCCGUCUCAGUUACUUUAUAGC UUAUAAAGCAAUGAGACUGAUU hsa-miR-342 UCUCACACAGAAAUCGCACCCGU AGGGGUGCUAUCUGUGAUUGA hsa-miR-345 GCCCUGAACGAGGGGUCUGGAG GCUGACUCCUAGUCCAGGGCUC hsa-miR-346 UGUCUGCCCGCAUGCCUGCCUCU AGGCAGGCAUGCGGGCAGACAUU hsa-miR-34a UGGCAGUGUCUUAGCUGGUUGU CAAUCAGCAAGUAUACUGCCCU hsa-miR-34b UAGGCAGUGUCAUUAGCUGAUUG CAAUCACUAACUCCACUGCCAU hsa-miR-34c AAUCACUAACCACACGGCCAGG AGGCAGUGUAGUUAGCUGAUUGC hsa-miR-3529 AACAACAAAAUCACUAGUCUUCCA AGGUAGACUGGGAUUUGUUGUU hsa-miR-3591 AAACACCAUUGUCACACUCCAC UUUAGUGUGAUAAUGGCGUUUGA hsa-miR-3605 CCUCCGUGUUACCUGUCCUCUAG UGAGGAUGGAUAGCAAGGAAGCC hsa-miR-3606 UUAGUGAAGGCUAUUUUAAUU AAAAUUUCUUUCACUACUUAG hsa-miR-3607 ACUGUAAACGCUUUCUGAUG GCAUGUGAUGAAGCAAAUCAGU hsa-miR-3609 CAAAGUGAUGAGUAAUACUGGCUG GCCAGUAUUACUCAUCACUUUGUU hsa-miR-361 UCCCCCAGGUGUGAUUCUGAUUU UUAUCAGAAUCUCCAGGGGUAC hsa-miR-3610 GAAUCGGAAAGGAGGCGCCG GCGCCUCCUUUCCGAUUCUU hsa-miR-3611 UUGUGAAGAAAGAAAUUCUUA AGAAUUUCUUUCUUCACAAUU hsa-miR-3612 AGGAGGCAUCUUGAGAAAUGGA CAUUUCUCAAGAUGCCUCCUUU hsa-miR-3613 UGUUGUACUUUUUUUUUUGUUC ACAAAAAAAAAAGCCCAACCCUUC hsa-miR-3614 CCACUUGGAUCUGAAGGCUGCCC UAGCCUUCAGAUCUUGGUGUUUU hsa-miR-3615 UCUCUCGGCUCCUCGCGGCUC GCCGCGAGGAGCCGAGAGAUU hsa-miR-3616 AUGAAGUGCACUCAUGAUAUGU CGAGGGCAUUUCAUGAUGCAGGC hsa-miR-3617 CAUCAGCACCCUAUGUCCUUUCU AAAGACAUAGUUGCAAGAUGGG hsa-miR-3618 UGUCUACAUUAAUGAAAAGAGC UCUUUUCAUUAAUGUAGACAUU hsa-miR-3619 UCAGCAGGCAGGCUGGUGCAGC GGGACCAUCCUGCCUGCUGUGG hsa-miR-362 AACACACCUAUUCAAGGAUUCA AAUCCUUGGAACCUAGGUGUGAGU hsa-miR-3620 UCACCCUGCAUCCCGCACCCAG GUGGGCUGGGCUGGGCUGGGCC hsa-miR-3621 CGCGGGUCGGGGUCUGCAGG UGCAGACCCCGACCCGCGUU hsa-miR-3622a UCACCUGACCUCCCAUGCCUGU CAGGCACGGGAGCUCAGGUGAG hsa-miR-3622b UCACCUGAGCUCCCGUGCCUG AGGCAUGGGAGGUCAGGUGA hsa-miR-363 AAUUGCACGGUAUCCAUCUGUA CGGGUGGAUCACGAUGCAAUUU hsa-miR-3646 AAAAUGAAAUGAGCCCAGCCCA GGCUGGGCUCAUUUCAUUUUUU hsa-miR-3648 AGCCGCGGGGAUCGCCGAGGG CUCGGCGAUCCCCGCGGCUUU hsa-miR-3649 AGGGACCUGAGUGUCUAAG UAGACACUCAGGUCCCUUU hsa-miR-3650 AGGUGUGUCUGUAGAGUCC ACUCUACAGACACACCUUU hsa-miR-3651 CAUAGCCCGGUCGCUGGUACAUGA AUGUACCAGCGACCGGGCUAUGUU hsa-miR-3652 CGGCUGGAGGUGUGAGGA CUCACACCUCCAGCCGUU hsa-miR-3653 CCUCCUGAUGAUUCUUCUUC CUAAGAAGUUGACUGAAG hsa-miR-3654 GACUGGACAAGCUGAGGAA CCUCAGCUUGUCCAGUCUU hsa-miR-3655 GCUUGUCGCUGCGGUGUUGCU CAACACCGCAGCGACAAGCUU hsa-miR-3656 GGCGGGUGCGGGGGUGG ACCCCCGCACCCGCCUU hsa-miR-3657 UGUGUCCCAUUAUUGGUGAUU UCACCAAUAAUGGGACACAUU hsa-miR-3658 UUUAAGAAAACACCAUGGAGAU CUCCAUGGUGUUUUCUUAAAUU hsa-miR-3659 UGAGUGUUGUCUACGAGGGCA CCCUCGUAGACAACACUCAUU hsa-miR-365a UAAUGCCCCUAAAAAUCCUUAU AGGGACUUUUGGGGGCAGAUGUG hsa-miR-365b UAAUGCCCCUAAAAAUCCUUAU AGGGACUUUCAGGGGCAGCUGU hsa-miR-3660 ACUGACAGGAGAGCAUUUUGA AAAAUGCUCUCCUGUCAGUUU hsa-miR-3661 UGACCUGGGACUCGGACAGCUG GCUGUCCGAGUCCCAGGUCAUU hsa-miR-3662 GAAAAUGAUGAGUAGUGACUGAUG UCAGUCACUACUCAUCAUUUUCUU hsa-miR-3663 UGAGCACCACACAGGCCGGGCGC GCUGGUCUGCGUGGUGCUCGG hsa-miR-3664 UCUCAGGAGUAAAGACAGAGUU AACUCUGUCUUCACUCAUGAGU hsa-miR-3665 AGCAGGUGCGGGGCGGCG CCGCCCCGCACCUGCUUU hsa-miR-3666 CAGUGCAAGUGUAGAUGCCGA GGCAUCUACACUUGCACUGUU hsa-miR-3667 ACCUUCCUCUCCAUGGGUCUUU AAAGACCCAUUGAGGAGAAGGU hsa-miR-3668 AAUGUAGAGAUUGAUCAAAAU UUUGAUCAAUCUCUACAUUUU hsa-miR-367 AAUUGCACUUUAGCAAUGGUGA ACUGUUGCUAAUAUGCAACUCU hsa-miR-3670 AGAGCUCACAGCUGUCCUUCUCUA GAGAAGGACAGCUGUGAGCUCUUU hsa-miR-3671 AUCAAAUAAGGACUAGUCUGCA CAGACUAGUCCUUAUUUGAUUU hsa-miR-3672 AUGAGACUCAUGUAAAACAUCUU GAUGUUUUACAUGAGUCUCAUUU hsa-miR-3674 AUUGUAGAACCUAAGAUUGGCC CCAAUCUUAGGUUCUACAAUUU hsa-miR-3675 CAUCUCUAAGGAACUCCCCCAA UAUGGGGCUUCUGUAGAGAUUUC hsa-miR-3677 CAGUGGCCAGAGCCCUGCAGUG CUCGUGGGCUCUGGCCACGGCC hsa-miR-3678 CUGCAGAGUUUGUACGGACCGG UCCGUACAAACUCUGCUGUG hsa-miR-3679 CUUCCCCCCAGUAAUCUUCAUC UGAGGAUAUGGCAGGGAAGGGGA hsa-miR-3680 GACUCACUCACAGGAUUGUGCA UUUUGCAUGACCCUGGGAGUAGG hsa-miR-3681 UAGUGGAUGAUGCACUCUGUGC ACACAGUGCUUCAUCCACUACU hsa-miR-3682 CUACUUCUACCUGUGUUAUCAU UGAUGAUACAGGUGGAGGUAG hsa-miR-3683 UGCGACAUUGGAAGUAGUAUCA AUACUACUUCCAAUGUCGCAUU hsa-miR-3684 UUAGACCUAGUACACGUCCUU GGACGUGUACUAGGUCUAAUU hsa-miR-3685 UUUCCUACCCUACCUGAAGACU UCUUCAGGUAGGGUAGGAAAUU hsa-miR-3686 AUCUGUAAGAGAAAGUAAAUGA AUUUACUUUCUCUUACAGAUUU hsa-miR-3687 CCCGGACAGGCGUUCGUGCGACGU GUCGCACGAACGCCUGUCCGGGUU hsa-miR-3688 UAUGGAAAGACUUUGCCACUCU AGUGGCAAAGUCUUUCCAUAU hsa-miR-3689a CUGGGAGGUGUGAUAUCGUGGU UGUGAUAUCAUGGUUCCUGGGA hsa-miR-3689b CUGGGAGGUGUGAUAUUGUGGU UGUGAUAUCAUGGUUCCUGGGA hsa-miR-3689c CUGGGAGGUGUGAUAUUGUGGU CACAAUAUCACACCUCCCAGUU hsa-miR-3689d GGGAGGUGUGAUCUCACACUCG AGUGUGAGAUCACACCUCCCUU hsa-miR-3689e UGUGAUAUCAUGGUUCCUGGGA CCAGGAACCAUGAUAUCACAUU hsa-miR-3689f UGUGAUAUCGUGCUUCCUGGGA CCAGGAAGCACGAUAUCACAUU hsa-miR-369 AAUAAUACAUGGUUGAUCUUU AGAUCGACCGUGUUAUAUUCGC hsa-miR-3690 ACCUGGACCCAGCGUAGACAAAG UUGUCUACGCUGGGUCCAGGUUU hsa-miR-3691 AGUGGAUGAUGGAGACUCGGUAC ACCAAGUCUGCGUCAUCCUCUC hsa-miR-3692 GUUCCACACUGACACUGCAGAAGU CCUGCUGGUCAGGAGUGGAUACUG hsa-miR-370 GCCUGCUGGGGUGGAACCUGGU CAGGUCACGUCUCUGCAGUUAC hsa-miR-3713 GGUAUCCGUUUGGGGAUGGU CAUCCCCAAACGGAUACCUU hsa-miR-3714 GAAGGCAGCAGUGCUCCCCUGU AGGGGAGCACUGCUGCCUUCUU hsa-miR-371a ACUCAAACUGUGGGGGCACU AAGUGCCGCCAUCUUUUGAGUGU hsa-miR-371b ACUCAAAAGAUGGCGGCACUUU AAGUGCCCCCACAGUUUGAGUGC hsa-miR-372 CCUCAAAUGUGGAGCACUAUUCU AAAGUGCUGCGACAUUUGAGCGU hsa-miR-373 GAAGUGCUUCGAUUUUGGGGUGU ACUCAAAAUGGGGGCGCUUUCC hsa-miR-374a UUAUAAUACAACCUGAUAAGUG CUUAUCAGAUUGUAUUGUAAUU hsa-miR-374b CUUAGCAGGUUGUAUUAUCAUU AUAUAAUACAACCUGCUAAGUG hsa-miR-374c CACUUAGCAGGUUGUAUUAUAU AUAAUACAACCUGCUAAGUGCU hsa-miR-375 UUUGUUCGUUCGGCUCGCGUGA ACGCGAGCCGAACGAACAAAUU hsa-miR-376a-1 AUCAUAGAGGAAAAUCCACGU GUAGAUUCUCCUUCUAUGAGUA hsa-miR-376a-2 AUCAUAGAGGAAAAUCCACGU GGUAGAUUUUCCUUCUAUGGU hsa-miR-376b CGUGGAUAUUCCUUCUAUGUUU AUCAUAGAGGAAAAUCCAUGUU hsa-miR-376c GGUGGAUAUUCCUUCUAUGUU AACAUAGAGGAAAUUCCACGU hsa-miR-377 AGAGGUUGCCCUUGGUGAAUUC AUCACACAAAGGCAACUUUUGU hsa-miR-378a CUCCUGACUCCAGGUCCUGUGU ACUGGACUUGGAGUCAGAAGGC hsa-miR-378b ACUGGACUUGGAGGCAGAA CUGCCUCCAAGUCCAGUUU hsa-miR-378c ACUGGACUUGGAGUCAGAAGAGUGG ACUCUUCUGACUCCAAGUCCAGUUU hsa-miR-378d ACUGGACUUGGAGUCAGAAA UCUGACUCCAAGUCCAGUUU hsa-miR-378e ACUGGACUUGGAGUCAGGA CUGACUCCAAGUCCAGUUU hsa-miR-378f ACUGGACUUGGAGCCAGAAG UCUGGCUCCAAGUCCAGUUU hsa-miR-378g ACUGGGCUUGGAGUCAGAAG UCUGACUCCAAGCCCAGUUU hsa-miR-378h ACUGGACUUGGUGUCAGAUGG AUCUGACACCAAGUCCAGUUU hsa-miR-378i ACUGGACUAGGAGUCAGAAGG UUCUGACUCCUAGUCCAGUUU hsa-miR-378j ACUGGAUUUGGAGCCAGAA CUGGCUCCAAAUCCAGUUU hsa-miR-379 UGGUAGACUAUGGAACGUAGG UAUGUAACAUGGUCCACUAACU hsa-miR-380 UGGUUGACCAUAGAACAUGCGC UAUGUAAUAUGGUCCACAUCUU hsa-miR-381 AGCGAGGUUGCCCUUUGUAUAU UAUACAAGGGCAAGCUCUCUGU hsa-miR-382 AAUCAUUCACGGACAACACUU GAAGUUGUUCGUGGUGGAUUCG hsa-miR-383 ACAGCACUGCCUGGUCAGA AGAUCAGAAGGUGAUUGUGGCU hsa-miR-384 AUUCCUAGAAAUUGUUCAUA UGAACAAUUUCUAGGAAUUU hsa-miR-3907 AGGUGCUCCAGGCUGGCUCACA UGAGCCAGCCUGGAGCACCUUU hsa-miR-3908 GAGCAAUGUAGGUAGACUGUUU ACAGUCUACCUACAUUGCUCUU hsa-miR-3909 UGUCCUCUAGGGCCUGCAGUCU ACUGCAGGCCCUAGAGGACAUU hsa-miR-3910 AAAGGCAUAAAACCAAGACA UCUUGGUUUUAUGCCUUUUU hsa-miR-3911 UGUGUGGAUCCUGGAGGAGGCA CCUCCUCCAGGAUCCACACAUU hsa-miR-3912 UAACGCAUAAUAUGGACAUGU AUGUCCAUAUUAUGGGUUAGU hsa-miR-3913 UUUGGGACUGAUCUUGAUGUCU AGACAUCAAGAUCAGUCCCAAA hsa-miR-3914 AAGGAACCAGAAAAUGAGAAGU UUCUCAUUUUCUGGUUCCUUUU hsa-miR-3915 UUGAGGAAAAGAUGGUCUUAUU UAAGACCAUCUUUUCCUCAAUU hsa-miR-3916 AAGAGGAAGAAAUGGCUGGUUCUCAG GAGAACCAGCCAUUUCUUCCUCUUUU hsa-miR-3917 GCUCGGACUGAGCAGGUGGG CACCUGCUCAGUCCGAGCUU hsa-miR-3918 ACAGGGCCGCAGAUGGAGACU UCUCCAUCUGCGGCCCUGUUU hsa-miR-3919 GCAGAGAACAAAGGACUCAGU UGAGUCCUUUGUUCUCUGCUU hsa-miR-3920 ACUGAUUAUCUUAACUCUCUGA AGAGAGUUAAGAUAAUCAGUUU hsa-miR-3921 UCUCUGAGUACCAUAUGCCUUGU AAGGCAUAUGGUACUCAGAGAUU hsa-miR-3922 UCUGGCCUUGACUUGACUCUUU UCAAGGCCAGAGGUCCCACAGCA hsa-miR-3923 AACUAGUAAUGUUGGAUUAGGG CUAAUCCAACAUUACUAGUUUU hsa-miR-3924 AUAUGUAUAUGUGACUGCUACU UAGCAGUCACAUAUACAUAUUU hsa-miR-3925 AAGAGAACUGAAAGUGGAGCCU ACUCCAGUUUUAGUUCUCUUG hsa-miR-3926 UGGCCAAAAAGCAGGCAGAGA UCUGCCUGCUUUUUGGCCAUU hsa-miR-3927 CAGGUAGAUAUUUGAUAGGCAU GCCUAUCACAUAUCUGCCUGU hsa-miR-3928 UGAAGCUCUAAGGUUCCGCCUGC GGAGGAACCUUGGAGCUUCGGC hsa-miR-3929 GAGGCUGAUGUGAGUAGACCACU UGGUCUACUCACAUCAGCCUCUU hsa-miR-3934 UCAGGUGUGGAAACUGAGGCAG UGCUCAGGUUGCACAGCUGGGA hsa-miR-3935 UGUAGAUACGAGCACCAGCCAC GGCUGGUGCUCGUAUCUACAUU hsa-miR-3936 UAAGGGGUGUAUGGCAGAUGCA CAUCUGCCAUACACCCCUUAUU hsa-miR-3937 ACAGGCGGCUGUAGCAAUGGGGG CCCAUUGCUACAGCCGCCUGUUU hsa-miR-3938 AAUUCCCUUGUAGAUAACCCGG GGGUUAUCUACAAGGGAAUUUU hsa-miR-3939 UACGCGCAGACCACAGGAUGUC CAUCCUGUGGUCUGCGCGUAUU hsa-miR-3940 GUGGGUUGGGGCGGGCUCUG CAGCCCGGAUCCCAGCCCACUU hsa-miR-3941 UUACACACAACUGAGGAUCAUA UGAUCCUCAGUUGUGUGUAAUU hsa-miR-3942 AAGCAAUACUGUUACCUGAAAU UUUCAGAUAACAGUAUUACAU hsa-miR-3943 UAGCCCCCAGGCUUCACUUGGCG CCAAGUGAAGCCUGGGGGCUAUU hsa-miR-3944 UUCGGGCUGGCCUGCUGCUCCGG UGUGCAGCAGGCCAACCGAGA hsa-miR-3945 AGGGCAUAGGAGAGGGUUGAUAU AUCAACCCUCUCCUAUGCCCUUU hsa-miR-3960 GGCGGCGGCGGAGGCGGGGG CCCGCCUCCGCCGCCGCCUU hsa-miR-3972 CUGCCAGCCCCGUUCCAGGGCA CCCUGGAACGGGGCUGGCAGUU hsa-miR-3973 ACAAAGUACAGCAUUAGCCUUAG AAGGCUAAUGCUGUACUUUGUUU hsa-miR-3974 AAAGGUCAUUGUAAGGUUAAUGC AUUAACCUUACAAUGACCUUUUU hsa-miR-3975 UGAGGCUAAUGCACUACUUCAC GAAGUAGUGCAUUAGCCUCAUU hsa-miR-3976 UAUAGAGAGCAGGAAGAUUAAUGU AUUAAUCUUCCUGCUCUCUAUAUU hsa-miR-3977 GUGCUUCAUCGUAAUUAACCUUA AGGUUAAUUACGAUGAAGCACUU hsa-miR-3978 GUGGAAAGCAUGCAUCCAGGGUGU ACCCUGGAUGCAUGCUUUCCACUU hsa-miR-409 GAAUGUUGCUCGGUGAACCCCU AGGUUACCCGAGCAACUUUGCAU hsa-miR-410 AGGUUGUCUGUGAUGAGUUCG AAUAUAACACAGAUGGCCUGU hsa-miR-411 UAUGUAACACGGUCCACUAACC UAGUAGACCGUAUAGCGUACG hsa-miR-412 UGGUCGACCAGUUGGAAAGUAAU ACUUCACCUGGUCCACUAGCCGU hsa-miR-421 AUCAACAGACAUUAAUUGGGCGC GCCCAAUUAAUGUCUGUUGAUUU hsa-miR-422a ACUGGACUUAGGGUCAGAAGGC CUUCUGACCCUAAGUCCAGUUU hsa-miR-423 UGAGGGGCAGAGAGCGAGACUUU AGCUCGGUCUGAGGCCCCUCAGU hsa-miR-424 CAGCAGCAAUUCAUGUUUUGAA CAAAACGUGAGGCGCUGCUAU hsa-miR-425 AUCGGGAAUGUCGUGUCCGCCC AAUGACACGAUCACUCCCGUUGA hsa-miR-4251 CCUGAGAAAAGGGCCAA GGCCCUUUUCUCAGGUU hsa-miR-4252 GGCCACUGAGUCAGCACCA GUGCUGACUCAGUGGCCUU hsa-miR-4253 AGGGCAUGUCCAGGGGGU CCCCUGGACAUGCCCUUU hsa-miR-4254 GCCUGGAGCUACUCCACCAUCUC GAUGGUGGAGUAGCUCCAGGCUU hsa-miR-4255 CAGUGUUCAGAGAUGGA CAUCUCUGAACACUGUU hsa-miR-4256 AUCUGACCUGAUGAAGGU CUUCAUCAGGUCAGAUUU hsa-miR-4257 CCAGAGGUGGGGACUGAG CAGUCCCCACCUCUGGUU hsa-miR-4258 CCCCGCCACCGCCUUGG AAGGCGGUGGCGGGGUU hsa-miR-4259 CAGUUGGGUCUAGGGGUCAGGA CUGACCCCUAGACCCAACUGUU hsa-miR-4260 CUUGGGGCAUGGAGUCCCA GGACUCCAUGCCCCAAGUU hsa-miR-4261 AGGAAACAGGGACCCA GGUCCCUGUUUCCUUU hsa-miR-4262 GACAUUCAGACUACCUG GGUAGUCUGAAUGUCUU hsa-miR-4263 AUUCUAAGUGCCUUGGCC CCAAGGCACUUAGAAUUU hsa-miR-4264 ACUCAGUCAUGGUCAUU UGACCAUGACUGAGUUU hsa-miR-4265 CUGUGGGCUCAGCUCUGGG CAGAGCUGAGCCCACAGUU hsa-miR-4266 CUAGGAGGCCUUGGCC CCAAGGCCUCCUAGUU hsa-miR-4267 UCCAGCUCGGUGGCAC GCCACCGAGCUGGAUU hsa-miR-4268 GGCUCCUCCUCUCAGGAUGUG CAUCCUGAGAGGAGGAGCCUU hsa-miR-4269 GCAGGCACAGACAGCCCUGGC CAGGGCUGUCUGUGCCUGCUU hsa-miR-4270 UCAGGGAGUCAGGGGAGGGC CCUCCCCUGACUCCCUGAUU hsa-miR-4271 GGGGGAAGAAAAGGUGGGG CCACCUUUUCUUCCCCCUU hsa-miR-4272 CAUUCAACUAGUGAUUGU AAUCACUAGUUGAAUGUU hsa-miR-4273 GUGUUCUCUGAUGGACAG GUCCAUCAGAGAACACUU hsa-miR-4274 CAGCAGUCCCUCCCCCUG GGGGGAGGGACUGCUGUU hsa-miR-4275 CCAAUUACCACUUCUUU AGAAGUGGUAAUUGGUU hsa-miR-4276 CUCAGUGACUCAUGUGC ACAUGAGUCACUGAGUU hsa-miR-4277 GCAGUUCUGAGCACAGUACAC GUACUGUGCUCAGAACUGCUU hsa-miR-4278 CUAGGGGGUUUGCCCUUG AGGGCAAACCCCCUAGUU hsa-miR-4279 CUCUCCUCCCGGCUUC AGCCGGGAGGAGAGUU hsa-miR-4280 GAGUGUAGUUCUGAGCAGAGC UCUGCUCAGAACUACACUCUU hsa-miR-4281 GGGUCCCGGGGAGGGGGG CCCCUCCCCGGGACCCUU hsa-miR-4282 UAAAAUUUGCAUCCAGGA CUGGAUGCAAAUUUUAUU hsa-miR-4283 UGGGGCUCAGCGAGUUU ACUCGCUGAGCCCCAUU hsa-miR-4284 GGGCUCACAUCACCCCAU GGGGUGAUGUGAGCCCUU hsa-miR-4285 GCGGCGAGUCCGACUCAU GAGUCGGACUCGCCGCUU hsa-miR-4286 ACCCCACUCCUGGUACC UACCAGGAGUGGGGUUU hsa-miR-4287 UCUCCCUUGAGGGCACUUU AGUGCCCUCAAGGGAGAUU hsa-miR-4288 UUGUCUGCUGAGUUUCC AAACUCAGCAGACAAUU hsa-miR-4289 GCAUUGUGCAGGGCUAUCA AUAGCCCUGCACAAUGCUU hsa-miR-429 UAAUACUGUCUGGUAAAACCGU GGUUUUACCAGACAGUAUUAUU hsa-miR-4290 UGCCCUCCUUUCUUCCCUC GGGAAGAAAGGAGGGCAUU hsa-miR-4291 UUCAGCAGGAACAGCU CUGUUCCUGCUGAAUU hsa-miR-4292 CCCCUGGGCCGGCCUUGG AAGGCCGGCCCAGGGGUU hsa-miR-4293 CAGCCUGACAGGAACAG GUUCCUGUCAGGCUGUU hsa-miR-4294 GGGAGUCUACAGCAGGG CUGCUGUAGACUCCCUU hsa-miR-4295 CAGUGCAAUGUUUUCCUU GGAAAACAUUGCACUGUU hsa-miR-4296 AUGUGGGCUCAGGCUCA AGCCUGAGCCCACAUUU hsa-miR-4297 UGCCUUCCUGUCUGUG CAGACAGGAAGGCAUU hsa-miR-4298 CUGGGACAGGAGGAGGAGGCAG GCCUCCUCCUCCUGUCCCAGUU hsa-miR-4299 GCUGGUGACAUGAGAGGC CUCUCAUGUCACCAGCUU hsa-miR-4300 UGGGAGCUGGACUACUUC AGUAGUCCAGCUCCCAUU hsa-miR-4301 UCCCACUACUUCACUUGUGA ACAAGUGAAGUAGUGGGAUU hsa-miR-4302 CCAGUGUGGCUCAGCGAG CGCUGAGCCACACUGGUU hsa-miR-4303 UUCUGAGCUGAGGACAG GUCCUCAGCUCAGAAUU hsa-miR-4304 CCGGCAUGUCCAGGGCA CCCUGGACAUGCCGGUU hsa-miR-4305 CCUAGACACCUCCAGUUC ACUGGAGGUGUCUAGGUU hsa-miR-4306 UGGAGAGAAAGGCAGUA CUGCCUUUCUCUCCAUU hsa-miR-4307 AAUGUUUUUUCCUGUUUCC AAACAGGAAAAAACAUUUU hsa-miR-4308 UCCCUGGAGUUUCUUCUU GAAGAAACUCCAGGGAUU hsa-miR-4309 CUGGAGUCUAGGAUUCCA GAAUCCUAGACUCCAGUU hsa-miR-431 UGUCUUGCAGGCCGUCAUGCA CAGGUCGUCUUGCAGGGCUUCU hsa-miR-4310 GCAGCAUUCAUGUCCC GACAUGAAUGCUGCUU hsa-miR-4311 GAAAGAGAGCUGAGUGUG CACUCAGCUCUCUUUCUU hsa-miR-4312 GGCCUUGUUCCUGUCCCCA GGGACAGGAACAAGGCCUU hsa-miR-4313 AGCCCCCUGGCCCCAAACCC GUUUGGGGCCAGGGGGCUUU hsa-miR-4314 CUCUGGGAAAUGGGACAG GUCCCAUUUCCCAGAGUU hsa-miR-4315 CCGCUUUCUGAGCUGGAC CCAGCUCAGAAAGCGGUU hsa-miR-4316 GGUGAGGCUAGCUGGUG CCAGCUAGCCUCACCUU hsa-miR-4317 ACAUUGCCAGGGAGUUU ACUCCCUGGCAAUGUUU hsa-miR-4318 CACUGUGGGUACAUGCU CAUGUACCCACAGUGUU hsa-miR-4319 UCCCUGAGCAAAGCCAC GGCUUUGCUCAGGGAUU hsa-miR-432 UCUUGGAGUAGGUCAUUGGGUGG CUGGAUGGCUCCUCCAUGUCU hsa-miR-4320 GGGAUUCUGUAGCUUCCU GAAGCUACAGAAUCCCUU hsa-miR-4321 UUAGCGGUGGACCGCCCUGCG CAGGGCGGUCCACCGCUAAUU hsa-miR-4322 CUGUGGGCUCAGCGCGUGGGG CCACGCGCUGAGCCCACAGUU hsa-miR-4323 CAGCCCCACAGCCUCAGA UGAGGCUGUGGGGCUGUU hsa-miR-4324 CCCUGAGACCCUAACCUUAA AAGGUUAGGGUCUCAGGGUU hsa-miR-4325 UUGCACUUGUCUCAGUGA ACUGAGACAAGUGCAAUU hsa-miR-4326 UGUUCCUCUGUCUCCCAGAC CUGGGAGACAGAGGAACAUU hsa-miR-4327 GGCUUGCAUGGGGGACUGG AGUCCCCCAUGCAAGCCUU hsa-miR-4328 CCAGUUUUCCCAGGAUU UCCUGGGAAAACUGGUU hsa-miR-4329 CCUGAGACCCUAGUUCCAC GGAACUAGGGUCUCAGGUU hsa-miR-433 UACGGUGAGCCUGUCAUUAUUC AUCAUGAUGGGCUCCUCGGUGU hsa-miR-4330 CCUCAGAUCAGAGCCUUGC AAGGCUCUGAUCUGAGGUU hsa-miR-4417 GGUGGGCUUCCCGGAGGG CUCCGGGAAGCCCACCUU hsa-miR-4418 CACUGCAGGACUCAGCAG GCUGAGUCCUGCAGUGUU hsa-miR-4419a UGAGGGAGGAGACUGCA CAGUCUCCUCCCUCAUU hsa-miR-4419b GAGGCUGAAGGAAGAUGG AUCUUCCUUCAGCCUCUU hsa-miR-4420 GUCACUGAUGUCUGUAGCUGAG CAGCUACAGACAUCAGUGACUU hsa-miR-4421 ACCUGUCUGUGGAAAGGAGCUA GCUCCUUUCCACAGACAGGUUU hsa-miR-4422 AAAAGCAUCAGGAAGUACCCA GGUACUUCCUGAUGCUUUUUU hsa-miR-4423 AGUUGCCUUUUUGUUCCCAUGC AUAGGCACCAAAAAGCAACAA hsa-miR-4424 AGAGUUAACUCAAAAUGGACUA GUCCAUUUUGAGUUAACUCUUU hsa-miR-4425 UGUUGGGAUUCAGCAGGACCAU GGUCCUGCUGAAUCCCAACAUU hsa-miR-4426 GAAGAUGGACGUACUUU AGUACGUCCAUCUUCUU hsa-miR-4427 UCUGAAUAGAGUCUGAAGAGU UCUUCAGACUCUAUUCAGAUU hsa-miR-4428 CAAGGAGACGGGAACAUGGAGC UCCAUGUUCCCGUCUCCUUGUU hsa-miR-4429 AAAAGCUGGGCUGAGAGGCG CCUCUCAGCCCAGCUUUUUU hsa-miR-4430 AGGCUGGAGUGAGCGGAG CCGCUCACUCCAGCCUUU hsa-miR-4431 GCGACUCUGAAAACUAGAAGGU CUUCUAGUUUUCAGAGUCGCUU hsa-miR-4432 AAAGACUCUGCAAGAUGCCU GCAUCUUGCAGAGUCUUUUU hsa-miR-4433a ACAGGAGUGGGGGUGGGACAU CGUCCCACCCCCCACUCCUGU hsa-miR-4433b CAGGAGUGGGGGGUGGGACGU AUGUCCCACCCCCACUCCUGU hsa-miR-4434 AGGAGAAGUAAAGUAGAA CUACUUUACUUCUCCUUU hsa-miR-4435 AUGGCCAGAGCUCACACAGAGG UCUGUGUGAGCUCUGGCCAUUU hsa-miR-4436a GCAGGACAGGCAGAAGUGGAU CCACUUCUGCCUGUCCUGCUU hsa-miR-4436b GUCCACUUCUGCCUGCCCUGCC CAGGGCAGGAAGAAGUGGACAA hsa-miR-4437 UGGGCUCAGGGUACAAAGGUU CCUUUGUACCCUGAGCCCAUU hsa-miR-4438 CACAGGCUUAGAAAAGACAGU UGUCUUUUCUAAGCCUGUGUU hsa-miR-4439 GUGACUGAUACCUUGGAGGCAU GCCUCCAAGGUAUCAGUCACUU hsa-miR-4440 UGUCGUGGGGCUUGCUGGCUUG AGCCAGCAAGCCCCACGACAUU hsa-miR-4441 ACAGGGAGGAGAUUGUA CAAUCUCCUCCCUGUUU hsa-miR-4442 GCCGGACAAGAGGGAGG UCCCUCUUGUCCGGCUU hsa-miR-4443 UUGGAGGCGUGGGUUUU AACCCACGCCUCCAAUU hsa-miR-4444 CUCGAGUUGGAAGAGGCG CCUCUUCCAACUCGAGUU hsa-miR-4445 AGAUUGUUUCUUUUGCCGUGCA CACGGCAAAAGAAACAAUCCA hsa-miR-4446 AUUUCCCUGCCAUUCCCUUGGC CAGGGCUGGCAGUGACAUGGGU hsa-miR-4447 GGUGGGGGCUGUUGUUU ACAACAGCCCCCACCUU hsa-miR-4448 GGCUCCUUGGUCUAGGGGUA CCCCUAGACCAAGGAGCCUU hsa-miR-4449 CGUCCCGGGGCUGCGCGAGGCA CCUCGCGCAGCCCCGGGACGUU hsa-miR-4450 UGGGGAUUUGGAGAAGUGGUGA ACCACUUCUCCAAAUCCCCAUU hsa-miR-4451 UGGUAGAGCUGAGGACA UCCUCAGCUCUACCAUU hsa-miR-4452 UUGAAUUCUUGGCCUUAAGUGAU CACUUAAGGCCAAGAAUUCAAUU hsa-miR-4453 GAGCUUGGUCUGUAGCGGUU CCGCUACAGACCAAGCUCUU hsa-miR-4454 GGAUCCGAGUCACGGCACCA GUGCCGUGACUCGGAUCCUU hsa-miR-4455 AGGGUGUGUGUGUUUUU AAACACACACACCCUUU hsa-miR-4456 CCUGGUGGCUUCCUUUU AAGGAAGCCACCAGGUU hsa-miR-4457 UCACAAGGUAUUGACUGGCGUA CGCCAGUCAAUACCUUGUGAUU hsa-miR-4458 AGAGGUAGGUGUGGAAGAA CUUCCACACCUACCUCUUU hsa-miR-4459 CCAGGAGGCGGAGGAGGUGGAG CCACCUCCUCCGCCUCCUGGUU hsa-miR-4460 AUAGUGGUUGUGAAUUUACCUU GGUAAAUUCACAACCACUAUUU hsa-miR-4461 GAUUGAGACUAGUAGGGCUAGGC CUAGCCCUACUAGUCUCAAUCUU hsa-miR-4462 UGACACGGAGGGUGGCUUGGGAA CCCAAGCCACCCUCCGUGUCAUU hsa-miR-4463 GAGACUGGGGUGGGGCC CCCCACCCCAGUCUCUU hsa-miR-4464 AAGGUUUGGAUAGAUGCAAUA UUGCAUCUAUCCAAACCUUUU hsa-miR-4465 CUCAAGUAGUCUGACCAGGGGA CCCUGGUCAGACUACUUGAGUU hsa-miR-4466 GGGUGCGGGCCGGCGGGG CCGCCGGCCCGCACCCUU hsa-miR-4467 UGGCGGCGGUAGUUAUGGGCUU GCCCAUAACUACCGCCGCCAUU hsa-miR-4468 AGAGCAGAAGGAUGAGAU CUCAUCCUUCUGCUCUUU hsa-miR-4469 GCUCCCUCUAGGGUCGCUCGGA CGAGCGACCCUAGAGGGAGCUU hsa-miR-4470 UGGCAAACGUGGAAGCCGAGA UCGGCUUCCACGUUUGCCAUU hsa-miR-4471 UGGGAACUUAGUAGAGGUUUAA AAACCUCUACUAAGUUCCCAUU hsa-miR-4472 GGUGGGGGGUGUUGUUUU AACAACACCCCCCACCUU hsa-miR-4473 CUAGUGCUCUCCGUUACAAGUA CUUGUAACGGAGAGCACUAGUU hsa-miR-4474 UUGUGGCUGGUCAUGAGGCUAA UUAGUCUCAUGAUCAGACACA hsa-miR-4475 CAAGGGACCAAGCAUUCAUUAU AAUGAAUGCUUGGUCCCUUGUU hsa-miR-4476 CAGGAAGGAUUUAGGGACAGGC CUGUCCCUAAAUCCUUCCUGUU hsa-miR-4477a CUAUUAAGGACAUUUGUGAUUC AUCACAAAUGUCCUUAAUAGUU hsa-miR-4477b AUUAAGGACAUUUGUGAUUGAU CAAUCACAAAUGUCCUUAAUUU hsa-miR-4478 GAGGCUGAGCUGAGGAG CCUCAGCUCAGCCUCUU hsa-miR-4479 CGCGCGGCCGUGCUCGGAGCAG GCUCCGAGCACGGCCGCGCGUU hsa-miR-448 UUGCAUAUGUAGGAUGUCCCAU GGGACAUCCUACAUAUGCAAUU hsa-miR-4480 AGCCAAGUGGAAGUUACUUUA AAGUAACUUCCACUUGGCUUU hsa-miR-4481 GGAGUGGGCUGGUGGUU CCACCAGCCCACUCCUU hsa-miR-4482 UUUCUAUUUCUCAGUGGGGCUC AACCCAGUGGGCUAUGGAAAUG hsa-miR-4483 GGGGUGGUCUGUUGUUG ACAACAGACCACCCCUU hsa-miR-4484 AAAAGGCGGGAGAAGCCCCA GGGCUUCUCCCGCCUUUUUU hsa-miR-4485 UAACGGCCGCGGUACCCUAA ACCGCCUGCCCAGUGA hsa-miR-4486 GCUGGGCGAGGCUGGCA CCAGCCUCGCCCAGCUU hsa-miR-4487 AGAGCUGGCUGAAGGGCAG GCCCUUCAGCCAGCUCUUU hsa-miR-4488 AGGGGGCGGGCUCCGGCG CCGGAGCCCGCCCCCUUU hsa-miR-4489 UGGGGCUAGUGAUGCAGGACG UCCUGCAUCACUAGCCCCAUU hsa-miR-4490 UCUGGUAAGAGAUUUGGGCAUA UGCCCAAAUCUCUUACCAGAUU hsa-miR-4491 AAUGUGGACUGGUGUGACCAAA UGGUCACACCAGUCCACAUUUU hsa-miR-4492 GGGGCUGGGCGCGCGCC CGCGCGCCCAGCCCCUU hsa-miR-4493 AGAAGGCCUUUCCAUCUCUGU AGAGAUGGAAAGGCCUUCUUU hsa-miR-4494 CCAGACUGUGGCUGACCAGAGG UCUGGUCAGCCACAGUCUGGUU hsa-miR-4495 AAUGUAAACAGGCUUUUUGCU CAAAAAGCCUGUUUACAUUUU hsa-miR-4496 GAGGAAACUGAAGCUGAGAGGG CUCUCAGCUUCAGUUUCCUCUU hsa-miR-4497 CUCCGGGACGGCUGGGC CCAGCCGUCCCGGAGUU hsa-miR-4498 UGGGCUGGCAGGGCAAGUGCUG GCACUUGCCCUGCCAGCCCAUU hsa-miR-4499 AAGACUGAGAGGAGGGA CCUCCUCUCAGUCUUUU hsa-miR-449a UGGCAGUGUAUUGUUAGCUGGU CAGCUAACAAUACACUGCCAUU hsa-miR-449b CAGCCACAACUACCCUGCCACU AGGCAGUGUAUUGUUAGCUGGC hsa-miR-449c UAGGCAGUGUAUUGCUAGCGGCUGU UUGCUAGUUGCACUCCUCUCUGU hsa-miR-4500 UGAGGUAGUAGUUUCUU GAAACUACUACCUCAUU hsa-miR-4501 UAUGUGACCUCGGAUGAAUCA AUUCAUCCGAGGUCACAUAUU hsa-miR-4502 GCUGAUGAUGAUGGUGCUGAAG UCAGCACCAUCAUCAUCAGCUU hsa-miR-4503 UUUAAGCAGGAAAUAGAAUUUA AAUUCUAUUUCCUGCUUAAAUU hsa-miR-4504 UGUGACAAUAGAGAUGAACAUG UGUUCAUCUCUAUUGUCACAUU hsa-miR-4505 AGGCUGGGCUGGGACGGA CGUCCCAGCCCAGCCUUU hsa-miR-4506 AAAUGGGUGGUCUGAGGCAA GCCUCAGACCACCCAUUUUU hsa-miR-4507 CUGGGUUGGGCUGGGCUGGG CAGCCCAGCCCAACCCAGUU hsa-miR-4508 GCGGGGCUGGGCGCGCG CGCGCCCAGCCCCGCUU hsa-miR-4509 ACUAAAGGAUAUAGAAGGUUUU AACCUUCUAUAUCCUUUAGUUU hsa-miR-450a-1 UUUUGCGAUGUGUUCCUAAUAU AUUGGGAACAUUUUGCAUGUAU hsa-miR-450a-2 UUUUGCGAUGUGUUCCUAAUAU AUUGGGGACAUUUUGCAUUCAU hsa-miR-450b UUUUGCAAUAUGUUCCUGAAUA UUGGGAUCAUUUUGCAUCCAUA hsa-miR-4510 UGAGGGAGUAGGAUGUAUGGUU CCAUACAUCCUACUCCCUCAUU hsa-miR-4511 GAAGAACUGUUGCAUUUGCCCU GGCAAAUGCAACAGUUCUUCUU hsa-miR-4512 CAGGGCCUCACUGUAUCGCCCA GGCGAUACAGUGAGGCCCUGUU hsa-miR-4513 AGACUGACGGCUGGAGGCCCAU GGGCCUCCAGCCGUCAGUCUUU hsa-miR-4514 ACAGGCAGGAUUGGGGAA CCCCAAUCCUGCCUGUUU hsa-miR-4515 AGGACUGGACUCCCGGCAGCCC GCUGCCGGGAGUCCAGUCCUUU hsa-miR-4516 GGGAGAAGGGUCGGGGC CCCGACCCUUCUCCCUU hsa-miR-4517 AAAUAUGAUGAAACUCACAGCUGAG CAGCUGUGAGUUUCAUCAUAUUUUU hsa-miR-4518 GCUCAGGGAUGAUAACUGUGCUGAGA UCAGCACAGUUAUCAUCCCUGAGCUU hsa-miR-4519 CAGCAGUGCGCAGGGCUG GCCCUGCGCACUGCUGUU hsa-miR-451a AAACCGUUACCAUUACUGAGUU CUCAGUAAUGGUAACGGUUUUU hsa-miR-451b UAGCAAGAGAACCAUUACCAUU UGGUAAUGGUUCUCUUGCUAUU hsa-miR-452 AACUGUUUGCAGAGGAAACUGA CUCAUCUGCAAAGAAGUAAGUG hsa-miR-4520-1 CCUGCGUGUUUUCUGUCCAA UUGGACAGAAAACACGCAGGAA hsa-miR-4520-2 CCUGCGUGUUUUCUGUCCAA UUUGGACAGAAAACACGCAGGU hsa-miR-4521 GCUAAGGAAGUCCUGUGCUCAG GAGCACAGGACUUCCUUAGCUU hsa-miR-4522 UGACUCUGCCUGUAGGCCGGU CGGCCUACAGGCAGAGUCAUU hsa-miR-4523 GACCGAGAGGGCCUCGGCUGU AGCCGAGGCCCUCUCGGUCUU hsa-miR-4524a AUAGCAGCAUGAACCUGUCUCA UGAGACAGGCUUAUGCUGCUAU hsa-miR-4524b AUAGCAGCAUAAGCCUGUCUC GAGACAGGUUCAUGCUGCUA hsa-miR-4525 GGGGGGAUGUGCAUGCUGGUU CCAGCAUGCACAUCCCCCCUU hsa-miR-4526 GCUGACAGCAGGGCUGGCCGCU CGGCCAGCCCUGCUGUCAGCUU hsa-miR-4527 UGGUCUGCAAAGAGAUGACUGU AGUCAUCUCUUUGCAGACCAUU hsa-miR-4528 UCAUUAUAUGUAUGAUCUGGAC CCAGAUCAUACAUAUAAUGAUU hsa-miR-4529 AGGCCAUCAGCAGUCCAAUGAA AUUGGACUGCUGAUGGCCCGU hsa-miR-4530 CCCAGCAGGACGGGAGCG CUCCCGUCCUGCUGGGUU hsa-miR-4531 AUGGAGAAGGCUUCUGA AGAAGCCUUCUCCAUUU hsa-miR-4532 CCCCGGGGAGCCCGGCG CCGGGCUCCCCGGGGUU hsa-miR-4533 UGGAAGGAGGUUGCCGGACGCU CGUCCGGCAACCUCCUUCCAUU hsa-miR-4534 GGAUGGAGGAGGGGUCU ACCCCUCCUCCAUCCUU hsa-miR-4535 GUGGACCUGGCUGGGAC CCCAGCCAGGUCCACUU hsa-miR-4536 UCGUGCAUAUAUCUACCACAU UGUGGUAGAUAUAUGCACGAU hsa-miR-4537 UGAGCCGAGCUGAGCUUAGCUG GCUAAGCUCAGCUCGGCUCAUU hsa-miR-4538 GAGCUUGGAUGAGCUGGGCUGA AGCCCAGCUCAUCCAAGCUCUU hsa-miR-4539 GCUGAACUGGGCUGAGCUGGGC CCAGCUCAGCCCAGUUCAGCUU hsa-miR-454 ACCCUAUCAAUAUUGUCUCUGC UAGUGCAAUAUUGCUUAUAGGGU hsa-miR-4540 UUAGUCCUGCCUGUAGGUUUA AACCUACAGGCAGGACUAAUU hsa-miR-455 GCAGUCCAUGGGCAUAUACAC UAUGUGCCUUUGGACUACAUCG hsa-miR-4632 UGCCGCCCUCUCGCUGCUCUAG GAGGGCAGCGUGGGUGUGGCGGA hsa-miR-4633 AUAUGCCUGGCUAGCUCCUC AGGAGCUAGCCAGGCAUAUGCA hsa-miR-4634 CGGCGCGACCGGCCCGGGG CCGGGCCGGUCGCGCCGUU hsa-miR-4635 UCUUGAAGUCAGAACCCGCAA GCGGGUUCUGACUUCAAGAUU hsa-miR-4636 AACUCGUGUUCAAAGCCUUUAG AAAGGCUUUGAACACGAGUUUU hsa-miR-4637 UACUAACUGCAGAUUCAAGUGA ACUUGAAUCUGCAGUUAGUAUU hsa-miR-4638 CCUGGACACCGCUCAGCCGGCCG ACUCGGCUGCGGUGGACAAGU hsa-miR-4639 UCACUCUCACCUUGCUUUGC UUGCUAAGUAGGCUGAGAUUGA hsa-miR-4640 UGGGCCAGGGAGCAGCUGGUGGG CACCCCCUGUUUCCUGGCCCAC hsa-miR-4641 UGCCCAUGCCAUACUUUUGCCUCA AGGCAAAAGUAUGGCAUGGGCAUU hsa-miR-4642 AUGGCAUCGUCCCCUGGUGGCU CCACCAGGGGACGAUGCCAUUU hsa-miR-4643 GACACAUGACCAUAAAUGCUAA AGCAUUUAUGGUCAUGUGUCUU hsa-miR-4644 UGGAGAGAGAAAAGAGACAGAAG UCUGUCUCUUUUCUCUCUCCAUU hsa-miR-4645 ACCAGGCAAGAAAUAUUGU AGACAGUAGUUCUUGCCUGGUU hsa-miR-4646 AUUGUCCCUCUCCCUUCCCAG ACUGGGAAGAGGAGCUGAGGGA hsa-miR-4647 GAAGAUGGUGCUGUGCUGAGGAA CCUCAGCACAGCACCAUCUUCUU hsa-miR-4648 UGUGGGACUGCAAAUGGGAG CCCAUUUGCAGUCCCACAUU hsa-miR-4649 UGGGCGAGGGGUGGGCUCUCAGAG UCUGAGGCCUGCCUCUCCCCA hsa-miR-4650 AGGUAGAAUGAGGCCUGACAU UCAGGCCUCUUUCUACCUU hsa-miR-4651 CGGGGUGGGUGAGGUCGGGC CCGACCUCACCCACCCCGUU hsa-miR-4652 AGGGGACUGGUUAAUAGAACUA GUUCUGUUAACCCAUCCCCUCA hsa-miR-4653 UCUCUGAGCAAGGCUUAACACC UGGAGUUAAGGGUUGCUUGGAGA hsa-miR-4654 UGUGGGAUCUGGAGGCAUCUGG AGAUGCCUCCAGAUCCCACAUU hsa-miR-4655 ACCCUCGUCAGGUCCCCGGGG CACCGGGGAUGGCAGAGGGUCG hsa-miR-4656 UGGGCUGAGGGCAGGAGGCCUGU AGGCCUCCUGCCCUCAGCCCAUU hsa-miR-4657 AAUGUGGAAGUGGUCUGAGGCAU GCCUCAGACCACUUCCACAUUUU hsa-miR-4658 GUGAGUGUGGAUCCUGGAGGAAU UCCUCCAGGAUCCACACUCACUU hsa-miR-4659a UUUCUUCUUAGACAUGGCAACG CUGCCAUGUCUAAGAAGAAAAC hsa-miR-4659b UUUCUUCUUAGACAUGGCAGCU UUGCCAUGUCUAAGAAGAA hsa-miR-466 AUACACAUACACGCAACACACAU GUGUGUUGCGUGUAUGUGUAUUU hsa-miR-4660 UGCAGCUCUGGUGGAAAAUGGAG CCAUUUUCCACCAGAGCUGCAUU hsa-miR-4661 AACUAGCUCUGUGGAUCCUGAC CAGGAUCCACAGAGCUAGUCCA hsa-miR-4662a UUAGCCAAUUGUCCAUCUUUAG AAAGAUAGACAAUUGGCUAAAU hsa-miR-4662b AAAGAUGGACAAUUGGCUAAAU UUAGCCAAUUGUCCAUCUUUUU hsa-miR-4663 AGCUGAGCUCCAUGGACGUGCAGU UGCACGUCCAUGGAGCUCAGCUUU hsa-miR-4664 CUUCCGGUCUGUGAGCCCCGUC UGGGGUGCCCACUCCGCAAGUU hsa-miR-4665 CUCGGCCGCGGCGCGUAGCCCCCGCC CUGGGGGACGCGUGAGCGCGAGC hsa-miR-4666a AUACAUGUCAGAUUGUAUGCC CAUACAAUCUGACAUGUAUUU hsa-miR-4666b UUGCAUGUCAGAUUGUAAUUCCC GAAUUACAAUCUGACAUGCAAUU hsa-miR-4667 ACUGGGGAGCAGAAGGAGAACC UCCCUCCUUCUGUCCCCACAG hsa-miR-4668 AGGGAAAAAAAAAAGGAUUUGUC GAAAAUCCUUUUUGUUUUUCCAG hsa-miR-4669 UGUGUCCGGGAAGUGGAGGAGG UCCUCCACUUCCCGGACACAUU hsa-miR-4670 AAGCGACCAUGAUGUAACUUCA UGAAGUUACAUCAUGGUCGCUU hsa-miR-4671 ACCGAAGACUGUGCGCUAAUCU UUAGUGCAUAGUCUUUGGUCU hsa-miR-4672 UUACACAGCUGGACAGAGGCA CCUCUGUCCAGCUGUGUAAUU hsa-miR-4673 UCCAGGCAGGAGCCGGACUGGA CAGUCCGGCUCCUGCCUGGAUU hsa-miR-4674 CUGGGCUCGGGACGCGCGGCU CCGCGCGUCCCGAGCCCAGUU hsa-miR-4675 GGGGCUGUGAUUGACCAGCAGG UGCUGGUCAAUCACAGCCCCUU hsa-miR-4676 GAGCCAGUGGUGAGACAGUGA CACUGUUUCACCACUGGCUCUU hsa-miR-4677 UUGUUCUUUGGUCUUUCAGCCA UCUGUGAGACCAAAGAACUACU hsa-miR-4678 AAGGUAUUGUUCAGACUUAUGA AUAAGUCUGAACAAUACCUUUU hsa-miR-4679 UCUGUGAUAGAGAUUCUUUGCU CAAAGAAUCUCUAUCACAGAUU hsa-miR-4680 UCUGAAUUGUAAGAGUUGUUA AGAACUCUUGCAGUCUUAGAUGU hsa-miR-4681 AACGGGAAUGCAGGCUGUAUCU AUACAGCCUGCAUUCCCGUUUU hsa-miR-4682 UCUGAGUUCCUGGAGCCUGGUCU ACCAGGCUCCAGGAACUCAGAUU hsa-miR-4683 UGGAGAUCCAGUGCUCGCCCGAU CGGGCGAGCACUGGAUCUCCAUU hsa-miR-4684 CUCUCUACUGACUUGCAACAUA UGUUGCAAGUCGGUGGAGACGU hsa-miR-4685 CCCAGGGCUUGGAGUGGGGCAAGGUU UCUCCCUUCCUGCCCUGGCUAG hsa-miR-4686 UAUCUGCUGGGCUUUCUGGUGUU CACCAGAAAGCCCAGCAGAUAUU hsa-miR-4687 UGGCUGUUGGAGGGGGCAGGC CAGCCCUCCUCCCGCACCCAAA hsa-miR-4688 UAGGGGCAGCAGAGGACCUGGG CAGGUCCUCUGCUGCCCCUAUU hsa-miR-4689 UUGAGGAGACAUGGUGGGGGCC CCCCCACCAUGUCUCCUCAAUU hsa-miR-4690 GCAGCCCAGCUGAGGCCUCUG GAGCAGGCGAGGCUGGGCUGAA hsa-miR-4691 GUCCUCCAGGCCAUGAGCUGCGG CCAGCCACGGACUGAGAGUGCAU hsa-miR-4692 UCAGGCAGUGUGGGUAUCAGAU CUGAUACCCACACUGCCUGAUU hsa-miR-4693 AUACUGUGAAUUUCACUGUCACA UGAGAGUGGAAUUCACAGUAUUU hsa-miR-4694 AGGUGUUAUCCUAUCCAUUUGC CAAAUGGACAGGAUAACACCU hsa-miR-4695 CAGGAGGCAGUGGGCGAGCAGG UGAUCUCACCGCUGCCUCCUUC hsa-miR-4696 UGCAAGACGGAUACUGUCAUCU AUGACAGUAUCCGUCUUGCAUU hsa-miR-4697 AGGGGGCGCAGUCACUGACGUG UGUCAGUGACUCCUGCCCCUUGGU hsa-miR-4698 UCAAAAUGUAGAGGAAGACCCCA GGGUCUUCCUCUACAUUUUGAUU hsa-miR-4699 AAUUUACUCUGCAAUCUUCUCC AGAAGAUUGCAGAGUAAGUUCC hsa-miR-4700 CACAGGACUGACUCCUCACCCCAGUG UCUGGGGAUGAGGACAGUGUGU hsa-miR-4701 UUGGCCACCACACCUACCCCUU AUGGGUGAUGGGUGUGGUGU hsa-miR-4703 UGUAGUUGUAUUGUAUUGCCAC UAGCAAUACAGUACAAAUAUAGU hsa-miR-4704 UCAGUCACAUAUCUAGUGUCUA GACACUAGGCAUGUGAGUGAUU hsa-miR-4705 UCAAUCACUUGGUAAUUGCUGU AGCAAUUACCAAGUGAUUGAUU hsa-miR-4706 AGCGGGGAGGAAGUGGGCGCUGCUU GCAGCGCCCACUUCCUCCCCGCUUU hsa-miR-4707 AGCCCGCCCCAGCCGAGGUUCU GCCCCGGCGCGGGCGGGUUCUGG hsa-miR-4708 AGAGAUGCCGCCUUGCUCCUU AGCAAGGCGGCAUCUCUCUGAU hsa-miR-4709 ACAACAGUGACUUGCUCUCCAA UUGAAGAGGAGGUGCUCUGUAGC hsa-miR-4710 GGGUGAGGGCAGGUGGUU CCACCUGCCCUCACCCUU hsa-miR-4711 CGUGUCUUCUGGCUUGAU UGCAUCAGGCCAGAAGACAUGAG hsa-miR-4712 AAUGAGAGACCUGUACUGUAU UCCAGUACAGGUCUCUCAUUUC hsa-miR-4713 UUCUCCCACUACCAGGCUCCCA UGGGAUCCAGACAGUGGGAGAA hsa-miR-4714 AACUCUGACCCCUUAGGUUGAU CCAACCUAGGUGGUCAGAGUUG hsa-miR-4715 GUGCCACCUUAACUGCAGCCAAU AAGUUGGCUGCAGUUAAGGUGG hsa-miR-4716 AAGGGGGAAGGAAACAUGGAGA UCCAUGUUUCCUUCCCCCUUCU hsa-miR-4717 ACACAUGGGUGGCUGUGGCCU UAGGCCACAGCCACCCAUGUGU hsa-miR-4718 AGCUGUACCUGAAACCAAGCA CUUGGUUUCAGGUACAGCUUU hsa-miR-4719 UCACAAAUCUAUAAUAUGCAGG UGCAUAUUAUAGAUUUGUGAUU hsa-miR-4720 UGCUUAAGUUGUACCAAGUAU CCUGGCAUAUUUGGUAUAACUU hsa-miR-4721 UGAGGGCUCCAGGUGACGGUGG ACCGUCACCUGGAGCCCUCAUU hsa-miR-4722 GGCAGGAGGGCUGUGCCAGGUUG ACCUGCCAGCACCUCCCUGCAG hsa-miR-4723 UGGGGGAGCCAUGAGAUAAGAGCA CCCUCUCUGGCUCCUCCCCAAA hsa-miR-4724 AACUGAACCAGGAGUGAGCUUCG GUACCUUCUGGUUCAGCUAGU hsa-miR-4725 AGACCCUGCAGCCUUCCCACC UGGGGAAGGCGUCAGUGUCGGG hsa-miR-4726 ACCCAGGUUCCCUCUGGCCGCA AGGGCCAGAGGAGCCUGGAGUGG hsa-miR-4727 AUAGUGGGAAGCUGGCAGAUUC AUCUGCCAGCUUCCACAGUGG hsa-miR-4728 CAUGCUGACCUCCCUCCUGCCCCAG UGGGAGGGGAGAGGCAGCAAGCA hsa-miR-4729 UCAUUUAUCUGUUGGGAAGCUA GCUUCCCAACAGAUAAAUGAUU hsa-miR-4730 CUGGCGGAGCCCAUUCCAUGCCA GCAUGGAAUGGGCUCCGCCAGUU hsa-miR-4731 UGCUGGGGGCCACAUGAGUGUG CACACAAGUGGCCCCCAACACU hsa-miR-4732 UGUAGAGCAGGGAGCAGGAAGCU GCCCUGACCUGUCCUGUUCUG hsa-miR-4733 AAUCCCAAUGCUAGACCCGGUG CCACCAGGUCUAGCAUUGGGAU hsa-miR-4734 GCUGCGGGCUGCGGUCAGGGCG CCCUGACCGCAGCCCGCAGCUU hsa-miR-4735 CCUAAUUUGAACACCUUCGGUA AAAGGUGCUCAAAUUAGACAU hsa-miR-4736 AGGCAGGUUAUCUGGGCUG GCCCAGAUAACCUGCCUUU hsa-miR-4737 AUGCGAGGAUGCUGACAGUG CUGUCAGCAUCCUCGCAUUU hsa-miR-4738 UGAAACUGGAGCGCCUGGAGGA ACCAGCGCGUUUUCAGUUUCAU hsa-miR-4739 AAGGGAGGAGGAGCGGAGGGGCCCU GGCCCCUCCGCUCCUCCUCCCUUUU hsa-miR-4740 GCCCGAGAGGAUCCGUCCCUGC AGGACUGAUCCUCUCGGGCAGG hsa-miR-4741 CGGGCUGUCCGGAGGGGUCGGCU CCGACCCCUCCGGACAGCCCGUU hsa-miR-4742 UCAGGCAAAGGGAUAUUUACAGA UCUGUAUUCUCCUUUGCCUGCAG hsa-miR-4743 UUUCUGUCUUUUCUGGUCCAG UGGCCGGAUGGGACAGGAGGCAU hsa-miR-4744 UCUAAAGACUAGACUUCGCUAUG UAGCGAAGUCUAGUCUUUAGAUU hsa-miR-4745 UGAGUGGGGCUCCCGGGACGGCG UGGCCCGGCGACGUCUCACGGUC hsa-miR-4746 AGCGGUGCUCCUGCGGGCCGA CCGGUCCCAGGAGAACCUGCAGA hsa-miR-4747 AAGGCCCGGGCUUUCCUCCCAG AGGGAAGGAGGCUUGGUCUUAG hsa-miR-4748 GAGGUUUGGGGAGGAUUUGCU CAAAUCCUCCCCAAACCUCUU hsa-miR-4749 UGCGGGGACAGGCCAGGGCAUC CGCCCCUCCUGCCCCCACAG hsa-miR-4750 CCUGACCCACCCCCUCCCGCAG CUCGGGCGGAGGUGGUUGAGUG hsa-miR-4751 AGAGGACCCGUAGCUGCUAGAAGG UUCUAGCAGCUACGGGUCCUCUUU hsa-miR-4752 UUGUGGAUCUCAAGGAUGUGCU CACAUCCUUGAGAUCCACAAUU hsa-miR-4753 CAAGGCCAAAGGAAGAGAACAG UUCUCUUUCUUUAGCCUUGUGU hsa-miR-4754 AUGCGGACCUGGGUUAGCGGAGU UCCGCUAACCCAGGUCCGCAUUU hsa-miR-4755 UUUCCCUUCAGAGCCUGGCUUU AGCCAGGCUCUGAAGGGAAAGU hsa-miR-4756 CCAGAGAUGGUUGCCUUCCUAU CAGGGAGGCGCUCACUCUCUGCU hsa-miR-4757 CAUGACGUCACAGAGGCUUCGC AGGCCUCUGUGACGUCACGGUGU hsa-miR-4758 GUGAGUGGGAGCCGGUGGGGCUG UGCCCCACCUGCUGACCACCCUC hsa-miR-4759 UAGGACUAGAUGUUGGAAUUA AUUCCAACAUCUAGUCCUAUU hsa-miR-4760 AAAUUCAUGUUCAAUCUAAACC UUUAGAUUGAACAUGAAGUUAG hsa-miR-4761 ACAAGGUGUGCAUGCCUGACC GAGGGCAUGCGCACUUUGUCC hsa-miR-4762 CCAAAUCUUGAUCAGAAGCCU CUUCUGAUCAAGAUUUGUGGUG hsa-miR-4763 AGGCAGGGGCUGGUGCUGGGCGGG CGCCUGCCCAGCCCUCCUGCU hsa-miR-4764 UUAACUCCUUUCACACCCAUGG UGGAUGUGGAAGGAGUUAUCU hsa-miR-4765 UGAGUGAUUGAUAGCUAUGUUC ACAUAGCUAUCAAUCACUCAUU hsa-miR-4766 UCUGAAAGAGCAGUUGGUGUU AUAGCAAUUGCUCUUUUGGAA hsa-miR-4767 CGCGGGCGCUCCUGGCCGCCGCC CGGCGGCCAGGAGCGCCCGCGUU hsa-miR-4768 CCAGGAGAUCCAGAGAGAAU AUUCUCUCUGGAUCCCAUGGAU hsa-miR-4769 UCUGCCAUCCUCCCUCCCCUAC GGUGGGAUGGAGAGAAGGUAUGAG hsa-miR-4770 UGAGAUGACACUGUAGCU CUACAGUGUCAUCUCAUU hsa-miR-4771 AGCAGACUUGACCUACAAUUA AUUGUAGGUCAAGUCUGCUUU hsa-miR-4772 CCUGCAACUUUGCCUGAUCAGA UGAUCAGGCAAAAUUGCAGACU hsa-miR-4773 CAGAACAGGAGCAUAGAAAGGC CUUUCUAUGCUCCUGUUCUGUU hsa-miR-4774 AUUGCCUAACAUGUGCCAGAA UCUGGUAUGUAGUAGGUAAUAA hsa-miR-4775 UUAAUUUUUUGUUUCGGUCACU UGACCGAAACAAAAAAUUAAUU hsa-miR-4776 GUGGACCAGGAUGGCAAGGGCU CUUGCCAUCCUGGUCCACUGCAU hsa-miR-4777 UUCUAGAUGAGAGAUAUAUAUA AUACCUCAUCUAGAAUGCUGUA hsa-miR-4778 UCUUCUUCCUUUGCAGAGUUGA AAUUCUGUAAAGGAAGAAGAGG hsa-miR-4779 UAGGAGGGAAUAGUAAAAGCAG GCUUUUACUAUUCCCUCCUAUU hsa-miR-4780 ACCCUUGAGCCUGAUCCCUAGC UAGGGAUCAGGCUCAAGGGUUU hsa-miR-4781 UAGCGGGGAUUCCAAUAUUGG AAUGUUGGAAUCCUCGCUAGAG hsa-miR-4782 UGAUUGUCUUCAUAUCUAGAAC UUCUGGAUAUGAAGACAAUCAA hsa-miR-4783 CCCCGGUGUUGGGGCGCGUCUGC GGCGCGCCCAGCUCCCGGGCU hsa-miR-4784 UGAGGAGAUGCUGGGACUGA AGUCCCAGCAUCUCCUCAUU hsa-miR-4785 AGAGUCGGCGACGCCGCCAGC UGGCGGCGUCGCCGACUCUUU hsa-miR-4786 UGAAGCCAGCUCUGGUCUGGGC UGAGACCAGGACUGGAUGCACC hsa-miR-4787 GAUGCGCCGCCCACUGCCCCGCGC GCGGGGGUGGCGGCGGCAUCCC hsa-miR-4788 UUACGGACCAGCUAAGGGAGGC CUCCCUUAGCUGGUCCGUAAUU hsa-miR-4789 GUAUACACCUGAUAUGUGUAUG CACACAUAGCAGGUGUAUAUA hsa-miR-4790 AUCGCUUUACCAUUCAUGUU UGAAUGGUAAAGCGAUGUCACA hsa-miR-4791 UGGAUAUGAUGACUGAAA UCAGUCAUCAUAUCCAUU hsa-miR-4792 CGGUGAGCGCUCGCUGGC CAGCGAGCGCUCACCGUU hsa-miR-4793 ACAUCCUGCUCCACAGGGCAGAGG UCUGCACUGUGAGUUGGCUGGCU hsa-miR-4794 UCUGGCUAUCUCACGAGACUGU AGUCUCGUGAGAUAGCCAGAUU hsa-miR-4795 AGAAGUGGCUAAUAAUAUUGA AUAUUAUUAGCCACUUCUGGAU hsa-miR-4796 UAAAGUGGCAGAGUAUAGACAC UGUCUAUACUCUGUCACUUUAC hsa-miR-4797 GACAGAGUGCCACUUACUGAA UCUCAGUAAGUGGCACUCUGU hsa-miR-4798 UUCGGUAUACUUUGUGAAUUGG AACUCACGAAGUAUACCGAAGU hsa-miR-4799 AUCUAAAUGCAGCAUGCCAGUC ACUGGCAUGCUGCAUUUAUAUA hsa-miR-4800 CAUCCGUCCGUCUGUCCAC AGUGGACCGAGGAAGGAAGGA hsa-miR-4801 UACACAAGAAAACCAAGGCUCA AGCCUUGGUUUUCUUGUGUAUU hsa-miR-4802 UAUGGAGGUUCUAGACCAUGUU UACAUGGAUGGAAACCUUCAAGC hsa-miR-4803 UAACAUAAUAGUGUGGAUUGA AAUCCACACUAUUAUGUUAUU hsa-miR-4804 UGCUUAACCUUGCCCUCGAAA UUGGACGGUAAGGUUAAGCAA hsa-miR-483 UCACUCCUCUCCUCCCGUCUU AAGACGGGAGGAAAGAAGGGAG hsa-miR-484 UCAGGCUCAGUCCCCUCCCGAU CGGGAGGGGACUGAGCCUGAUU hsa-miR-485 AGAGGCUGGCCGUGAUGAAUUC GUCAUACACGGCUCUCCUCUCU hsa-miR-486 CGGGGCAGCUCAGUACAGGAU UCCUGUACUGAGCUGCCCCGAG hsa-miR-487a GUGGUUAUCCCUGCUGUGUUCG AAUCAUACAGGGACAUCCAGUU hsa-miR-487b GUGGUUAUCCCUGUCCUGUUCG AAUCGUACAGGGUCAUCCACUU hsa-miR-488 UUGAAAGGCUAUUUCUUGGUC CCCAGAUAAUGGCACUCUCAA hsa-miR-489 GUGACAUCACAUAUACGGCAGC GGUCGUAUGUGUGACGCCAUUU hsa-miR-490 CCAUGGAUCUCCAGGUGGGU CAACCUGGAGGACUCCAUGCUG hsa-miR-491 AGUGGGGAACCCUUCCAUGAGG CUUAUGCAAGAUUCCCUUCUAC hsa-miR-492 AGGACCUGCGGGACAAGAUUCUU GAAUCUUGUCCCGCAGGUCCUUU hsa-miR-493 UGAAGGUCUACUGUGUGCCAGG UUGUACAUGGUAGGCUUUCAUU hsa-miR-494 AGGUUGUCCGUGUUGUCUUCUCU UGAAACAUACACGGGAAACCUC hsa-miR-495 GAAGUUGCCCAUGUUAUUUUCG AAACAAACAUGGUGCACUUCUU hsa-miR-496 UGAGUAUUACAUGGCCAAUCUC GAUUGGCCAUGUAAUACUCAUU hsa-miR-497 CAGCAGCACACUGUGGUUUGU CAAACCACACUGUGGUGUUAGA hsa-miR-498 UUUCAAGCCAGGGGGCGUUUUUC AAAACGCCCCCUGGCUUGAAAUU hsa-miR-4999 UGCUGUAUUGUCAGGUAGUGA UCACUACCUGACAAUACAGU hsa-miR-499a UUAAGACUUGCAGUGAUGUUU AACAUCACAGCAAGUCUGUGCU hsa-miR-499b ACAGACUUGCUGUGAUGUUCA AACAUCACUGCAAGUCUUAACA hsa-miR-5000 UCAGGACACUUCUGAACUUGGA CAGUUCAGAAGUGUUCCUGAGU hsa-miR-5001 AGGGCUGGACUCAGCGGCGGAGCU UUCUGCCUCUGUCCAGGUCCUU hsa-miR-5002 UGACUGCCUCACUGACCACUU AAUUUGGUUUCUGAGGCACUUAGU hsa-miR-5003 UCACAACAACCUUGCAGGGUAGA UACUUUUCUAGGUUGUUGGGG hsa-miR-5004 CUUGGAUUUUCCUGGGCCUCAG UGAGGACAGGGCAAAUUCACGA hsa-miR-5006 UUGCCAGGGCAGGAGGUGGAA UUUCCCUUUCCAUCCUGGCAG hsa-miR-5007 UAGAGUCUGGCUGAUAUGGUUU AUCAUAUGAACCAAACUCUAAU hsa-miR-5008 UGAGGCCCUUGGGGCACAGUGG CCUGUGCUCCCAGGGCCUCGC hsa-miR-5009 UCCUAAAUCUGAAAGUCCAAAA UUGGACUUUUUCAGAUUUGGGGAU hsa-miR-500a AUGCACCUGGGCAAGGAUUCUG UAAUCCUUGCUACCUGGGUGAGA hsa-miR-500b AAUCCUUGCUACCUGGGU GCACCCAGGCAAGGAUUCUG hsa-miR-501 AAUGCACCCGGGCAAGGAUUCU AAUCCUUUGUCCCUGGGUGAGA hsa-miR-5010 AGGGGGAUGGCAGAGCAAAAUU UUUUGUGUCUCCCAUUCCCCAG hsa-miR-5011 UAUAUAUACAGCCAUGCACUC GUGCAUGGCUGUAUAUAUAACA hsa-miR-502 AAUGCACCUGGGCAAGGAUUCA AUCCUUGCUAUCUGGGUGCUA hsa-miR-503 UAGCAGCGGGAACAGUUCUGCAG GGGGUAUUGUUUCCGCUGCCAGG hsa-miR-504 GGGAGUGCAGGGCAGGGUUUC AGACCCUGGUCUGCACUCUAUC hsa-miR-5047 UUGCAGCUGCGGUUGUAAGGU CUUACAACCGCAGCUGCAAUU hsa-miR-505 CGUCAACACUUGCUGGUUUCCU GGGAGCCAGGAAGUAUUGAUGU hsa-miR-506 UAAGGCACCCUUCUGAGUAGA UAUUCAGGAAGGUGUUACUUAA hsa-miR-507 UUUUGCACCUUUUGGAGUGAA CACUCCAAAAGGUGCAAAAUU hsa-miR-508 UGAUUGUAGCCUUUUGGAGUAGA UACUCCAGAGGGCGUCACUCAUG hsa-miR-5087 GGGUUUGUAGCUUUGCUGGCAUG UGCCAGCAAAGCUACAAACCCUU hsa-miR-5088 UCCCUUCUUCCUGGGCCCUCA CAGGGCUCAGGGAUUGGAUGGAGG hsa-miR-5089 GUGGGAUUUCUGAGUAGCAUC AUGCUACUCGGAAAUCCCACUGA hsa-miR-509-1 UGAUUGGUACGUCUGUGGGUAG UACUGCAGACAGUGGCAAUCA hsa-miR-509-3 UGAUUGGUACGUCUGUGGGUAG UACUGCAGACGUGGCAAUCAUG hsa-miR-5090 CCGGGGCAGAUUGGUGUAGGGUG CCCUACACCAAUCUGCCCCGGUU hsa-miR-5091 ACGGAGACGACAAGACUGUGCUG GCACAGUCUUGUCGUCUCCGUUU hsa-miR-5092 AAUCCACGCUGAGCUUGGCAUC UGCCAAGCUCAGCGUGGAUUUU hsa-miR-5093 AGGAAAUGAGGCUGGCUAGGAGC UCCUAGCCAGCCUCAUUUCCUUU hsa-miR-5094 AAUCAGUGAAUGCCUUGAACCU GUUCAAGGCAUUCACUGAUUUU hsa-miR-5095 UUACAGGCGUGAACCACCGCG CGGUGGUUCACGCCUGUAAUU hsa-miR-5096 GUUUCACCAUGUUGGUCAGGC CUGACCAACAUGGUGAAACUU hsa-miR-510 UACUCAGGAGAGUGGCAAUCAC AUUGAAACCUCUAAGAGUGGA hsa-miR-5100 UUCAGAUCCCAGCGGUGCCUCU AGGCACCGCUGGGAUCUGAAUU hsa-miR-511 GUGUCUUUUGCUCUGCAGUCA AAUGUGUAGCAAAAGACAGA hsa-miR-512 AAGUGCUGUCAUAGCUGAGGUC CACUCAGCCUUGAGGGCACUUUC hsa-miR-513a UAAAUUUCACCUUUCUGAGAAGG UUCACAGGGAGGUGUCAU hsa-miR-513b AAAUGUCACCUUUUUGAGAGGA UUCACAAGGAGGUGUCAUUUAU hsa-miR-513c UUCUCAAGGAGGUGUCGUUUAU UAAAUUUCACCUUUCUGAGAAGA hsa-miR-514a AUUGACACUUCUGUGAGUAGA UACUCUGGAGAGUGACAAUCAUG hsa-miR-514b AUUGACACCUCUGUGAGUGGA UUCUCAAGAGGGAGGCAAUCAU hsa-miR-515 GAGUGCCUUCUUUUGGAGCGUU UUCUCCAAAAGAAAGCACUUUCUG hsa-miR-516a UUCUCGAGGAAAGAAGCACUUUC UGCUUCCUUUCAGAGGGU hsa-miR-516b AUCUGGAGGUAAGAAGCACUUU UGCUUCCUUUCAGAGGGU hsa-miR-517a AUCGUGCAUCCCUUUAGAGUGU CCUCUAGAUGGAAGCACUGUCU hsa-miR-517b AUCGUGCAUCCCUUUAGAGUGU CCUCUAGAUGGAAGCACUGUCU hsa-miR-517c AUCGUGCAUCCUUUUAGAGUGU CCUCUAGAUGGAAGCACUGUCU hsa-miR-5186 AGAGAUUGGUAGAAAUCAGGU CUGAUUUCUACCAAUCUCUUU hsa-miR-5187 ACUGAAUCCUCUUUUCCUCAG UGGGAUGAGGGAUUGAAGUGGA hsa-miR-5188 AAUCGGACCCAUUUAAACCGGAG CCGGUUUAAAUGGGUCCGAUUUU hsa-miR-5189 UCUGGGCACAGGCGGAUGGACAGG UGCCAACCGUCAGAGCCCAGA hsa-miR-518a GAAAGCGCUUCCCUUUGCUGGA CUGCAAAGGGAAGCCCUUUC hsa-miR-518b CAAAGCGCUCCCCUUUAGAGGU CUCUAAAGGGGAGCGCUUUGUU hsa-miR-518c CAAAGCGCUUCUCUUUAGAGUGU UCUCUGGAGGGAAGCACUUUCUG hsa-miR-518d CUCUAGAGGGAAGCACUUUCUG CAAAGCGCUUCCCUUUGGAGC hsa-miR-518e CUCUAGAGGGAAGCGCUUUCUG AAAGCGCUUCCCUUCAGAGUG hsa-miR-518f CUCUAGAGGGAAGCACUUUCUC GAAAGCGCUUCUCUUUAGAGG hsa-miR-5190 CCAGUGACUGAGCUGGAGCCA GCUCCAGCUCAGUCACUGGUU hsa-miR-5191 AGGAUAGGAAGAAUGAAGUGCU CACUUCAUUCUUCCUAUCCUUU hsa-miR-5192 AGGAGAGUGGAUUCCAGGUGGU CACCUGGAAUCCACUCUCCUUU hsa-miR-5193 UCCUCCUCUACCUCAUCCCAGU UGGGAUGAGGUAGAGGAGGAUU hsa-miR-5194 UGAGGGGUUUGGAAUGGGAUGG AUCCCAUUCCAAACCCCUCAUU hsa-miR-5195 AACCCCUAAGGCAACUGGAUGG AUCCAGUUCUCUGAGGGGGCU hsa-miR-5196 AGGGAAGGGGACGAGGGUUGGG UCAUCCUCGUCUCCCUCCCAG hsa-miR-5197 AAGAAGAGACUGAGUCAUCGAAU CAAUGGCACAAACUCAUUCUUGA hsa-miR-519a CUCUAGAGGGAAGCGCUUUCUG AAAGUGCAUCCUUUUAGAGUGU hsa-miR-519b AAAGUGCAUCCUUUUAGAGGUU CUCUAGAGGGAAGCGCUUUCUG hsa-miR-519c AAAGUGCAUCUUUUUAGAGGAU CUCUAGAGGGAAGCGCUUUCUG hsa-miR-519d CAAAGUGCCUCCCUUUAGAGUG CCUCCAAAGGGAAGCGCUUUCUGUU hsa-miR-519e UUCUCCAAAAGGGAGCACUUUC AAGUGCCUCCUUUUAGAGUGUU hsa-miR-520a AAAGUGCUUCCCUUUGGACUGU CUCCAGAGGGAAGUACUUUCU hsa-miR-520b AAAGUGCUUCCUUUUAGAGGG CUCUAAAAGGAAGCACUUUUU hsa-miR-520c CUCUAGAGGGAAGCACUUUCUG AAAGUGCUUCCUUUUAGAGGGU hsa-miR-520d CUACAAAGGGAAGCCCUUUC AAAGUGCUUCUCUUUGGUGGGU hsa-miR-520e AAAGUGCUUCCUUUUUGAGGG CUCAAAAAGGAAGCACUUUUU hsa-miR-520f CCUCUAAAGGGAAGCGCUUUCU AAGUGCUUCCUUUUAGAGGGUU hsa-miR-520g UCUAGAGGAAGCACUUUCUGUUU ACAAAGUGCUUCCCUUUAGAGUGU hsa-miR-520h ACAAAGUGCUUCCCUUUAGAGU UCUAAAGGGAAGCACUUUGUUU hsa-miR-521 AACGCACUUCCCUUUAGAGUGU ACUCUAAAGGGAAGUGCGUUUU hsa-miR-522 CUCUAGAGGGAAGCGCUUUCUG AAAAUGGUUCCCUUUAGAGUGU hsa-miR-523 CUCUAGAGGGAAGCGCUUUCUG GAACGCGCUUCCCUAUAGAGGGU hsa-miR-524 GAAGGCGCUUCCCUUUGGAGU CUACAAAGGGAAGCACUUUCUC hsa-miR-525 CUCCAGAGGGAUGCACUUUCU GAAGGCGCUUCCCUUUAGAGCG hsa-miR-526a CUCUAGAGGGAAGCACUUUCUG GAAAGUGCUUCCCUCUAGAGUU hsa-miR-526b GAAAGUGCUUCCUUUUAGAGGC CUCUUGAGGGAAGCACUUUCUGU hsa-miR-527 CUGCAAAGGGAAGCCCUUUC AAGGGCUUCCCUUUGCAGUU hsa-miR-532 CCUCCCACACCCAAGGCUUGCA CAUGCCUUGAGUGUAGGACCGU hsa-miR-539 GGAGAAAUUAUCCUUGGUGUGU AUCAUACAAGGACAAUUUCUUU hsa-miR-541 UGGUGGGCACAGAAUCUGGACU AAAGGAUUCUGCUGUCGGUCCCACU hsa-miR-542 UGUGACAGAUUGAUAACUGAAA UCGGGGAUCAUCAUGUCACGAGA hsa-miR-543 AAACAUUCGCGGUGCACUUCUU GAAGUGCACCGCGAAUGUUUUU hsa-miR-544a AUUCUGCAUUUUUAGCAAGUUC ACUUGCUAAAAAUGCAGAAUUU hsa-miR-544b ACCUGAGGUUGUGCAUUUCUAA AGAAAUGCACAACCUCAGGUUU hsa-miR-545 UCAGUAAAUGUUUAUUAGAUGA UCAGCAAACAUUUAUUGUGUGC hsa-miR-548a CAAAACUGGCAAUUACUUUUGC AAAAGUAAUUGCGAGUUUUACC hsa-miR-548aa AAAAACCACAAUUACUUUUGCACCA GUGCAAAAGUAAUUGUGGUUUUUUU hsa-miR-548ab AAAAGUAAUUGUGGAUUUUGCU CAAAAUCCACAAUUACUUUUUU hsa-miR-548ac CAAAAACCGGCAAUUACUUUUG AAAGUAAUUGCCGGUUUUUGUU hsa-miR-548ad AAAAGUAAUUGUGGUUUUUG GAAAACGACAAUGACUUUUGCA hsa-miR-548ae CAAAAACUGCAAUUACUUUCA AAAAGUAAUUGUGGUUUUUG hsa-miR-548ag AAAGGUAAUUGUGGUUUCUGC AGAAACCACAAUUACCUUUUU hsa-miR-548ah CAAAAACUGCAGUUACUUUUGC AAAAGUGAUUGCAGUGUUUG hsa-miR-548ai AAAGGUAAUUGCAGUUUUUCCC GAAAAACUGCAAUUACCUUUUU hsa-miR-548aj UGCAAAAGUAAUUGCAGUUUUUG UAAAAACUGCAAUUACUUUUA hsa-miR-548ak AAAAGUAACUGCGGUUUUUGA AAAAACCGCAGUUACUUUUUU hsa-miR-548a1 AACGGCAAUGACUUUUGUACCA GUACAAAAGUCAUUGCCGUUUU hsa-miR-548am AAAAGUAAUUGCGGUUUUUGCC CAAAAACUGCAGUUACUUUUGU hsa-miR-548an AAAAGGCAUUGUGGUUUUUG AAAACCACAAUGCCUUUUUU hsa-miR-548ao AGAAGUAACUACGGUUUUUGCA AAAGACCGUGACUACUUUUGCA hsa-miR-548ap AAAAGUAAUUGCGGUCUUU AAAAACCACAAUUACUUUU hsa-miR-548aq GAAAGUAAUUGCUGUUUUUGCC CAAAAACUGCAAUUACUUUUGC hsa-miR-548ar AAAAGUAAUUGCAGUUUUUGC UAAAACUGCAGUUAUUUUUGC hsa-miR-548as UAAAACCCACAAUUAUGUUUGU AAAAGUAAUUGCGGGUUUUGCC hsa-miR-548at AAAAGUUAUUGCGGUUUUGGCU CAAAACCGCAGUAACUUUUGU hsa-miR-548au UGGCAGUUACUUUUGCACCAG AAAAGUAAUUGCGGUUUUUGC hsa-miR-548av AAAACUGCAGUUACUUUUGC AAAAGUACUUGCGGAUUU hsa-miR-548aw GUGCAAAAGUCAUCACGGUU CCGUGAUGACUUUUGCACUU hsa-miR-548ax AGAAGUAAUUGCGGUUUUGCCA GCAAAACCGCAAUUACUUCUUU hsa-miR-548ay CAAAACCGCGAUUACUCUUGCA AAAAGUAAUUGUGGUUUUUGC hsa-miR-548az AAAAACUGCAAUCACUUUUGC CAAAAGUGAUUGUGGUUUUUGC hsa-miR-548b AAAAGUAAUUGUGGUUUUGGCC CAAGAACCUCAGUUGCUUUUGU hsa-miR-548ba AAAGGUAACUGUGAUUUUUGCU CAAAAAUCACAGUUACCUUUUU hsa-miR-548bb AAAAGUAACUAUGGUUUUUGCC CAAAAACCAUAGUUACUUUUGC hsa-miR-548c AAAAGUAAUUGCGGUUUUUGCC CAAAAAUCUCAAUUACUUUUGC hsa-miR-548d CAAAAACCACAGUUUCUUUUGC AAAAGUAAUUGUGGUUUUUGCC hsa-miR-548e AAAAACUGAGACUACUUUUGCA CAAAAGCAAUCGCGGUUUUUGC hsa-miR-548f AAAAACUGUAAUUACUUUU UGCAAAAGUAAUCACAGUUUUU hsa-miR-548g UGCAAAAGUAAUUGCAGUUUUUG AAAACUGUAAUUACUUUUGUAC hsa-miR-548h CAAAAACCGCAAUUACUUUUGCA AAAAGUAAUCGCGGUUUUUGUC hsa-miR-548i AAAAGUAAUUGCGGAUUUUGCC CAAAAUCCGCAAUUACUUUUUU hsa-miR-548j CAAAAACUGCAUUACUUUUGC AAAAGUAAUUGCGGUCUUUGGU hsa-miR-548k AAAAGUACUUGCGGAUUUUGCU CAAAAUCCGCAAGUACUUUUUU hsa-miR-5481 AAAAGUAUUUGCGGGUUUUGUC CAAAACCCGCAAAUACUUUUUU hsa-miR-548m CAAAGGUAUUUGUGGUUUUUG AAAACCACAAAUACCUUUGUU hsa-miR-548n CAAAAGUAAUUGUGGAUUUUGU AAAAUCCACAAUUACUUUUGUU hsa-miR-548o CCAAAACUGCAGUUACUUUUGC AAAAGUAAUUGCGGUUUUUGCC hsa-miR-548p UAGCAAAAACUGCAGUUACUUU AGUAACUGCAGUUUUUGCUAUU hsa-miR-548q GCUGGUGCAAAAGUAAUGGCGG GCCAUUACUUUUGCACCAGCUU hsa-miR-548s AUGGCCAAAACUGCAGUUAUUUU AAUAACUGCAGUUUUGGCCAUUU hsa-miR-548t AAAAACCACAAUUACUUUUGCACCA CAAAAGUGAUCGUGGUUUUUG hsa-miR-548u CAAAGACUGCAAUUACUUUUGCG CAAAAGUAAUUGCAGUCUUUGUU hsa-miR-548v AGCUACAGUUACUUUUGCACCA GUGCAAAAGUAACUGUAGCUUU hsa-miR-548w AAAAGUAACUGCGGUUUUUGCCU GCAAAAACCGCAGUUACUUUUUU hsa-miR-548x UGCAAAAGUAAUUGCAGUUUUUG UAAAAACUGCAAUUACUUUC hsa-miR-548y AAAAGUAAUCACUGUUUUUGCC CAAAAACAGUGAUUACUUUUUU hsa-miR-548z CAAAAACCGCAAUUACUUUUGCA CAAAAGUAAUUGCGGUUUUUGUU hsa-miR-549a UGACAACUAUGGAUGAGCUCU AGCUCAUCCAUAGUUGUCAUU hsa-miR-550a-1 UGUCUUACUCCCUCAGGCACAU AGUGCCUGAGGGAGUAAGAGCCC hsa-miR-550a-3 UGUCUUACUCCCUCAGGCACAU AGUGCCUGAGGGAGUAAGAG hsa-miR-550b UCUUACUCCCUCAGGCACUG AUGUGCCUGAGGGAGUAAGACA hsa-miR-551a GCGACCCACUCUUGGUUUCCA GAAACCAAGAGUGGGUCGCUU hsa-miR-551b GAAAUCAAGCGUGGGUGAGACC GCGACCCAUACUUGGUUUCAG hsa-miR-552 GUUUAACCUUUUGCCUGUUGG AACAGGUGACUGGUUAGACAA hsa-miR-553 AAAACGGUGAGAUUUUGUUUU AACAAAAUCUCACCGUUUUUU hsa-miR-554 GCUAGUCCUGACUCAGCCAGU UGGCUGAGUCAGGACUAGCUU hsa-miR-555 AGGGUAAGCUGAACCUCUGAU CAGAGGUUCAGCUUACCCUUU hsa-miR-556 GAUGAGCUCAUUGUAAUAUGAG AUAUUACCAUUAGCUCAUCUUU hsa-miR-557 GUUUGCACGGGUGGGCCUUGUCU ACAAGGCCCACCCGUGCAAACUU hsa-miR-5571 GUCCUAGGAGGCUCCUCUG CAAUUCUCAAAGGAGCCUCCC hsa-miR-5572 GUUGGGGUGCAGGGGUCUGCU CAGACCCCUGCACCCCAACUU hsa-miR-5579 UAUGGUACUCCUUAAGCUAAC UUAGCUUAAGGAGUACCAGAUC hsa-miR-558 UGAGCUGCUGUACCAAAAU UUUGGUACAGCAGCUCAUU hsa-miR-5580 CACAUAUGAAGUGAGCCAGCAC UGCUGGCUCAUUUCAUAUGUGU hsa-miR-5581 AGCCUUCCAGGAGAAAUGGAGA UUCCAUGCCUCCUAGAAGUUCC hsa-miR-5582 UAAAACUUUAAGUGUGCCUAGG UAGGCACACUUAAAGUUAUAGC hsa-miR-5583 GAAUAUGGGUAUAUUAGUUUGG AAACUAAUAUACCCAUAUUCUG hsa-miR-5584 CAGGGAAAUGGGAAGAACUAGA UAGUUCUUCCCUUUGCCCAAUU hsa-miR-5585 CUGAAUAGCUGGGACUACAGGU UGAAGUACCAGCUACUCGAGAG hsa-miR-5586 UAUCCAGCUUGUUACUAUAUGC CAGAGUGACAAGCUGGUUAAAG hsa-miR-5587 AUGGUCACCUCCGGGACU GCCCCGGGCAGUGUGAUCAUC hsa-miR-5588 ACUGGCAUUAGUGGGACUUUU AAGUCCCACUAAUGCCAGC hsa-miR-5589 GGCUGGGUGCUCUUGUGCAGU UGCACAUGGCAACCUAGCUCCCA hsa-miR-559 UAAAGUAAAUAUGCACCAAAA UUGGUGCAUAUUUACUUUAUU hsa-miR-5590 AAUAAAGUUCAUGUAUGGCAA UUGCCAUACAUAGACUUUAUU hsa-miR-5591 UGGGAGCUAAGCUAUGGGUAU AUACCCAUAGCUUAGCUCCCA hsa-miR-561 CAAAGUUUAAGAUCCUUGAAGU AUCAAGGAUCUUAAACUUUGCC hsa-miR-562 AAAGUAGCUGUACCAUUUGC AAAUGGUACAGCUACUUUUU hsa-miR-563 AGGUUGACAUACGUUUCCC GAAACGUAUGUCAACCUUU hsa-miR-564 AGGCACGGUGUCAGCAGGC CUGCUGACACCGUGCCUUU hsa-miR-566 GGGCGCCUGUGAUCCCAAC UGGGAUCACAGGCGCCCUU hsa-miR-567 AGUAUGUUCUUCCAGGACAGAAC UCUGUCCUGGAAGAACAUACUUU hsa-miR-568 AUGUAUAAAUGUAUACACAC GUGUAUACAUUUAUACAUUU hsa-miR-5680 GAGAAAUGCUGGACUAAUCUGC AGAUUAGUCCAGCAUUUCUCUU hsa-miR-5681a AGAAAGGGUGGCAAUACCUCUU GAGGUAUUGCCACCCUUUCUUU hsa-miR-5681b AGGUAUUGCCACCCUUUCUAGU UAGAAAGGGUGGCAAUACCUUU hsa-miR-5682 GUAGCACCUUGCAGGAUAAGGU CUUAUCCUGCAAGGUGCUACUU hsa-miR-5683 UACAGAUGCAGAUUCUCUGACUUC AGUCAGAGAAUCUGCAUCUGUAUU hsa-miR-5684 AACUCUAGCCUGAGCAACAG GUUGCUCAGGCUAGAGUUUU hsa-miR-5685 ACAGCCCAGCAGUUAUCACGGG CGUGAUAACUGCUGGGCUGUUU hsa-miR-5687 UUAGAACGUUUUAGGGUCAAAU UUGACCCUAAAACGUUCUAAUU hsa-miR-5688 UAACAAACACCUGUAAAACAGC UGUUUUACAGGUGUUUGUUAUU hsa-miR-5689 AGCAUACACCUGUAGUCCUAGA UAGGACUACAGGUGUAUGCUUU hsa-miR-569 AGUUAAUGAAUCCUGGAAAGU UUUCCAGGAUUCAUUAACUUU hsa-miR-5690 UCAGCUACUACCUCUAUUAGG UAAUAGAGGUAGUAGCUGAUU hsa-miR-5691 UUGCUCUGAGCUCCGAGAAAGC UUUCUCGGAGCUCAGAGCAAUU hsa-miR-5692a CAAAUAAUACCACAGUGGGUGU ACCCACUGUGGUAUUAUUUGUU hsa-miR-5692b AAUAAUAUCACAGUAGGUGU ACCUACUGUGAUAUUAUUUU hsa-miR-5692c AAUAAUAUCACAGUAGGUGUAC ACACCUACUGUGAUAUUAUUUU hsa-miR-5693 GCAGUGGCUCUGAAAUGAACUC GUUCAUUUCAGAGCCACUGCUU hsa-miR-5694 CAGAUCAUGGGACUGUCUCAG GAGACAGUCCCAUGAUCUGUU hsa-miR-5695 ACUCCAAGAAGAAUCUAGACAG GUCUAGAUUCUUCUUGGAGUUU hsa-miR-5696 CUCAUUUAAGUAGUCUGAUGCC CAUCAGACUACUUAAAUGAGUU hsa-miR-5697 UCAAGUAGUUUCAUGAUAAAGG UUUAUCAUGAAACUACUUGAUU hsa-miR-5698 UGGGGGAGUGCAGUGAUUGUGG ACAAUCACUGCACUCCCCCAUU hsa-miR-5699 UCCUGUCUUUCCUUGUUGGAGC UGCCCCAACAAGGAAGGACAAG hsa-miR-570 CGAAAACAGCAAUUACCUUUGC AAAGGUAAUUGCAGUUUUUCCC hsa-miR-5700 UAAUGCAUUAAAUUAUUGAAGG UUCAAUAAUUUAAUGCAUUAUU hsa-miR-5701 UUAUUGUCACGUUCUGAUU UCAGAACGUGACAAUAAUU hsa-miR-5702 UGAGUCAGCAACAUAUCCCAUG UGGGAUAUGUUGCUGACUCAUU hsa-miR-5703 AGGAGAAGUCGGGAAGGU CUUCCCGACUUCUCCUUU hsa-miR-5704 UUAGGCCAUCAUCCCAUUAUGC AUAAUGGGAUGAUGGCCUAAUU hsa-miR-5705 UGUUUCGGGGCUCAUGGCCUGUG CAGGCCAUGAGCCCCGAAACAUU hsa-miR-5706 UUCUGGAUAACAUGCUGAAGCU CUUCAGCAUGUUAUCCAGAAUU hsa-miR-5707 ACGUUUGAAUGCUGUACAAGGC CUUGUACAGCAUUCAAACGUUU hsa-miR-5708 AUGAGCGACUGUGCCUGACC UCAGGCACAGUCGCUCAUUU hsa-miR-571 UGAGUUGGCCAUCUGAGUGAG CACUCAGAUGGCCAACUCAUU hsa-miR-572 GUCCGCUCGGCGGUGGCCCA GGCCACCGCCGAGCGGACUU hsa-miR-573 CUGAAGUGAUGUGUAACUGAUCAG GAUCAGUUACACAUCACUUCAGUU hsa-miR-5739 GCGGAGAGAGAAUGGGGAGC UCCCCAUUCUCUCUCCGCUU hsa-miR-574 UGAGUGUGUGUGUGUGAGUGUGU CACGCUCAUGCACACACCCACA hsa-miR-575 GAGCCAGUUGGACAGGAGC UCCUGUCCAACUGGCUCUU hsa-miR-576 AAGAUGUGGAAAAAUUGGAAUC AUUCUAAUUUCUCCACGUCUUU hsa-miR-577 UAGAUAAAAUAUUGGUACCUG GGUACCAAUAUUUUAUCUAUU hsa-miR-578 CUUCUUGUGCUCUAGGAUUGU AAUCCUAGAGCACAAGAAGUU hsa-miR-5787 GGGCUGGGGCGCGGGGAGGU CUCCCCGCGCCCCAGCCCUU hsa-miR-579 UUCAUUUGGUAUAAACCGCGAUU UCGCGGUUUGUGCCAGAUGACG hsa-miR-580 UAAUGAUUCAUCAGACUCAGAU UUGAGAAUGAUGAAUCAUUAGG hsa-miR-581 UCUUGUGUUCUCUAGAUCAGU UGAUCUAGAGAACACAAGAUU hsa-miR-582 UUACAGUUGUUCAACCAGUUACU UAACUGGUUGAACAACUGAACC hsa-miR-583 CAAAGAGGAAGGUCCCAUUAC AAUGGGACCUUCCUCUUUGUU hsa-miR-584 UUAUGGUUUGCCUGGGACUGAG UCAGUUCCAGGCCAACCAGGCU hsa-miR-585 UGGGCGUAUCUGUAUGCUA CUAGCACACAGAUACGCCCAGA hsa-miR-586 UAUGCAUUGUAUUUUUAGGUCC ACCUAAAAAUACAAUGCAUAUU hsa-miR-587 UUUCCAUAGGUGAUGAGUCAC GACUCAUCACCUAUGGAAAUU hsa-miR-588 UUGGCCACAAUGGGUUAGAAC UCUAACCCAUUGUGGCCAAUU hsa-miR-589 UCAGAACAAAUGCCGGUUCCCAGA UGAGAACCACGUCUGCUCUGAG hsa-miR-590 GAGCUUAUUCAUAAAAGUGCAG UAAUUUUAUGUAUAAGCUAGU hsa-miR-591 AGACCAUGGGUUCUCAUUGU AAUGAGAACCCAUGGUCUUU hsa-miR-592 UUGUGUCAAUAUGCGAUGAUGU AUCAUCGCAUAUUGACACAAUU hsa-miR-593 UGUCUCUGCUGGGGUUUCU AGGCACCAGCCAGGCAUUGCUCAGC hsa-miR-595 GAAGUGUGCCGUGGUGUGUCU ACACACCACGGCACACUUCUU hsa-miR-596 AAGCCUGCCCGGCUCCUCGGG CGAGGAGCCGGGCAGGCUUUU hsa-miR-597 UGGUUCUCUUGUGGCUCAAGCGU UGUGUCACUCGAUGACCACUGU hsa-miR-598 UACGUCAUCGUUGUCAUCGUCA GCGGUGAUCCCGAUGGUGUGAGC hsa-miR-599 GUUGUGUCAGUUUAUCAAAC UUGAUAAACUGACACAACUU hsa-miR-600 ACUUACAGACAAGAGCCUUGCUC GCAAGGCUCUUGUCUGUAAGUUU hsa-miR-601 UGGUCUAGGAUUGUUGGAGGAG CCUCCAACAAUCCUAGACCAUU hsa-miR-602 GACACGGGCGACAGCUGCGGCCC GCCGCAGCUGUCGCCCGUGUCUU hsa-miR-603 CACACACUGCAAUUACUUUUGC AAAAGUAAUUGCAGUGUGUGUU hsa-miR-604 AGGCUGCGGAAUUCAGGAC CCUGAAUUCCGCAGCCUUU hsa-miR-605 AGAAGGCACUAUGAGAUUUAGA UAAAUCCCAUGGUGCCUUCUCCU hsa-miR-606 AAACUACUGAAAAUCAAAGAU CUUUGAUUUUCAGUAGUUUUU hsa-miR-6068 CCUGCGAGUCUCCGGCGGUGG ACCGCCGGAGACUCGCAGGUU hsa-miR-6069 GGGCUAGGGCCUGCUGCCCCC GGGCAGCAGGCCCUAGCCCUU hsa-miR-607 GUUCAAAUCCAGAUCUAUAAC UAUAGAUCUGGAUUUGAACUU hsa-miR-6070 CCGGUUCCAGUCCCUGGAG CCAGGGACUGGAACCGGUU hsa-miR-6071 UUCUGCUGCCGGCCAAGGC CUUGGCCGGCAGCAGAAUU hsa-miR-6072 UCCUCAUCACACUGCACCUUAG AAGGUGCAGUGUGAUGAGGAUU hsa-miR-6073 GGUAGUGAGUUAUCAGCUAC AGCUGAUAACUCACUACCUU hsa-miR-6074 GAUAUUCAGAGGCUAGGUGG ACCUAGCCUCUGAAUAUCUU hsa-miR-6075 ACGGCCCAGGCGGCAUUGGUG CCAAUGCCGCCUGGGCCGUUU hsa-miR-6076 AGCAUGACAGAGGAGAGGUGG ACCUCUCCUCUGUCAUGCUUU hsa-miR-6077 GGGAAGAGCUGUACGGCCUUC AGGCCGUACAGCUCUUCCCUU hsa-miR-6078 CCGCCUGAGCUAGCUGUGG ACAGCUAGCUCAGGCGGUU hsa-miR-6079 UUGGAAGCUUGGACCAACUAGCUG GCUAGUUGGUCCAAGCUUCCAAUU hsa-miR-608 AGGGGUGGUGUUGGGACAGCUCCGU GGAGCUGUCCCAACACCACCCCUUU hsa-miR-6080 UCUAGUGCGGGCGUUCCCG GGAACGCCCGCACUAGAUU hsa-miR-6081 AGGAGCAGUGCCGGCCAAGGCGCC CGCCUUGGCCGGCACUGCUCCUUU hsa-miR-6082 GAAUACGUCUGGUUGAUCC AUCAACCAGACGUAUUCUU hsa-miR-6083 CUUAUAUCAGAGGCUGUGGG CACAGCCUCUGAUAUAAGUU hsa-miR-6084 UUCCGCCAGUCGGUGGCCGG GGCCACCGACUGGCGGAAUU hsa-miR-6085 AAGGGGCUGGGGGAGCACA UGCUCCCCCAGCCCCUUUU hsa-miR-6086 GGAGGUUGGGAAGGGCAGAG CUGCCCUUCCCAACCUCCUU hsa-miR-6087 UGAGGCGGGGGGGCGAGC UCGCCCCCCCGCCUCAUU hsa-miR-6088 AGAGAUGAAGCGGGGGGGCG CCCCCCCGCUUCAUCUCUUU hsa-miR-6089 GGAGGCCGGGGUGGGGCGGGGCGG GCCCCGCCCCACCCCGGCCUCCUU hsa-miR-609 AGGGUGUUUCUCUCAUCUCU AGAUGAGAGAAACACCCUUU hsa-miR-6090 GGGGAGCGAGGGGCGGGGC CCCGCCCCUCGCUCCCCUU hsa-miR-610 UGAGCUAAAUGUGUGCUGGGA CCAGCACACAUUUAGCUCAUU hsa-miR-611 GCGAGGACCCCUCGGGGUCUGAC CAGACCCCGAGGGGUCCUCGCUU hsa-miR-612 GCUGGGCAGGGCUUCUGAGCUCCUU GGAGCUCAGAAGCCCUGCCCAGCUU hsa-miR-6124 GGGAAAAGGAAGGGGGAGGA CUCCCCCUUCCUUUUCCCUU hsa-miR-6125 GCGGAAGGCGGAGCGGCGGA CGCCGCUCCGCCUUCCGCUU hsa-miR-6126 GUGAAGGCCCGGCGGAGA UCCGCCGGGCCUUCACUU hsa-miR-6127 UGAGGGAGUGGGUGGGAGG UCCCACCCACUCCCUCAUU hsa-miR-6128 ACUGGAAUUGGAGUCAAAA UUGACUCCAAUUCCAGUUU hsa-miR-6129 UGAGGGAGUUGGGUGUAUA UACACCCAACUCCCUCAUU hsa-miR-613 AGGAAUGUUCCUUCUUUGCC CAAAGAAGGAACAUUCCUUU hsa-miR-6130 UGAGGGAGUGGAUUGUAUG UACAAUCCACUCCCUCAUU hsa-miR-6131 GGCUGGUCAGAUGGGAGUG CUCCCAUCUGACCAGCCUU hsa-miR-6132 AGCAGGGCUGGGGAUUGCA CAAUCCCCAGCCCUGCUUU hsa-miR-6133 UGAGGGAGGAGGUUGGGUA CCCAACCUCCUCCCUCAUU hsa-miR-6134 UGAGGUGGUAGGAUGUAGA UACAUCCUACCACCUCAUU hsa-miR-614 GAACGCCUGUUCUUGCCAGGUGG ACCUGGCAAGAACAGGCGUUCUU hsa-miR-615 GGGGGUCCCCGGUGCUCGGAUC UCCGAGCCUGGGUCUCCCUCUU hsa-miR-616 ACUCAAAACCCUUCAGUGACUU AGUCAUUGGAGGGUUUGAGCAG hsa-miR-6165 CAGCAGGAGGUGAGGGGAG CCCCUCACCUCCUGCUGUU hsa-miR-617 AGACUUCCCAUUUGAAGGUGGC CACCUUCAAAUGGGAAGUCUUU hsa-miR-618 AAACUCUACUUGUCCUUCUGAGU UCAGAAGGACAAGUAGAGUUUUU hsa-miR-619 GCUGGGAUUACAGGCAUGAGCC GACCUGGACAUGUUUGUGCCCAGU hsa-miR-620 AUGGAGAUAGAUAUAGAAAU UUCUAUAUCUAUCUCCAUUU hsa-miR-621 GGCUAGCAACAGCGCUUACCU GUAAGCGCUGUUGCUAGCCUU hsa-miR-622 ACAGUCUGCUGAGGUUGGAGC UCCAACCUCAGCAGACUGUUU hsa-miR-623 AUCCCUUGCAGGGGCUGUUGGGU CCAACAGCCCCUGCAAGGGAUUU hsa-miR-624 UAGUACCAGUACCUUGUGUUCA CACAAGGUAUUGGUAUUACCU hsa-miR-625 AGGGGGAAAGUUCUAUAGUCC GACUAUAGAACUUUCCCCCUCA hsa-miR-626 AGCUGUCUGAAAAUGUCUU GACAUUUUCAGACAGCUUU hsa-miR-627 UCUUUUCUUUGAGACUCACU GUGAGUCUCUAAGAAAAGAGGA hsa-miR-628 UCUAGUAAGAGUGGCAGUCGA AUGCUGACAUAUUUACUAGAGG hsa-miR-629 UGGGUUUACGUUGGGAGAACU GUUCUCCCAACGUAAGCCCAGC hsa-miR-630 AGUAUUCUGUACCAGGGAAGGU CUUCCCUGGUACAGAAUACUUU hsa-miR-631 AGACCUGGCCCAGACCUCAGC UGAGGUCUGGGCCAGGUCUUU hsa-miR-632 GUGUCUGCUUCCUGUGGGA CCACAGGAAGCAGACACUU hsa-miR-633 CUAAUAGUAUCUACCACAAUAAA UAUUGUGGUAGAUACUAUUAGUU hsa-miR-634 AACCAGCACCCCAACUUUGGAC CCAAAGUUGGGGUGCUGGUUUU hsa-miR-635 ACUUGGGCACUGAAACAAUGUCC ACAUUGUUUCAGUGCCCAAGUUU hsa-miR-636 UGUGCUUGCUCGUCCCGCCCGCA CGGGCGGGACGAGCAAGCACAUU hsa-miR-637 ACUGGGGGCUUUCGGGCUCUGCGU GCAGAGCCCGAAAGCCCCCAGUUU hsa-miR-638 AGGGAUCGCGGGCGGGUGGCGGCCU GCCGCCACCCGCCCGCGAUCCCUUU hsa-miR-639 AUCGCUGCGGUUGCGAGCGCUGU AGCGCUCGCAACCGCAGCGAUUU hsa-miR-640 AUGAUCCAGGAACCUGCCUCU AGGCAGGUUCCUGGAUCAUUU hsa-miR-641 AAAGACAUAGGAUAGAGUCACCUC GGUGACUCUAUCCUAUGUCUUUUU hsa-miR-642a GUCCCUCUCCAAAUGUGUCUUG AGACACAUUUGGAGAGGGAACC hsa-miR-642b GGUUCCCUCUCCAAAUGUGUCU AGACACAUUUGGAGAGGGACCC hsa-miR-643 ACUUGUAUGCUAGCUCAGGUAG ACCUGAGCUAGCAUACAAGUUU hsa-miR-644a AGUGUGGCUUUCUUAGAGC UCUAAGAAAGCCACACUUU hsa-miR-645 UCUAGGCUGGUACUGCUGA AGCAGUACCAGCCUAGAUU hsa-miR-646 AAGCAGCUGCCUCUGAGGC CUCAGAGGCAGCUGCUUUU hsa-miR-647 GUGGCUGCACUCACUUCCUUC AGGAAGUGAGUGCAGCCACUU hsa-miR-648 AAGUGUGCAGGGCACUGGU CAGUGCCCUGCACACUUUU hsa-miR-649 AAACCUGUGUUGUUCAAGAGUC CUCUUGAACAACACAGGUUUUU hsa-miR-6499 AGCAGUGUUUGUUUUGCCCACA UCGGGCGCAAGAGCACUGCAGU hsa-miR-650 AGGAGGCAGCGCUCUCAGGAC CCUGAGAGCGCUGCCUCCUUU hsa-miR-6500 ACACUUGUUGGGAUGACCUGC AGGAGCUAUCCACUCCAGGUGUCC hsa-miR-6501 CCAGAGCAGCCUGCGGUAACAGU AGUUGCCAGGGCUGCCUUUGGU hsa-miR-6502 AGCUCUAGAAAGAUUGUUGACC UAGACCAUCUUUCUAGAGUAU hsa-miR-6503 GGGACUAGGAUGCAGACCUCC AGGUCUGCAUUCAAAUCCCCAGA hsa-miR-6504 CAUUACAGCACAGCCAUUCU UCUGGCUGUGCUGUAAUGCAG hsa-miR-6505 UGACUUCUACCUCUUCCAAAG UUGGAAUAGGGGAUAUCUCAGC hsa-miR-6506 ACUGGGAUGUCACUGAAUAUGGU UCGUAUCAGAGAUUCCAGACAC hsa-miR-6507 CAAAGUCCUUCCUAUUUUUCCC GAAGAAUAGGAGGGACUUUGU hsa-miR-6508 UCUAGAAAUGCAUGACCCACC UGGGCCAUGCAUUUCUAGAACU hsa-miR-6509 AUUAGGUAGUGGCAGUGGAAC UUCCACUGCCACUACCUAAUUU hsa-miR-651 UUUAGGAUAAGCUUGACUUUUG AAAGGAAAGUGUAUCCUAAAAG hsa-miR-6510 CAGCAGGGGAGAGAGAGGAGUC CACCGACUCUGUCUCCUGCAG hsa-miR-6511a CAGGCAGAAGUGGGGCUGACAGG CCUCACCAUCCCUUCUGCCUGC hsa-miR-6511b CUGCAGGCAGAAGUGGGGCUGACA CCUCACCACCCCUUCUGCCUGCA hsa-miR-6512 UACCAUUAGAAGAGCUGGAAGA UUCCAGCCCUUCUAAUGGUAGG hsa-miR-6513 UUUGGGAUUGACGCCACAUGUCU UCAAGUGUCAUCUGUCCCUAG hsa-miR-6514 CUGCCUGUUCUUCCACUCCAG UAUGGAGUGGACUUUCAGCUGGC hsa-miR-6515 UCUCUUCAUCUACCCCCCAG UUGGAGGGUGUGGAAGACAUC hsa-miR-6516 UUUGCAGUAACAGGUGUGAGCA AUCAUGUAUGAUACUGCAAACA hsa-miR-652 AAUGGCGCCACUAGGGUUGUG CAACCCUAGGAGAGGGUGCCAUUCA hsa-miR-653 GUGUUGAAACAAUCUCUACUG UUCACUGGAGUUUGUUUCAAUA hsa-miR-654 UGGUGGGCCGCAGAACAUGUGC UAUGUCUGCUGACCAUCACCUU hsa-miR-655 AGAGGUUAUCCGUGUUAUGUUC AUAAUACAUGGUUAACCUCUUU hsa-miR-656 AGGUUGCCUGUGAGGUGUUCA AAUAUUAUACAGUCAACCUCU hsa-miR-657 GGCAGGUUCUCACCCUCUCUAGG UAGAGAGGGUGAGAACCUGCCUU hsa-miR-658 GGCGGAGGGAAGUAGGUCCGUUGGU CAACGGACCUACUUCCCUCCGCCUU hsa-miR-659 AGGACCUUCCCUGAACCAAGGA CUUGGUUCAGGGAGGGUCCCCA hsa-miR-660 ACCUCCUGUGUGCAUGGAUUA UACCCAUUGCAUAUCGGAGUUG hsa-miR-661 UGCCUGGGUCUCUGGCCUGCGCGU GCGCAGGCCAGAGACCCAGGCAUU hsa-miR-662 UCCCACGUUGUGGCCCAGCAG GCUGGGCCACAACGUGGGAUU hsa-miR-663a AGGCGGGGCGCCGCGGGACCGC GGUCCCGCGGCGCCCCGCCUUU hsa-miR-663b GGUGGCCCGGCCGUGCCUGAGG UCAGGCACGGCCGGGCCACCUU hsa-miR-664a ACUGGCUAGGGAAAAUGAUUGGAU UAUUCAUUUAUCCCCAGCCUACA hsa-miR-664b UUCAUUUGCCUCCCAGCCUACA UGGGCUAAGGGAGAUGAUUGGGUA hsa-miR-665 ACCAGGAGGCUGAGGCCCCU GGGCCUCAGCCUCCUGGUUU hsa-miR-668 UGUCACUCGGCUCGGCCCACUAC UGCGCCUCGGGUGAGCAUG hsa-miR-670 UUUCCUCAUAUUCAUUCAGGA GUCCCUGAGUGUAUGUGGUG hsa-miR-671 UCCGGUUCUCAGGGCUCCACC AGGAAGCCCUGGAGGGGCUGGAG hsa-miR-6715a CCAAACCAGUCGUGCCUGUGG ACAGGCACGACUGGUUUGGUU hsa-miR-6715b CUCAAACCGGCUGUGCCUGUGG ACAGGCACGACUGGUUUGGCA hsa-miR-6716 UGGGAAUGGGGGUAAGGGCC UCCGAACUCUCCAUUCCUCUGC hsa-miR-6717 AGGCGAUGUGGGGAUGUAGAGA UCUACAUCCCCACAUCGCCUUU hsa-miR-6718 UAGUGGUCAGAGGGCUUAUGA AUAAGCCCUCUGACCACUAUU hsa-miR-6719 UCUGACAUCAGUGAUUCUCCUG GGAGAAUCACUGAUGUCAGAUU hsa-miR-6720 UUCCAGCCCUGGUAGGCGCCGCG CGCGCCUGCAGGAACUGGUAGA hsa-miR-6721 UGGGCAGGGGCUUAUUGUAGGAG CCUACAAUAAGCCCCUGCCCAUU hsa-miR-6722 UGCAGGGGUCGGGUGGGCCAGG AGGCGCACCCGACCACAUGC hsa-miR-6723 AUAGUCCGAGUAACGUCGGGGC CCCGACGUUACUCGGACUAUUU hsa-miR-6724 CUGGGCCCGCGGCGGGCGUGGGG CCACGCCCGCCGCGGGCCCAGUU hsa-miR-6726 CGGGAGCUGGGGUCUGCAGGU CUCGCCCUGUCUCCCGCUAG hsa-miR-6727 UCCUGCCACCUCCUCCGCAG CUCGGGGCAGGCGGCUGGGAGCG hsa-miR-6728 UCUCUGCUCUGCUCUCCCCAG UUGGGAUGGUAGGACCAGAGGGG hsa-miR-6729 UCAUCCCCCUCGCCCUCUCAG UGGGCGAGGGCGGCUGAGCGGC hsa-miR-6730 AGAAAGGUGGAGGGGUUGUCAGA CCUGACACCCCAUCUGCCCUCA hsa-miR-6731 UGGGAGAGCAGGGUAUUGUGGA UCUAUUCCCCACUCUCCCCAG hsa-miR-6732 UAGGGGGUGGCAGGCUGGCC UAACCCUGUCCUCUCCCUCCCAG hsa-miR-6733 UCAGUGUCUGGAUUUCCUAG UGGGAAAGACAAACUCAGAGUU hsa-miR-6734 CCCUUCCCUCACUCUUCUCUCAG UUGAGGGGAGAAUGAGGUGGAGA hsa-miR-6735 AGGCCUGUGGCUCCUCCCUCAG CAGGGCAGAGGGCACAGGAAUCUGA hsa-miR-6736 UCAGCUCCUCUCUACCCACAG CUGGGUGAGGGCAUCUGUGGU hsa-miR-6737 UUGGGGUGGUCGGCCCUGGAG UCUGUGCUUCACCCCUACCCAG hsa-miR-6738 CUUCUGCCUGCAUUCUACUCCCAG CGAGGGGUAGAAGAGCACAGGGG hsa-miR-6739 AUUGUUCUGUCUUUCUCCCAG UGGGAAAGAGAAAGAACAAGUA hsa-miR-6740 UGUCUUCUCUCCUCCCAAACAG AGUUUGGGAUGGAGAGAGGAGA hsa-miR-6741 UCGGCUCUCUCCCUCACCCUAG GUGGGUGCUGGUGGGAGCCGUG hsa-miR-6742 AGUGGGGUGGGACCCAGCUGUU ACCUGGGUUGUCCCCUCUAG hsa-miR-6743 AAGGGGCAGGGACGGGUGGCCC AGCCGCUCUUCUCCCUGCCCACA hsa-miR-6744 GGGCCUCUCUUGUCAUCCUGCAG UGGAUGACAGUGGAGGCCU hsa-miR-6745 UGGGUGGAAGAAGGUCUGGUU CCAGACCUUCUUCCACCCAUU hsa-miR-6746 CCGGGAGAAGGAGGUGGCCUGG CAGCCGCCGCCUGUCUCCACAG hsa-miR-6747 UCCUGCCUUCCUCUGCACCAG AGGGGUGUGGAAAGAGGCAGAACA hsa-miR-6748 UCCUGUCCCUGUCUCCUACAG UGUGGGUGGGAAGGACUGGAUU hsa-miR-6749 UCGGGCCUGGGGUUGGGGGAGC CUCCUCCCCUGCCUGGCCCAG hsa-miR-675 UGGUGCGGAGAGGGCCCACAGUG CUGUAUGCCCUCACCGCUCA hsa-miR-6750 CAGGGAACAGCUGGGUGAGCUGCU GAACUCACCCUCUGCUCCCAG hsa-miR-6751 UUGGGGGUGAGGUUGGUGUCUGG ACUGAGCCUCUCUCUCUCCAG hsa-miR-6752 UCCCUGCCCCCAUACUCCCAG GGGGGGUGUGGAGCCAGGGGGC hsa-miR-6753 UGGUCUGUCUCUGCCCUGGCAC CACCAGGGCAGAGCAGGGCUGA hsa-miR-6754 UCUUCACCUGCCUCUGCCUGCA CCAGGGAGGCUGGUUUGGAGGA hsa-miR-6755 UGUUGUCAUGUUUUUUCCCUAG UAGGGUAGACACUGACAACGUU hsa-miR-6756 UCCCCUUCCUCCCUGCCCAG AGGGUGGGGCUGGAGGUGGGGCU hsa-miR-6757 UAGGGAUGGGAGGCCAGGAUGA AACACUGGCCUUGCUAUCCCCA hsa-miR-6758 ACUCAUUCUCCUCUGUCCAG UAGAGAGGGGAAGGAUGUGAUGU hsa-miR-6759 UUGUGGGUGGGCAGAAGUCUGU UGACCUUUGCCUCUCCCCUCAG hsa-miR-676 CUGUCCUAAGGUUGUUGAGUU UCUUCAACCUCAGGACUUGCA hsa-miR-6760 CAGGGAGAAGGUGGAAGUGCAGA ACACUGUCCCCUUCUCCCCAG hsa-miR-6761 UCUGAGAGAGCUCGAUGGCAG UCCUACGCUGCUCUCUCACUCC hsa-miR-6762 CGGGGCCAUGGAGCAGCCUGUGU UGGCUGCUUCCCUUGGUCUCCAG hsa-miR-6763 CUGGGGAGUGGCUGGGGAG CUCCCCGGCCUCUGCCCCCAG hsa-miR-6764 UCUCUGGUCUUUCCUUGACAG UCCCAGGGUCUGGUCAGAGUUG hsa-miR-6765 UCACCUGGCUGGCCCGCCCAG GUGAGGCGGGGCCAGGAGGGUGUGU hsa-miR-6766 CGGGUGGGAGCAGAUCUUAUUGAG UGAUUGUCUUCCCCCACCCUCA hsa-miR-6767 UCGCAGACAGGGACACAUGGAGA CCACGUGCUUCUCUUUCCGCAG hsa-miR-6768 CAAAGGCCACAUUCUCCUGUGCAC CACACAGGAAAAGCGGGGCCCUG hsa-miR-6769a GAGCCCCUCUCUGCUCUCCAG AGGUGGGUAUGGAGGAGCCCU hsa-miR-6769b UGGUGGGUGGGGAGGAGAAGUGC CCCUCUCUGUCCCACCCAUAG hsa-miR-6770 UGAGAAGGCACAGCUUGCACGUGA CUGGCGGCUGUGUCUUCACAG hsa-miR-6771 CUCGGGAGGGCAUGGGCCAGGC CAAACCCCUGUCUACCCGCAG hsa-miR-6772 UGGGUGUAGGCUGGAGCUGAGG UUGCUCCUGACUCUGUGCCCACA hsa-miR-6773 ACUGUCACUUCUCUGCCCAUAG UUGGGCCCAGGAGUAAACAGGAU hsa-miR-6774 ACUUGGGCAGGAGGGACCCUGUAUG UCGUGUCCCUCUUGUCCACAG hsa-miR-6775 AGGCCCUGUCCUCUGCCCCAG UCGGGGCAUGGGGGAGGGAGGCUGG hsa-miR-6776 UCUGGGUGCAGUGGGGGUU CAACCACCACUGUCUCUCCCCAG hsa-miR-6777 UCCACUCUCCUGGCCCCCAG ACGGGGAGUCAGGCAGUGGUGGA hsa-miR-6778 UGCCUCCCUGACAUUCCACAG AGUGGGAGGACAGGAGGCAGGU hsa-miR-6779 AAGCCCUGUCUCCUCCCAUCU CUGGGAGGGGCUGGGUUUGGC hsa-miR-6780a CUCCUCUGUUUUCUUUCCUAG UUGGGAGGGAAGACAGCUGGAGA hsa-miR-6780b UCCCUUGUCUCCUUUCCCUAG UGGGGAAGGCUUGGCAGGGAAGA hsa-miR-6781 CGGGCCGGAGGUCAAGGGCGU UGCCUCUUUUCCACGGCCUCAG hsa-miR-6782 UAGGGGUGGGGGAAUUCAGGGGUGU CACCUUUGUGUCCCCAUCCUGCA hsa-miR-6783 UUCCUGGGCUUCUCCUCUGUAG UAGGGGAAAAGUCCUGAUCCGG hsa-miR-6784 UCUCACCCCAACUCUGCCCCAG GCCGGGGCUUUGGGUGAGGG hsa-miR-6785 ACAUCGCCCCACCUUCCCCAG UGGGAGGGCGUGGAUGAUGGUG hsa-miR-6786 UGACGCCCCUUCUGAUUCUGCCU GCGGUGGGGCCGGAGGGGCGU hsa-miR-6787 UCUCAGCUGCUGCCCUCUCCAG UGGCGGGGGUAGAGCUGGCUGC hsa-miR-6788 CUGGGAGAAGAGUGGUGAAGA UUCGCCACUUCCCUCCCUGCAG hsa-miR-6789 CGGCGCCCGUGUCUCCUCCAG GUAGGGGCGUCCCGGGCGCGCGGG hsa-miR-6790 GUGAGUGUGGAUUUGGCGGGGUU CGACCUCGGCGACCCCUCACU hsa-miR-6791 CCCCUGGGGCUGGGCAGGCGGA UGCCUCCUUGGUCUCCGGCAG hsa-miR-6792 CUCCUCCACAGCCCCUGCUCAU GUAAGCAGGGGCUCUGGGUGA hsa-miR-6793 UGUGGGUUCUGGGUUGGGGUGA UCCCCAACCCCUGCCCGCAG hsa-miR-6794 CAGGGGGACUGGGGGUGAGC CUCACUCUCAGUCCCUCCCU hsa-miR-6795 UGGGGGGACAGGAUGAGAGGCUGU ACCCCUCGUUUCUUCCCCCAG hsa-miR-6796 GAAGCUCUCCCCUCCCCGCAG UUGUGGGGUUGGAGAGCUGGCUG hsa-miR-6797 UGCAUGACCCUUCCCUCCCCAC AGGAGGGAAGGGGCUGAGAACAGGA hsa-miR-6798 CCAGGGGGAUGGGCGAGCUUGGG CUACCCCCCAUCCCCCUGUAG hsa-miR-6799 GGGGAGGUGUGCAGGGCUGG UGCCCUGCAUGGUGUCCCCACAG hsa-miR-6800 GUAGGUGACAGUCAGGGGCGG CACCUCUCCUGGCAUCGCCCC hsa-miR-6801 UGGUCAGAGGCAGCAGGAAAUGA ACCCCUGCCACUCACUGGCC hsa-miR-6802 UUCACCCCUCUCACCUAAGCAG CUAGGUGGGGGGCUUGAAGC hsa-miR-6803 UCCCUCGCCUUCUCACCCUCAG CUGGGGGUGGGGGGCUGGGCGU hsa-miR-6804 UGAGGGUGUCAGCAGGUGACG CGCACCUGCCUCUCACCCACAG hsa-miR-6805 UUGCUCUGCUCCCCCGCCCCCAG UAGGGGGCGGCUUGUGGAGUGU hsa-miR-6806 UGAAGCUCUGACAUUCCUGCAG UGUAGGCAUGAGGCAGGGCCCAGG hsa-miR-6807 GUGAGCCAGUGGAAUGGAGAGG CACUGCAUUCCUGCUUGGCCCAG hsa-miR-6808 CAGGCAGGGAGGUGGGACCAUG GUGUGACCACCGUUCCUGCAG hsa-miR-6809 CUUCUCUUCUCUCCUUCCCAG UGGCAAGGAAAGAAGAGGAUCA hsa-miR-6810 AUGGGGACAGGGAUCAGCAUGGC UCCCCUGCUCCCUUGUUCCCCAG hsa-miR-6811 AGCCUGUGCUUGUCCCUGCAG AUGCAGGCCUGUGUACAGCACU hsa-miR-6812 AUGGGGUGAGAUGGGGAGGAGCAGC CCGCUCUUCCCCUGACCCCAG hsa-miR-6813 CAGGGGCUGGGGUUUCAGGUUCU AACCUUGGCCCCUCUCCCCAG hsa-miR-6814 ACUCGCAUCCUUCCCUUGGCAG UCCCAAGGGUGAGAUGCUGCCA hsa-miR-6815 UAGGUGGCGCCGGAGGAGUCAUU UGGCUUCUCUUGCACACCCAG hsa-miR-6816 UGGGGCGGGGCAGGUCCCUGC GAAGGACCUGCACCUUCG hsa-miR-6817 UCUGCCAUAGGAAGCUUGGAGUGG UCUCUCUGACUCCAUGGCA hsa-miR-6818 UUGUGUGAGUACAGAGAGCAUC UUGUCUCUUGUUCCUCACACAG hsa-miR-6819 UUGGGGUGGAGGGCCAAGGAGC AAGCCUCUGUCCCCACCCCAG hsa-miR-6820 UGCGGCAGAGCUGGGGUCA UGUGACUUCUCCCCUGCCACAG hsa-miR-6821 GUGCGUGGUGGCUCGAGGCGGGG UGACCUCUCCGCUCCGCACAG hsa-miR-6822 AGGCUCUAACUGGCUUUCCCUGCA CAGGGAACCAGUUGGGGCUU hsa-miR-6823 UCAGGGUUGGUAGGGGUUGCU UGAGCCUCUCCUUCCCUCCAG hsa-miR-6824 GUAGGGGAGGUUGGGCCAGGGA UCUCUGGUCUUGCCACCCCAG hsa-miR-6825 GCGCUGACCCGCCUUCUCCGCA UGGGGAGGUGUGGAGUCAGCAU hsa-miR-6826 CUCCCCUCUCUUUCCUGUUCAG UCAAUAGGAAAGAGGUGGGACCU hsa-miR-6827 UGGGAGCCAUGAGGGUCUGUGC ACCGUCUCUUCUGUUCCCCAG hsa-miR-6828 AUCUGCUCUCUUGUUCCCAG AGGAAGCAAGAGAACCCUGUGG hsa-miR-6829 UGGGCUGCUGAGAAGGGGCA UGCCUCCUCCGUGGCCUCAG hsa-miR-6830 CCAAGGAAGGAGGCUGGACAUC UGUCUUUCUUCUCUCCCUUGCAG hsa-miR-6831 UAGGUAGAGUGUGAGGAGGAGGUC UGACUAACUCCCACUCUACAG hsa-miR-6832 AGUAGAGAGGAAAAGUUAGGGUC ACCCUUUUUCUCUUUCCCAG hsa-miR-6833 UUUCUCUCUCCACUUCCUCAG GUGUGGAAGAUGGGAGGAGAAA hsa-miR-6834 GUGAGGGACUGGGAUUUGUGG UAUGUCCCAUCCCUCCAUCA hsa-miR-6835 AGGGGGUAGAAAGUGGCUGAAG AAAAGCACUUUUCUGUCUCCCAG hsa-miR-6836 AUGCCUCCCCCGGCCCCGCAG CGCAGGGCCCUGGCGCAGGCAU hsa-miR-6837 ACCAGGGCCAGCAGGGAAUGU CCUUCACUGUGACUCUGCUGCAG hsa-miR-6838 AAGCAGCAGUGGCAAGACUCCU AAGUCCUGCUUCUGUUGCAG hsa-miR-6839 UCUGGAUUGAAGAGACGACCCA UUGGGUUUUCUCUUCAAUCCAG hsa-miR-6840 ACCCCCGGGCAAAGACCUGCAGAU GCCCAGGACUUUGUGCGGGGUG hsa-miR-6841 UAGGGUACUCAGAGCAAGUUGU ACCUUGCAUCUGCAUCCCCAG hsa-miR-6842 UGGGGGUGGUCUCUAGCCAAGG UUGGCUGGUCUCUGCUCCGCAG hsa-miR-6843 AUGGUCUCCUGUUCUCUGCAG GCAGAGAACAGGAGACCAUUU hsa-miR-6844 UUCUUUGUUUUUAAUUCACAG GUGAAUUAAAAACAAAGAAUU hsa-miR-6845 CGGGGCCAGAGCAGAGAGC CCUCUCCUCCCUGUGCCCCAG hsa-miR-6846 UGACCCCUUCUGUCUCCCUAG UGGGGGCUGGAUGGGGUAGAGU hsa-miR-6847 GGCUCAUGUGUCUGUCCUCUUC ACAGAGGACAGUGGAGUGUGAGC hsa-miR-6848 UGGGGGCUGGGAUGGGCCAUGGU GUGGUCUCUUGGCCCCCAG hsa-miR-6849 ACCAGCCUGUGUCCACCUCCAG GAGUGGAUAGGGGAGUGUGUGGA hsa-miR-6850 CCCGGCCGGAACGCCGCACU GUGCGGAACGCUGGCCGGGGCG hsa-miR-6851 AGGAGGUGGUACUAGGGGCCAGC UGGCCCUUUGUACCCCUCCAG hsa-miR-6852 CCCUGGGGUUCUGAGGACAUG UGUCCUCUGUUCCUCAG hsa-miR-6853 AGCGUGGGAUGUCCAUGAAGUCAG UGUUCAUUGGAACCCUGCGCAG hsa-miR-6854 UGCGUUUCUCCUCUUGAGCAG AAGCUCAGGUUUGAGAACUGCUGA hsa-miR-6855 AGACUGACCUUCAACCCCACAG UUGGGGUUUGGGGUGCAGACAUUGC hsa-miR-6856 UACAGCCCUGUGAUCUUUCCAG AAGAGAGGAGCAGUGGUGCUGUGG hsa-miR-6857 UGACUGAGCUUCUCCCCACAG UUGGGGAUUGGGUCAGGCCAGU hsa-miR-6858 CAGCCAGCCCCUGCUCACCCCU GUGAGGAGGGGCUGGCAGGGAC hsa-miR-6859 UGACCCCCAUGUCGCCUCUGUAG GAGAGGAACAUGGGCUCAGGACA hsa-miR-6860 ACUGGGCAGGGCUGUGGUGAGU UCACCACAGCCCUGCCCAGUUU hsa-miR-6861 ACUGGGUAGGUGGGGCUCCAGG UGGACCUCUCCUCCCCAG hsa-miR-6862 CCUCACCCAGCUCUCUGGCCCUCU CGGGCAUGCUGGGAGAGACUUU hsa-miR-6863 UAGACGUGGUGAAGGAUUGAGUG CUCAAUCCUUCACCACGUCUAUU hsa-miR-6864 UUGAAGGGACAAGUCAGAUAUGCC GUGAGACUUCUCUCCCUUCAG hsa-miR-6865 ACACCCUCUUUCCCUACCGCC UAGGUGGCAGAGGAGGGACUUCA hsa-miR-6866 GAUCCCUUUAUCUGUCCUCUAG UUAGAGGCUGGAAUAGAGAUUCU hsa-miR-6867 UGUGUGUGUAGAGGAAGAAGGGA CUCUCCCUCUUUACCCACUAG hsa-miR-6868 ACUGGCAGAACACUGAAGCAGC UUCCUUCUGUUGUCUGUGCAG hsa-miR-6869 GUGAGUAGUGGCGCGCGGCGGC CGCCGCGCGCAUCGGCUCAGC hsa-miR-6870 UGGGGGAGAUGGGGGUUGA GCUCAUCCCCAUCUCCUUUCAG hsa-miR-6871 CAUGGGAGUUCGGGGUGGUUGC CAGCACCCUGUGGCUCCCACAG hsa-miR-6872 CCCAUGCCUCCUGCCGCGGUC UCUCGCAUCAGGAGGCAAGG hsa-miR-6873 UUCUCUCUGUCUUUCUCUCUCAG CAGAGGGAAUACAGAGGGCAAU hsa-miR-6874 AUGGAGCUGGAACCAGAUCAGGC CAGUUCUGCUGUUCUGACUCUAG hsa-miR-6875 UGAGGGACCCAGGACAGGAGA AUUCUUCCUGCCCUGGCUCCAU hsa-miR-6876 AGCUGUCUGUGUUUUCCUUCUCAG CAGGAAGGAGACAGGCAGUUCA hsa-miR-6877 CAGCCUCUGCCCUUGGCCUCC AGGGCCGAAGGGUGGAAGCUGC hsa-miR-6878 CUGGCCUCUUCUUUCUCCUAG AGGGAGAAAGCUAGAAGCUGAAG hsa-miR-6879 UGUCACCCGCUCCUUGCCCAG CAGGGCAGGGAAGGUGGGAGAG hsa-miR-6880 UGGUGGAGGAAGAGGGCAGCUC CCGCCUUCUCUCCUCCCCCAG hsa-miR-6881 AUCCUCUUUCGUCCUUCCCACU UGGGGUAAGGAUAGGAGGGUCA hsa-miR-6882 UGCUGCCUCUCCUCUUGCCUGCAG UACAAGUCAGGAGCUGAAGCAG hsa-miR-6883 UUCCCUAUCUCACUCUCCUCAG AGGGAGGGUGUGGUAUGGAUGU hsa-miR-6884 CCCAUCACCUUUCCGUCUCCCCU AGAGGCUGAGAAGGUGAUGUUG hsa-miR-6885 AGGGGGGCACUGCGCAAGCAAAGCC CUUUGCUUCCUGCUCCCCUAG hsa-miR-6886 UGCCCUUCUCUCCUCCUGCCU CCCGCAGGUGAGAUGAGGGCU hsa-miR-6887 UCCCCUCCACUUUCCUCCUAG UGGGGGGACAGAUGGAGAGGACA hsa-miR-6888 AAGGAGAUGCUCAGGCAGAU AUCUGUCUCGAUUGUUUCCAG hsa-miR-6889 UCGGGGAGUCUGGGGUCCGGAAU UCUGUGCCCCUACUUCCCAG hsa-miR-6890 CCACUGCCUAUGCCCCACAG CAUGGGGUAGGGCAGAGUAGG hsa-miR-6891 CCCUCAUCUUCCCCUCCUUUC UAAGGAGGGGGAUGAGGGG hsa-miR-6892 GUAAGGGACCGGAGAGUAGGA UCCCUCUCCCACCCCUUGCAG hsa-miR-6893 CCCUGCUGCCUUCACCUGCCAG CAGGCAGGUGUAGGGUGGAGC hsa-miR-6894 UUGCCUGCCCUCUUCCUCCAG AGGAGGAUGGAGAGCUGGGCCAGA hsa-miR-6895 CAGGGCCAGGCACAGAGUAAG UGUCUCUCGCCCUUGGCCUUAG hsa-miR-7-1 UGGAAGACUAGUGAUUUUGUUGU CAACAAAUCACAGUCUGCCAUA hsa-miR-7-2 UGGAAGACUAGUGAUUUUGUUGU CAACAAAUCCCAGUCUACCUAA hsa-miR-708 CAACUAGACUGUGAGCUUCUAG AAGGAGCUUACAAUCUAGCUGGG hsa-miR-7106 UGGGAGGAGGGGAUCUUGGG AGCUCCCUGAAUCCCUGUCCCAG hsa-miR-7107 UCGGCCUGGGGAGGAGGAAGGG UGGUCUGUUCAUUCUCUCUUUUUGGCC hsa-miR-7108 GUGUGGCCGGCAGGCGGGUGG ACCCGCCCGUCUCCCCACAG hsa-miR-7109 CAAGCCUCUCCUGCCCUUCCAG CUGGGGGGAGGAGACCCUGCU hsa-miR-711 GGGACCCAGGGAGAGACGUAAG UACGUCUCUCCCUGGGUCCCUU hsa-miR-7110 UCUCUCUCCCACUUCCCUGCAG UGGGGGUGUGGGGAGAGAGAG hsa-miR-7111 AUCCUCUCUUCCCUCCUCCCAG UGGGGGAGGAAGGACAGGCCAU hsa-miR-7112 UGCAUCACAGCCUUUGGCCCUAG ACGGGCAGGGCAGUGCACCCUG hsa-miR-7113 UCCAGGGAGACAGUGUGUGAG CCUCCCUGCCCGCCUCUCUGCAG hsa-miR-7114 UGACCCACCCCUCUCCACCAG UCUGUGGAGUGGGGUGCCUGU hsa-miR-7150 CUGGCAGGGGGAGAGGUA CCUCUCCCCCUGCCAGUU hsa-miR-7151 GAUCCAUCUCUGCCUGUAUUGGC CUACAGGCUGGAAUGGGCUCA hsa-miR-7152 UCUGGUCCUGGACAGGAGGC UUUCCUGUCCUCCAACCAGACC hsa-miR-7153 CACCAUGGACGGUUUACC UGAGAACUGACAAAUGUGGUAGG hsa-miR-7154 UUCAUGAACUGGGUCUAGCUUGG AGGAGGACAAGUUGUGGGAU hsa-miR-7155 UGGCCCAAGACCUCAGACC UCUGGGGUCUUGGGCCAUC hsa-miR-7156 CUGCAGCCACUUGGGGAACUGGU UUGUUCUCAAACUGGCUGUCAGA hsa-miR-7157 UCUGUGCUACUGGAUGAAGAGU UCAGCAUUCAUUGGCACCAGAGA hsa-miR-7158 GGCUCAAUCUCUGGUCCUGCAGCC CUGAACUAGAGAUUGGGCCCA hsa-miR-7159 UUUCUAUGUUAGUUGGAAG UUCAACAAGGGUGUAGGAUGG hsa-miR-7160 CAGGGCCCUGGCUUUAGCAGA UGCUGAGGUCCGGGCUGUGCC hsa-miR-7161 UAAAGACUGUAGAGGCAACUGGU UAGAUCUUUGACUCUGGCAGUCUCCAGG hsa-miR-7162 UCUGAGGUGGAACAGCAGC UGCUUCCUUUCUCAGCUG hsa-miR-718 CUUCCGCCCCGCCGGGCGUCG ACGCCCGGCGGGGCGGAAGUU hsa-miR-744 UGCGGGGCUAGGGCUAACAGCA CUGUUGCCACUAACCUCAACCU hsa-miR-7515 AGAAGGGAAGAUGGUGAC CACCAUCUUCCCUUCUUU hsa-miR-758 UUUGUGACCUGGUCCACUAACC GAUGGUUGACCAGAGAGCACAC hsa-miR-759 GCAGAGUGCAAACAAUUUUGAC CAAAAUUGUUUGCACUCUGCUU hsa-miR-760 CGGCUCUGGGUCUGUGGGGA CCCACAGACCCAGAGCCGUU hsa-miR-761 GCAGCAGGGUGAAACUGACACA UGUCAGUUUCACCCUGCUGCUU hsa-miR-762 GGGGCUGGGGCCGGGGCCGAGC UCGGCCCCGGCCCCAGCCCCUU hsa-miR-764 GCAGGUGCUCACUUGUCCUCCU GAGGACAAGUGAGCACCUGCUU hsa-miR-7641 UUGAUCUCGGAAGCUAAGC UUAGCUUCCGAGAUCAAUU hsa-miR-765 UGGAGGAGAAGGAAGGUGAUG UCACCUUCCUUCUCCUCCAUU hsa-miR-766 AGGAGGAAUUGGUGCUGGUCUU ACUCCAGCCCCACAGCCUCAGC hsa-miR-767 UGCACCAUGGUUGUCUGAGCAUG UCUGCUCAUACCCCAUGGUUUCU hsa-miR-769 CUGGGAUCUCCGGGGUCUUGGUU UGAGACCUCUGGGUUCUGAGCU hsa-miR-770 UCCAGUACCACGUGUCAGGGCCA GCCCUGACACGUGGUACUGGAUU hsa-miR-7702 CUUAGACUGCCAGACUCCCUGA AGGGAGUCUGGCAGUCUAAGUU hsa-miR-7703 UUGCACUCUGGCCUUCUCCCAGG UGGGAGAAGGCCAGAGUGCAAUU hsa-miR-7704 CGGGGUCGGCGGCGACGUG CGUCGCCGCCGACCCCGUU hsa-miR-7705 AAUAGCUCAGAAUGUCAGUUCUG GAACUGACAUUCUGAGCUAUUUU hsa-miR-7706 UGAAGCGCCUGUGCUCUGCCGAGA UCGGCAGAGCACAGGCGCUUCAUU hsa-miR-7843 AUGAAGCCUUCUCUGCCUUACG GAGGGCAGAGCCAGCUUCCUGA hsa-miR-7844 AAAACUAGGACUGUGUGGUGUA CACCACACAGUCCUAGUUUUUU hsa-miR-7845 AAGGGACAGGGAGGGUCGUGG ACGACCCUCCCUGUCCCUUUU hsa-miR-7846 CAGCGGAGCCUGGAGAGAAGG UUCUCUCCAGGCUCCGCUGUU hsa-miR-7847 CGUGGAGGACGAGGAGGAGGC CUCCUCCUCGUCCUCCACGUU hsa-miR-7848 CUACCCUCGGUCUGCUUACCACA UGGUAAGCAGACCGAGGGUAGUU hsa-miR-7849 GACAAUUGUUGAUCUUGGGCCU GCCCAAGAUCAACAAUUGUCUU hsa-miR-7850 GUUUGGACAUAGUGUGGCUGG AGCCACACUAUGUCCAAACUU hsa-miR-7851 UACCUGGGAGACUGAGGUUGGA CAACCUCAGUCUCCCAGGUAUU hsa-miR-7852 UAUGUAGUAGUCAAAGGCAUUU AUGCCUUUGACUACUACAUAUU hsa-miR-7853 UCAAAUGCAGAUCCUGACUUC AGUCAGGAUCUGCAUUUGAUU hsa-miR-7854 UGAGGUGACCGCAGAUGGGAA CCCAUCUGCGGUCACCUCAUU hsa-miR-7855 UUGGUGAGGACCCCAAGCUCGG GAGCUUGGGGUCCUCACCAAUU hsa-miR-7856 UUUUAAGGACACUGAGGGAUC UCCCUCAGUGUCCUUAAAAUU hsa-miR-7973 UGUGACCCUAGAAUAAUUAC AAUUAUUCUAGGGUCACAUU hsa-miR-7974 AGGCUGUGAUGCUCUCCUGAGCCC GCUCAGGAGAGCAUCACAGCCUUU hsa-miR-7975 AUCCUAGUCACGGCACCA GUGCCGUGACUAGGAUUU hsa-miR-7976 UGCCCUGAGACUUUUGCUC GCAAAAGUCUCAGGGCAUU hsa-miR-7977 UUCCCAGCCAACGCACCA GUGCGUUGGCUGGGAAUU hsa-miR-7978 UCUGGUGUAUAGCGUUGCUCA AGCAACGCUAUACACCAGAUU hsa-miR-802 CAGUAACAAAGAUUCAUCCUUGU AAGGAUGAAUCUUUGUUACUGUU hsa-miR-8052 CGGGACUGUAGAGGGCAUGAGC UCAUGCCCUCUACAGUCCCGUU hsa-miR-8053 UGGCGAUUUUGGAACUCAAUGGCA CCAUUGAGUUCCAAAAUCGCCAUU hsa-miR-8054 GAAAGUACAGAUCGGAUGGGU CCAUCCGAUCUGUACUUUCUU hsa-miR-8055 CUUUGAGCACAUGAGCAGACGGA CGUCUGCUCAUGUGCUCAAAGUU hsa-miR-8056 CGUGGAUUGUCUGGAUGCAU GCAUCCAGACAAUCCACGUU hsa-miR-8057 GUGGCUCUGUAGUAAGAUGGA CAUCUUACUACAGAGCCACUU hsa-miR-8058 CUGGACUUUGAUCUUGCCAUAA AUGGCAAGAUCAAAGUCCAGUU hsa-miR-8059 GGGGAACUGUAGAUGAAAAGGC CUUUUCAUCUACAGUUCCCCUU hsa-miR-8060 CCAUGAAGCAGUGGGUAGGAGGAC CCUCCUACCCACUGCUUCAUGGUU hsa-miR-8061 CUUAGAUUAGAGGAUAUUGUU CAAUAUCCUCUAAUCUAAGUU hsa-miR-8062 CAGUGAUUUGAGGAUUAUUGC AAUAAUCCUCAAAUCACUGUU hsa-miR-8063 UCAAAAUCAGGAGUCGGGGCUU GCCCCGACUCCUGAUUUUGAUU hsa-miR-8064 AGCACACUGAGCGAGCGGAC CCGCUCGCUCAGUGUGCUUU hsa-miR-8065 UGUAGGAACAGUUGAAUUUUGGCU CCAAAAUUCAACUGUUCCUACAUU hsa-miR-8066 CAAUGUGAUCUUUUGGAUGUA CAUCCAAAAGAUCACAUUGUU hsa-miR-8067 CCUAGAAACUGUAAACUUAGUC CUAAGUUUACAGUUUCUAGGUU hsa-miR-8068 UGUUUGUUGUAAGGAUCGUUGU AACGAUCCUUACAACAAACAUU hsa-miR-8069 GGAUGGUUGGGGGCGGUCGGCGU GCCGACCGCCCCCAACCAUCCUU hsa-miR-8070 AUGUGAUUGACGGCUGACUCCA GAGUCAGCCGUCAAUCACAUUU hsa-miR-8071 CGGUGGACUGGAGUGGGUGG ACCCACUCCAGUCCACCGUU hsa-miR-8072 GGCGGCGGGGAGGUAGGCAG GCCUACCUCCCCGCCGCCUU hsa-miR-8073 ACCUGGCAGCAGGGAGCGUCGU GACGCUCCCUGCUGCCAGGUUU hsa-miR-8074 CUAUGGCGAGACUGGCAUGUACUC GUACAUGCCAGUCUCGCCAUAGUU hsa-miR-8075 UGCUGAUGGCAGAUGUCGGGUCUG GACCCGACAUCUGCCAUCAGCAUU hsa-miR-8076 UAUAUGGACUUUUCUGAUACAAUG UUGUAUCAGAAAAGUCCAUAUAUU hsa-miR-8077 GGCUGAGUGGGGUUCUGACUCC AGUCAGAACCCCACUCAGCCUU hsa-miR-8078 GGUCUAGGCCCGGUGAGAGACUC GUCUCUCACCGGGCCUAGACCUU hsa-miR-8079 CAGUGAUCGUCUCUGCUGGC CAGCAGAGACGAUCACUGUU hsa-miR-8080 GAAGGACACUGGUGUCAACGGCU CCGUUGACACCAGUGUCCUUCUU hsa-miR-8081 CUUGAGUCGUGCCUUUCUGAAUG UUCAGAAAGGCACGACUCAAGUU hsa-miR-8082 UGAUGGAGCUGGGAAUACUCUG GAGUAUUCCCAGCUCCAUCAUU hsa-miR-8083 CAGGACUUGACGGCUGCAACU UUGCAGCCGUCAAGUCCUGUU hsa-miR-8084 GAAUACUAAGUAAAAAAUCAGUA CUGAUUUUUUACUUAGUAUUCUU hsa-miR-8085 UGGGAGAGAGGACUGUGAGGC CUCACAGUCCUCUCUCCCAUU hsa-miR-8086 UGCUAGUCUGGACUGAUAUGGU CAUAUCAGUCCAGACUAGCAUU hsa-miR-8087 GAAGACUUCUUGGAUUACAGGGG CCUGUAAUCCAAGAAGUCUUCUU hsa-miR-8088 CCUCGGUACUGGAAAGGGGUA CCCCUUUCCAGUACCGAGGUU hsa-miR-8089 CCUGGGGACAGGGGAUUGGGGCAG GCCCCAAUCCCCUGUCCCCAGGUU hsa-miR-8485 CACACACACACACACACGUAU ACGUGUGUGUGUGUGUGUGUU hsa-miR-873 GCAGGAACUUGUGAGUCUCCU GGAGACUGAUGAGUUCCCGGGA hsa-miR-874 CGGCCCCACGCACCAGGGUAAGA CUGCCCUGGCCCGAGGGACCGA hsa-miR-875 UAUACCUCAGUUUUAUCAGGUG CCUGGAAACACUGAGGUUGUG hsa-miR-876 UGGAUUUCUUUGUGAAUCACCA UGGUGGUUUACAAAGUAAUUCA hsa-miR-877 UCCUCUUCUCCCUCCUCCCAG GUAGAGGAGAUGGCGCAGGG hsa-miR-885 UCCAUUACACUACCCUGCCUCU AGGCAGCGGGGUGUAGUGGAUA hsa-miR-887 CUUGGGAGCCCUGUUAGACUC GUGAACGGGCGCCAUCCCGAGG hsa-miR-888 UACUCAAAAAGCUGUCAGUCA GACUGACACCUCUUUGGGUGAA hsa-miR-889 AAUGGCUGUCCGUAGUAUGGUC UUAAUAUCGGACAACCAUUGU hsa-miR-890 UACUUGGAAAGGCAUCAGUUG ACUGAUGCCUUUCCAAGUAUU hsa-miR-891a AGUGGCACAUGUUUGUUGUGAG UGCAACGAACCUGAGCCACUGA hsa-miR-891b UGCAACUUACCUGAGUCAUUGA AAUGACUCAGGUAAGUUGCAUU hsa-miR-892a CACUGUGUCCUUUCUGCGUAG ACGCAGAAAGGACACAGUGUU hsa-miR-892b CACUGGCUCCUUUCUGGGUAGA UACCCAGAAAGGAGCCAGUGUU hsa-miR-892c CACUGUUUCCUUUCUGAGUGGA UAUUCAGAAAGGUGCCAGUCA hsa-miR-9 UCUUUGGUUAUCUAGCUGUAUGA AUAAAGCUAGAUAACCGAAAGU hsa-miR-920 GGGGAGCUGUGGAAGCAGUA CUGCUUCCACAGCUCCCCUU hsa-miR-921 CUAGUGAGGGACAGAACCAGGAUUC AUCCUGGUUCUGUCCCUCACUAGUU hsa-miR-922 GCAGCAGAGAAUAGGACUACGUC CGUAGUCCUAUUCUCUGCUGCUU hsa-miR-924 AGAGUCUUGUGAUGUCUUGC AAGACAUCACAAGACUCUUU hsa-miR-92a-1 UAUUGCACUUGUCCCGGCCUGU AGGUUGGGAUCGGUUGCAAUGCU hsa-miR-92a-2 UAUUGCACUUGUCCCGGCCUGU GGGUGGGGAUUUGUUGCAUUAC hsa-miR-92b UAUUGCACUCGUCCCGGCCUCC AGGGACGGGACGCGGUGCAGUG hsa-miR-93 ACUGCUGAGCUAGCACUUCCCG CAAAGUGCUGUUCGUGCAGGUAG hsa-miR-933 UGUGCGCAGGGAGACCUCUCCC GAGAGGUCUCCCUGCGCACAUU hsa-miR-934 UGUCUACUACUGGAGACACUGG AGUGUCUCCAGUAGUAGACAUU hsa-miR-935 CCAGUUACCGCUUCCGCUACCGC GGUAGCGGAAGCGGUAACUGGUU hsa-miR-936 ACAGUAGAGGGAGGAAUCGCAG GCGAUUCCUCCCUCUACUGUUU hsa-miR-937 AUCCGCGCUCUGACUCUCUGCC GUGAGUCAGGGUGGGGCUGG hsa-miR-938 UGCCCUUAAAGGUGAACCCAGU UGGGUUCACCUUUAAGGGCAUU hsa-miR-939 CCCUGGGCCUCUGCUCCCCAG UGGGGAGCUGAGGCUCUGGGGGUG hsa-miR-940 AAGGCAGGGCCCCCGCUCCCC GGAGCGGGGGCCCUGCCUUUU hsa-miR-941 CACCCGGCUGUGUGCACAUGUGC ACAUGUGCACACAGCCGGGUGUU hsa-miR-942 UCUUCUCUGUUUUGGCCAUGUG CACAUGGCCGAAACAGAGAAGU hsa-miR-943 CUGACUGUUGCCGUCCUCCAG GGAGGACGGCAACAGUCAGUU hsa-miR-944 AAAUUAUUGUACAUCGGAUGAG CAUCCGAUGUACAAUAAUUUUU hsa-miR-95 UCAAUAAAUGUCUGUUGAAUU UUCAACGGGUAUUUAUUGAGCA hsa-miR-9500 AAGGGAAGAUGGUGACCAC GGUCACCAUCUUCCCUUUU hsa-miR-96 UUUGGCACUAGCACAUUUUUGCU AAUCAUGUGCAGUGCCAAUAUG hsa-miR-98 CUAUACAACUUACUACUUUCCC UGAGGUAGUAAGUUGUAUUGUU hsa-miR-99a CAAGCUCGCUUCUAUGGGUCUG AACCCGUAGAUCCGAUCUUGUG hsa-miR-99b CACCCGUAGAACCGACCUUGCG CAAGCUCGUGUCUGUGGGUCCG

Example 2: Measurement of Activity of miRNA Library Sample

In order to determine whether the double-stranded miRNAs synthesized in Example 1 would be active, miR-34a, miR-100 and miR-125b were selected from the consisting of about 1700 kinds of miRNAs. The selected miRNAs were selected because there are many studies on target mRNAs whose functions and expressions are to be controlled and on regions binding to mRNA 3′UTR. The 3′ UTR region of each of Bcl2, mTOR and Lin28b mRNA, expressions of which are known to be controlled by each of miR-34a, miR-100 and miR-125b, was substituted into the 3′ UTR of a firefly luciferase vector, thereby constructing a vector corresponding to each of the miRNAs. Each vector and an miR control, or miR-34a, miR-100 or miR-125b corresponding to each vector, were co-transfected into HEK-293T cells by use of Lipofectamine 2000 (Lipofectamine 2000, Invitrogen) which is an intracellular oligo delivery reagent (preparation of triplicate samples), and the cells were cultured under the conditions of 37° C. and 5% (v/v) CO₂ for 24 hours. Luciferase activity was measured by a luminometer (Thermo scientific) to determine the activities of the synthesized miRNAs (FIG. 1).

Example 3: Screening for Identification of microRNAs that Inhibit Proliferation of Lung Cancer Cells

3,000˜40,000 NCI-H460 cells were dispensed in each well of 96-well plates and cultured under the conditions of 37° C. and 5% (v/v) CO₂ for 24 hours, and then each of the miRNAs selected from the miRNA library was transfected into the cells to a final concentration of 100 nM by use of RNAiMAX reagent (Invitrogen). Since each miRNA was transfected three times, three 96-well plates were prepared per each miRNA. The cells were further cultured under the same conditions as described above for 24 hours, and then the fluorescence value generated by addition of Resazurin reagent (Promega) was measured using a fluorometer (Tecan). To comparatively evaluate the cell growth inhibitory abilities of the miRNAs, the mean value and standard deviation of the 96 values measured for the 96-well plate were calculated, and the standard deviation multiple (Z-score) of the value measured for each well (containing each miRNA) from the mean value was calculated using the following equation:

$z_{i} = \frac{x_{i} - \mu}{\sigma}$

wherein x_(i) is the value measured in each well, μ is the mean value of the values measured for all the wells of the plate, and σ is standard deviation. The standard deviation multiple z_(i) of each well was the mean value of the values obtained for the triplicate plates, and about first candidate miRNAs showing a z_(i) value smaller than −2 were selected (FIG. 2 and Table 2).

TABLE 2 First Selected miRNA Sequences SEQ ID NO: 1 hsa-miR-23c Strand 1 AUCACAUUGCCAGUGAUUACCC SEQ ID NO: 2 hsa-miR-23c Strand 2 GUAAUCACUGGCAAUGUGAUUU SEQ ID NO: 3 hsa-miR-219b Strand 1 AGAUGUCCAGCCACAAUUCUCG SEQ ID NO: 4 hsa-miR-219b Strand 2 AGAAUUGCGUUUGGACAAUCAGU SEQ ID NO: 5 hsa-miR-378c Strand 1 ACUGGACUUGGAGUCAGAAGAGUGG SEQ ID NO: 6 hsa-miR-378c Strand 2 ACUCUUCUGACUCCAAGUCCAGUUU SEQ ID NO: 7 hsa-miR-548aa Strand 1 AAAAACCACAAUUACUUUUGCACCA SEQ ID NO: 8 hsa-miR-548aa Strand 2 GUGCAAAAGUAAUUGUGGUUUUUUU SEQ ID NO: 9 hsa-miR-548u Strand 1 CAAAGACUGCAAUUACUUUUGCG SEQ ID NO: 10 hsa-miR-548u Strand 2 CAAAAGUAAUUGCAGUCUUUGUU SEQ ID NO: 11 hsa-miR-571 Strand 1 UGAGUUGGCCAUCUGAGUGAG SEQ ID NO: 12 hsa-miR-571 Strand 2 CACUCAGAUGGCCAACUCAUU SEQ ID NO: 13 hsa-miR-641 Strand 1 AAAGACAUAGGAUAGAGUCACCUC SEQ ID NO: 14 hsa-miR-641 Strand 2 GGUGACUCUAUCCUAUGUCUUUUU SEQ ID NO: 15 hsa-miR-1244 Strand 1 AAGUAGUUGGUUUGUAUGAGAUGGUU SEQ ID NO: 16 hsa-miR-1244 Strand 2 CCAUCUCAUACAAACCAACUACUUUU SEQ ID NO: 17 hsa-miR-1248 Strand 1 ACCUUCUUGUAUAAGCACUGUGCUAAA SEQ ID NO: 18 hsa-miR-1248 Strand 2 UAGCACAGUGCUUAUACAAGAAGGUUU SEQ ID NO: 19 hsa-miR-1298 Strand 1 CAUCUGGGCAACUGACUGAAC SEQ ID NO: 20 hsa-miR-1298 Strand 2 UUCAUUCGGCUGUCCAGAUGUA SEQ ID NO: 21 hsa-miR-2392 Strand 1 UAGGAUGGGGGUGAGAGGUG SEQ ID NO: 22 hsa-miR-2392 Strand 2 CCUCUCACCCCCAUCCUAUU SEQ ID NO: 23 hsa-miR-3119 Strand 1 UGGCUUUUAACUUUGAUGGC SEQ ID NO: 24 hsa-miR-3119 Strand 2 CAUCAAAGUUAAAAGCCAUU SEQ ID NO: 25 hsa-miR-3164 Strand 1 UGUGACUUUAAGGGAAAUGGCG SEQ ID NO: 26 hsa-miR-3164 Strand 2 CCAUUUCCCUUAAAGUCACAUU SEQ ID NO: 27 hsa-miR-3188 Strand 1 AGAGGCUUUGUGCGGAUACGGGG SEQ ID NO: 28 hsa-miR-3188 Strand 2 CCGUAUCCGCACAAAGCCUCUUU SEQ ID NO: 29 hsa-miR-3609 Strand 1 CAAAGUGAUGAGUAAUACUGGCUG SEQ ID NO: 30 hsa-miR-3609 Strand 2 GCCAGUAUUACUCAUCACUUUGUU SEQ ID NO: 31 hsa-miR-3612 Strand 1 AGGAGGCAUCUUGAGAAAUGGA SEQ ID NO: 32 hsa-miR-3612 Strand 2 CAUUUCUCAAGAUGCCUCCUUU SEQ ID NO: 33 hsa-miR-3662 Strand 1 GAAAAUGAUGAGUAGUGACUGAUG SEQ ID NO: 34 hsa-miR-3662 Strand 2 UCAGUCACUACUCAUCAUUUUCUU SEQ ID NO: 35 hsa-miR-3670 Strand 1 AGAGCUCACAGCUGUCCUUCUCUA SEQ ID NO: 36 hsa-miR-3670 Strand 2 GAGAAGGACAGCUGUGAGCUCUUU SEQ ID NO: 37 hsa-miR-3943 Strand 1 UAGCCCCCAGGCUUCACUUGGCG SEQ ID NO: 38 hsa-miR-3943 Strand 2 CCAAGUGAAGCCUGGGGGCUAUU SEQ ID NO: 39 hsa-miR-4424 Strand 1 AGAGUUAACUCAAAAUGGACUA SEQ ID NO: 40 hsa-miR-4424 Strand 2 GUCCAUUUUGAGUUAACUCUUU SEQ ID NO: 41 hsa-miR-4461 Strand 1 GAUUGAGACUAGUAGGGCUAGGC SEQ ID NO: 42 hsa-miR-4461 Strand 2 CUAGCCCUACUAGUCUCAAUCUU SEQ ID NO: 43 hsa-miR-4477a Strand 1 CUAUUAAGGACAUUUGUGAUUC SEQ ID NO: 44 hsa-miR-4477a Strand 2 AUCACAAAUGUCCUUAAUAGUU SEQ ID NO: 45 hsa-miR-4477b Strand 1 AUUAAGGACAUUUGUGAUUGAU SEQ ID NO: 46 hsa-miR-4477b Strand 2 CAAUCACAAAUGUCCUUAAUUU SEQ ID NO: 47 hsa-miR-4765 Strand 1 UGAGUGAUUGAUAGCUAUGUUC SEQ ID NO: 48 hsa-miR-4765 Strand 2 ACAUAGCUAUCAAUCACUCAUU SEQ ID NO: 49 hsa-miR-4773 Strand 1 CAGAACAGGAGCAUAGAAAGGC SEQ ID NO: 50 hsa-miR-4773 Strand 2 CUUUCUAUGCUCCUGUUCUGUU SEQ ID NO: 51 hsa-miR-4776 Strand 1 GUGGACCAGGAUGGCAAGGGCU SEQ ID NO: 52 hsa-miR-4776 Strand 2 CUUGCCAUCCUGGUCCACUGCAU SEQ ID NO: 53 hsa-miR-4999 Strand 1 UGCUGUAUUGUCAGGUAGUGA SEQ ID NO: 54 hsa-miR-4999 Strand 2 UCACUACCUGACAAUACAGU SEQ ID NO: 55 hsa-miR-5096 Strand 1 GUUUCACCAUGUUGGUCAGGC SEQ ID NO: 56 hsa-miR-5096 Strand 2 CUGACCAACAUGGUGAAACUU SEQ ID NO: 57 hsa-miR-5697 Strand 1 UCAAGUAGUUUCAUGAUAAAGG SEQ ID NO: 58 hsa-miR-5697 Strand 2 UUUAUCAUGAAACUACUUGAUU SEQ ID NO: 59 hsa-miR-5705 Strand 1 UGUUUCGGGGCUCAUGGCCUGUG SEQ ID NO: 60 hsa-miR-5705 Strand 2 CAGGCCAUGAGCCCCGAAACAUU SEQ ID NO: 61 hsa-miR-5707 Strand 1 ACGUUUGAAUGCUGUACAAGGC SEQ ID NO: 62 hsa-miR-5707 Strand 2 CUUGUACAGCAUUCAAACGUUU SEQ ID NO: 63 hsa-miR-8053 Strand 1 UGGCGAUUUUGGAACUCAAUGGCA SEQ ID NO: 64 hsa-miR-8053 Strand 2 CCAUUGAGUUCCAAAAUCGCCAUU SEQ ID NO: 65 hsa-miR-8078 Strand 1 GGUCUAGGCCCGGUGAGAGACUC SEQ ID NO: 66 hsa-miR-8078 Strand 2 GUCUCUCACCGGGCCUAGACCUU

Example 4: Second Screening for Identification of miRNAs that Inhibit Proliferation of Lung Cancer Cells

Using about 50 miRNA candidates obtained in first screening, second screening was performed with increased measurement precision. The experiment was performed under the same conditions as first screening, except that WST-1 reagent (Roche) was used instead of the Resazurin reagent to measure the proliferation potential of the cells. WST-1 has an advantage over Resazurin in that the intensity of signals can be more quantitatively measured. The values obtained by measuring the cell proliferation inhibitory ability of each miRNA were expressed as values relative to the control, and the results are shown in FIG. 3. As a positive control, miR-34a was used.

Example 5: Analysis of the Ability to Induce Cell Apoptosis

The method used in screening is a method of measuring the relative inhibition of cell proliferation by quantitatively measuring the number of cells. Mechanisms by which cell proliferation is inhibited include a method of reducing cell division rate, and a method of inducing apoptosis. In order to analyze the mechanism by which the miRNAs found in the present invention inhibit cell proliferation, the degree of apoptosis was analyzed using the Fluorescence Activated Cell Sorter (FACS). Specifically, cells were dispensed in 6-well plates, and the miRNA was transfected into the cells by use of RNAiMAX reagent, and then the cells were cultured under the same conditions as described above for 48 hours. Next, the cells treated with FITC-labeled Annexin V and analyzed using the Fluorescence Activated Cell Sorter (FACS) (FIG. 4). The results of the analysis indicated that the cells treated with each of miR-3670, miR-4477a and miR-8078 were mostly dead. This suggests that the tumor cell growth inhibitory effect of the miRNA identified in screening resulted from induction of apoptosis (Table 3).

TABLE 3 Finally Selected miRNA Sequences SEQ ID NO: 35 hsa-miR-3670 Strand 1 AGAGCUCACAGCUGUCCUUCUCUA SEQ ID NO: 36 hsa-miR-3670 Strand 2 GAGAAGGACAGCUGUGAGCUCUUU SEQ ID NO: 67 miR-3670-IC IC GACUGGUAUAGCUGCUUUUGGAGCCUCA SEQ ID NO: 43 hsa-miR-4477a Strand 1 CUAUUAAGGACAUUUGUGAUUC SEQ ID NO: 44 hsa-miR-4477a Strand 2 AUCACAAAUGUCCUUAAUAGUU SEQ ID NO: 68 miR-4477a-IC IC AUCACAAAUGUCCUUAAUGGCA SEQ ID NO: 65 hsa-miR-8078 Strand 1 GGUCUAGGCCCGGUGAGAGACUC SEQ ID NO: 66 hsa-miR-8078 Strand 2 GUCUCUCACCGGGCCUAGACCUU SEQ ID NO: 69 miR-8078-IC IC CUCCACCGGGCUGACCGGCCUG

Example 6: Inhibition of Tumor Cell Growth on Soft Agar by miRNAs

When tumor cells were cultured using soft agar, the characteristic of tumor cells can be measured. Normal cells require a support such as a culture dish for growth, whereas tumor cells are characterized by growing even in an environment such as soft agar, which is free of a physically strong support. Using this tumor-specific characteristic, cell colony-forming ability on soft agar was examined NCI-H460 lung cancer cells were treated with each of control miRNA, miR-34a, miR-8078, miR-3670, miR-4477a and miR-4765, and cultured for 24 hours. Next, the cells were mixed with soft agar and cultured in 6-well plates for 2 weeks. The cells were stained with crystal violet, and the number of colonies in each group was measured (FIG. 5). As a result, it could be seen that the cells treated with miR-8078 or miR-3670 formed little or no colonies, and the cells treated with miR-4477a showed colony-forming ability equal to about 30% of that of the control group.

Example 7: Measurement of Cell Proliferation Inhibitory Effects of miRNAs Upon Knock-Down of Target mRNA

Target mRNA whose expression is controlled by miRNA has a sequence complementary to a portion of the miRNA sequence. The seed region sequence of the miRNA is particularly important in inhibition of mRNA, because the seed region sequence binds to mRNA having a sequence complementary thereto to inhibit gene expression. However, since the seed region sequence is relatively short (8-9 nucleotides), mRNAs to be targeted by miRNA are predicted using software. However, it is known that, even when software is used, only some of predicted targets are substantial targets. In order to overcome this disadvantage, the intracellular contents of target genes predicted through software were reduced using siRNA, and then whether or not the growth of the cells would be inhibited was determined, thereby selecting target genes. To predict target mRNAs to be targeted by miRNA, TargetScan that is generally used in the art was used as target prediction software, and about 600 kinds of genes predicted to be targeted by miR-3670, miR-4477a or miR-8078 were selected. For each of the selected genes, 3 kinds of siRNAs were synthesized, and using the synthesized siRNAs, the experiment was performed in the same manner as described in Example 3. Specifically, cells were dispensed in 96-well plates, treated with each siRNA, and then cultured for 48 hours, after which the ability of the cell to proliferate was measured using Resazurin. In the same manner as described in Example 3, the Z-score of each gene was calculated from the mean of the values measured for a total of 1800 samples (about 600 genes×three different siRNAs). The results are shown in FIG. 6.

Example 8: Analysis of mRNA Targeted by miRNA

miRNA acts to inhibit protein from being produced from mRNA and to induce degradation of most mRNAs targeted thereby. Thus, miRNA is transfected into cells, and the intracellular content of mRNA to be targeted by miRNA is analyzed by qPCR to determine whether or not the content would be reduced, thereby determining whether or not the miRNA would target the mRNA. In order to determine whether or not the intracellular contents of the target genes found in Example 7 would be substantially reduced when miRNA was delivered into cells, each of miR-3670, miR-4477a and miR-8078 was transfected into lung cancer cells which were then cultured for 48 hours, after which RNA was extracted from each cell, and the content of RNA in the cells was quantitatively measured (FIG. 7). As a result, it could be seen that the content of mRNA predicted to be targeted by each of miR-3670, miR-4477a and miR-8078 was significantly reduced.

Example 9: Examination of Target mRNA by Luciferase Assay

miRNA binds to the 3′ UTR (untranslated region) of target mRNA to inhibit protein from being produced from the target mRNA. For this reason, a luciferase assay method is generally used to directly measures the relationship between miRNA and target mRNA. Under TargetScan software, a 3′ UTR sequence containing a miRNA-binding sequence was provided. As described in Example 2 above, the 3′ UTR sequence was cloned into the 3′ UTR of firefly luciferase to construct a vector. The constructed vector and miRNA were co-transfected into human embryonic kidney (HEK) cells, and the luciferase expression level of the vector was measured. To correct transfection efficiency, renilla luciferase was also transfected. After co-transfection of miRNA, firefly luciferase and renilla luciferase, the cells were cultured for 48 hours, and the luciferase activity of the cells was measured by a luminometer (FIG. 9). As a result, it could be seen that the target mRNA was controlled directly by the corresponding miRNA.

INDUSTRIAL APPLICABILITY

As described above, the pharmaceutical composition for treatment of cancer according to the present invention contains, as an active ingredient, one or more miRNAs selected from the group consisting of miR-3670, miR-4477a, and miR-8078. The pharmaceutical composition of the present invention exhibits improved anticancer effects compared to miR-34a, which is currently under clinical trials to determine suitability as an anticancer agent, and other pharmaceutical compositions for treatment of cancer, which contain other miRNAs as active ingredients. Thus, the pharmaceutical composition of the present invention can be widely used as an anticancer composition.

Although the present invention has been described in detail with reference to the specific features, it will be apparent to those skilled in the art that this description is only for a preferred embodiment and does not limit the scope of the present invention. Thus, the substantial scope of the present invention will be defined by the appended claims and equivalents thereof. 

1. A method for treating cancer comprising a step of administering a pharmaceutical composition comprising one or more miRNAs selected from the group consisting of miR-3670, miR-8078, and miR-4477a, as an active ingredient, to the patient/subject in need of cancer treatment.
 2. The method of claim 1, wherein the miR-3670 comprises a double-stranded RNA represented by the nucleotide sequences of SEQ ID NO: 35 and SEQ ID NO: 36; or SEQ ID NO: 35 and SEQ ID NO: 67, as an active ingredient.
 3. The method of claim 1, wherein the miR-4477a comprises a double-stranded RNA represented by the nucleotide sequences of SEQ ID NO: 43 and SEQ ID NO: 44; or SEQ ID NO: 43 and SEQ ID NO: 68, as an active ingredient.
 4. The method of claim 1, wherein the miR-8078 comprises a double-stranded RNA represented by the nucleotide sequences of SEQ ID NO: 65 and SEQ ID NO: 66; or SEQ ID NO: 65 and SEQ ID NO: 69, as an active ingredient.
 5. The method of claim 1, wherein the miRNA induces cancer cell apoptosis to treat said cancer.
 6. The method of claim 1, wherein the cancer is one or more cancers selected from the group consisting of: a primary cancer such as lung cancer, liver cancer, stomach cancer, colorectal cancer, pancreatic cancer, gallbladder and bile duct cancer, breast cancer, leukemia, esophageal cancer, non-Hodgkin lymphoma, thyroid cancer, cervical cancer, or skin cancer; a metastatic carcinoma arising from metastasis to other organs from the primary cancer site of origin; and a neoplastic cell disease caused by the promotion of abnormally excessive cell division.
 7. The method of claim 1, wherein the miRNA is a miRNA mimic.
 8. The method of claim 7, wherein the miRNA mimic is selected from the group consisting of: one partially including a phosphorothioate structure in which a RNA phosphate backbone structure is substituted with another element such as sulfur; one in which RNA is wholly or partially substituted with DNA, PNA (peptide nucleic acid) or LNA (locked nucleic acid) molecule; and one in which 2′ hydroxyl group of RNA sugar is substituted with various functional structures such as methylation, methoxylation or fluorination.
 9. The method of claim 7, the miRNA mimic consists of a miRNA precursor in the form of pri-miRNA or precursor miRNA; or a miRNA precursor in the form of plasmid.
 10. The method of claim 9, wherein the miRNA precursor is selected from the group consisting of: one partially comprising a phosphorothioate structure in which a RNA phosphate backbone structure is substituted with another element such as sulfur; one in which RNA is wholly or partially substituted with DNA, PNA (peptide nucleic acid) or LNA (locked nucleic acid) molecule; and one in which 2′ hydroxyl group of RNA sugar is substituted with various functional structures such as methylation, methoxylation or fluorination. 